Hyperchloremia    B-Perturbation107428450
is    O
an    O
electrolyte    O
disturbance    O
in    O
which    O
there    O
is    O
an    O
abnormally    O
elevated    O
level    O
of    O
the    O
chloride    O
ion    O
in    O
the    O
blood    O
.    O

Mukamel    B-Perturbation107428450
syndrome    I-Perturbation107428450

Mutations    O
in    O
this    O
gene    O
result    O
in    O
Leber's    B-Perturbation107428450
congenital    I-Perturbation107428450
amaurosis    I-Perturbation107428450
and    O
cone    O
-    O
rod    O
dystrophy-6    O
diseases    O
.    O

A    O
lack    O
of    O
RPE65    O
function    O
results    O
in    O
congenital    O
blindness    O
in    O
children    O
(    O
specifically    O
Leber    B-Perturbation107428450
congenital    I-Perturbation107428450
amaurosis    I-Perturbation107428450
)    O
.    O

Leber's    B-Perturbation107428450
congenital    I-Perturbation107428450
amaurosis    I-Perturbation107428450
(    O
LCA    B-Perturbation107428450
)    O
is    O
a    O
rare    O
inherited    O
eye    O
disease    O
that    O
appears    O
at    O
birth    O
or    O
in    O
the    O
first    O
few    O
months    O
of    O
life    O
.    O

(    O
H53.0    O
)    O
Leber's    B-Perturbation107428450
congenital    I-Perturbation107428450
amaurosis    I-Perturbation107428450
—    O
genetic    O
disorder    O
;    O
appears    O
at    O
birth    O
,    O
characterised    O
by    O
sluggish    O
or    O
no    O
pupillary    O
responses    O

One    O
of    O
Pernice    O
's    O
daughters    O
has    O
Leber's    B-Perturbation107428450
congenital    I-Perturbation107428450
amaurosis    I-Perturbation107428450
,    O
where    O
her    O
corneas    O
did    O
not    O
fully    O
develop    O
.    O

Leber's    B-Perturbation107428450
Congenital    I-Perturbation107428450
Amaurosis    I-Perturbation107428450

ABCD    B-Perturbation107428450
syndrome    I-Perturbation107428450
,    O
a    O
genetic    O
disorder    O

Reticulate    B-Perturbation107428450
acropigmentation    I-Perturbation107428450
of    I-Perturbation107428450
Kitamura    I-Perturbation107428450
consists    O
of    O
linear    O
palmar    O
pits    O
and    O
pigmented    O
macules    O
1    O
to    O
4    O
mm    O
in    O
diameter    O
on    O
the    O
volar    O
and    O
dorsal    O
aspects    O
of    O
the    O
hands    O
and    O
feet    O
,    O
usually    O
inherited    O
in    O
an    O
autosomal    O
-    O
dominant    O
fashion    O
.    O

People    O
with    O
palinopsia    O
frequently    O
report    O
other    O
visual    O
illusions    O
and    O
hallucinations    O
such    O
as    O
photopsias    O
,    O
dysmetropsia    O
i.e.    O
Alice    O
in    O
Wonderland    O
syndrome    O
(    O
micropsia    B-Perturbation107428450
,    O
macropsia    B-Perturbation107428450
,    O
teleopsia    O
,    O
and    O
pelopsia    O
)    O
,    O
visual    B-Perturbation107428450
snow    I-Perturbation107428450
,    O
oscillopsia    O
,    O
entoptic    O
phenomena    O
,    O
and    O
cerebral    O
polyopia    O
.    O

Perceptual    O
phenomena    O
such    O
as    O
synesthesia    O
,    O
macropsia    B-Perturbation107428450
,    O
and    O
micropsia    B-Perturbation107428450
may    O
occur    O
.    O

#    O
Macropsia    B-Perturbation107428450
or    O
micropsia    B-Perturbation107428450
,    O
an    O
alteration    O
in    O
the    O
perception    O
of    O
object    O
size    O
or    O
shape    O
.    O

A    O
patient    O
with    O
pituitary    O
adenoma    O
may    O
present    O
with    O
visual    O
field    O
defects    O
,    O
classically    O
bitemporal    B-Perturbation107428450
hemianopsia    I-Perturbation107428450
.    O

The    O
anatomy    O
of    O
this    O
structure    O
causes    O
pressure    O
on    O
it    O
to    O
produce    O
a    O
defect    O
in    O
the    O
temporal    O
visual    O
field    O
on    O
both    O
sides    O
,    O
a    O
condition    O
called    O
bitemporal    B-Perturbation107428450
hemianopsia    I-Perturbation107428450
.    O

Visual    O
field    O
loss    O
in    O
bitemporal    B-Perturbation107428450
hemianopsia    I-Perturbation107428450
:    O
peripheral    O
vision    O
loss    O
affecting    O
both    O
eyes    O
,    O
resulting    O
from    O
a    O
tumor    O
-    O
typically    O
a    O
pituitary    O
adenoma-    O
putting    O
pressure    O
on    O
the    O
optic    O
chiasm    O
.    O

Dermatopathic    B-Perturbation107428450
pigmentosa    I-Perturbation107428450
reticularis    I-Perturbation107428450

Dermatopathia    B-Perturbation107428450
pigmentosa    I-Perturbation107428450
reticularis    I-Perturbation107428450
,    O
a    O
rare    O
form    O
of    O
ectodermal    O
dysplasia    O

Scratch    B-Perturbation107428450
dermatitis    I-Perturbation107428450
(    O
flagellate    O
pigmentation    O
from    O
bleomycin    O
)    O

Adams    O
'    O
color    O
spaces    O
rely    O
on    O
the    O
Munsell    B-Perturbation107428450
value    O
for    O
lightness    O
.    O

Dyskeratosis    B-Perturbation107428450
corneal    I-Perturbation107428450
and    I-Perturbation107428450
photophobia    I-Perturbation107428450
in    I-Perturbation107428450
XLPDR    I-Perturbation107428450

Nevus    B-Perturbation107428450
anemicus    I-Perturbation107428450
is    O
a    O
congenital    O
disorder    O
characterized    O
by    O
macules    O
of    O
varying    O
size    O
and    O
shape    O
that    O
are    O
paler    O
than    O
the    O
surrounding    O
skin    O
and    O
can    O
not    O
be    O
made    O
red    O
by    O
trauma    O
,    O
cold    O
,    O
or    O
heat    O
.    O

Phylloid    B-Perturbation107428450
hypomelanosis    I-Perturbation107428450

It    O
is    O
usually    O
accompanied    O
by    O
a    O
homonymous    B-Perturbation107428450
hemianopsia    I-Perturbation107428450
in    O
the    O
right    O
side    O
of    O
the    O
visual    O
field    O
.    O

The    O
Peli    O
Lens    O
is    O
a    O
mobility    O
aid    O
for    O
people    O
with    O
homonymous    B-Perturbation107428450
hemianopia    I-Perturbation107428450
.    O

Signs    O
of    O
the    O
tumor    O
resulting    O
from    O
increased    O
intracranial    O
pressure    O
are    O
present    O
in    O
91%    O
of    O
patients    O
,    O
with    O
vomiting    O
,    O
homonymous    B-Perturbation107428450
visual    I-Perturbation107428450
field    I-Perturbation107428450
defects    I-Perturbation107428450
and    O
headache    O
being    O
the    O
most    O
common    O
symptoms    O
.    O

Lesions    O
in    O
the    O
optic    O
tract    O
correspond    O
to    O
visual    O
field    O
loss    O
on    O
the    O
left    O
or    O
right    O
half    O
of    O
the    O
vertical    O
midline    O
,    O
also    O
known    O
as    O
homonymous    B-Perturbation107428450
hemianopsia    I-Perturbation107428450
.    O

Homonymous    B-Perturbation107428450
hemianopsia    I-Perturbation107428450
,    O
or    O
homonymous    O
hemianopia    O
,    O
is    O
hemianopic    O
visual    O
field    O
loss    O
on    O
the    O
same    O
side    O
of    O
both    O
eyes    O
.    O

Griscelli    B-Perturbation107428450
syndrome    I-Perturbation107428450
type    I-Perturbation107428450
2    I-Perturbation107428450
(    O
also    O
known    O
as    O
"    O
Partial    O
albinism    O
with    O
immunodeficiency    O
"    O
)    O
is    O
a    O
rare    O
autosomal    O
recessive    O
syndrome    O
characterized    O
by    O
variable    O
pigmentary    O
dilution    O
,    O
hair    O
with    O
silvery    O
metallic    O
sheen    O
,    O
frequent    O
pyogenic    O
infections    O
,    O
neutropenia    O
,    O
and    O
thrombocytopenia    O
.    O

Pigmentation    B-Perturbation107428450
disorders    I-Perturbation107428450
are    O
disturbances    O
of    O
human    O
skin    O
color    O
,    O
either    O
loss    O
or    O
reduction    O
,    O
which    O
may    O
be    O
related    O
to    O
loss    O
of    O
melanocytes    O
or    O
the    O
inability    O
of    O
melanocytes    O
to    O
produce    O
melanin    O
or    O
transport    O
melanosomes    O
correctly    O
.    O

During    O
the    O
preseason    O
,    O
Gragg    O
was    O
hospitalized    O
with    O
heat    B-Perturbation107428450
cramps    I-Perturbation107428450
,    O
but    O
returned    O
to    O
practice    O
on    O
July    O
30    O
.    O

Heat    B-Perturbation107428450
cramp    I-Perturbation107428450

Waardenburg    B-Perturbation107428450
syndrome    I-Perturbation107428450
is    O
named    O
after    O
him    O
.    O

Waardenburg    B-Perturbation107428450
syndrome    I-Perturbation107428450
,    O
or    O
more    O
fully    O
,    O
the    O
van    O
der    O
Hoeve    O
-    O
Halbertsma    O
-    O
Waardenburg    O
-    O
Klein    O
syndrome    O
,    O
is    O
a    O
rare    O
genetic    O
disorder    O
most    O
often    O
characterized    O
by    O
varying    O
degrees    O
of    O
deafness    O
,    O
minor    O
defects    O
in    O
structures    O
arising    O
from    O
the    O
neural    O
crest    O
,    O
and    O
pigmentation    O
anomalies    O
.    O

Klein    O
made    O
contributions    O
towards    O
the    O
understanding    O
of    O
Waardenburg    B-Perturbation107428450
syndrome    I-Perturbation107428450
,    O
or    O
more    O
fully    O
,    O
the    O
"    O
van    O
der    O
Hoeve    O
-    O
Halbertsma    O
-    O
Waardenburg    O
-    O
Klein    O
syndrome    O
"    O
.    O

An    O
auditory    O
-    O
pigmentation    O
disorder    O
in    O
humans    O
,    O
Waardenberg    B-Perturbation107428450
syndrome    I-Perturbation107428450
,    O
reflects    O
some    O
of    O
the    O
problems    O
associated    O
with    O
heterozygous    O
and    O
homozygous    O
merle    O
dogs    O
and    O
genetic    O
research    O
in    O
dogs    O
has    O
been    O
undertaken    O
with    O
the    O
goal    O
of    O
better    O
understanding    O
the    O
genetic    O
basis    O
of    O
this    O
human    O
condition    O
.    O

Waardenburg    B-Perturbation107428450
syndrome    I-Perturbation107428450
(    O
ILDS    O
E70.320    O
)    O

Waardenburg    B-Perturbation107428450
syndrome    I-Perturbation107428450

Waardenburg    B-Perturbation107428450
syndrome    I-Perturbation107428450
,    O
a    O
genetic    O
disorder    O

Waardenburg    B-Perturbation107428450
syndrome    I-Perturbation107428450
,    O
a    O
genetic    O
disorder    O

WS2B    O
is    O
a    O
gene    O
associated    O
with    O
Waardenburg    B-Perturbation107428450
syndrome    I-Perturbation107428450
.    O

Vasospastic    B-Perturbation107428450
macule    I-Perturbation107428450

Hypochloraemia    B-Perturbation107428450

Hypochloremia    B-Perturbation107428450
(    O
or    O
Hypochloraemia    B-Perturbation107428450
)    O
is    O
an    O
electrolyte    O
disturbance    O
in    O
which    O
there    O
is    O
an    O
abnormally    O
low    O
level    O
of    O
the    O
chloride    O
ion    O
in    O
the    O
blood    O
.    O

Perceptual    O
phenomena    O
such    O
as    O
synesthesia    O
,    O
macropsia    B-Perturbation107428450
,    O
and    O
micropsia    B-Perturbation107428450
may    O
occur    O
.    O

#    O
Macropsia    B-Perturbation107428450
or    O
micropsia    B-Perturbation107428450
,    O
an    O
alteration    O
in    O
the    O
perception    O
of    O
object    O
size    O
or    O
shape    O
.    O

In    O
the    O
blood    O
of    O
most    O
animals    O
,    O
the    O
bicarbonate    O
buffer    O
system    O
is    O
coupled    O
to    O
the    O
lungs    O
via    O
respiratory    B-Perturbation107428450
compensation    I-Perturbation107428450
,    O
the    O
process    O
by    O
which    O
the    O
rate    O
of    O
breathing    O
changes    O
to    O
compensate    O
for    O
changes    O
in    O
the    O
blood    O
concentration    O
of    O
CO2    O
.    O

The    O
serum    O
anion    B-Perturbation107428450
gap    I-Perturbation107428450
is    O
useful    O
for    O
determining    O
whether    O
a    O
base    O
deficit    O
is    O
caused    O
by    O
addition    O
of    O
acid    O
or    O
loss    O
of    O
bicarbonate    O
.    O

A    O
low    O
serum    O
anion    B-Perturbation107428450
gap    I-Perturbation107428450
is    O
frequently    O
caused    O
by    O
hypoalbuminemia    O
.    O

|    O
anion    B-Perturbation107428450
gap    I-Perturbation107428450

Symptoms    O
include    O
supranuclear    O
gaze    B-Perturbation107428450
palsy    I-Perturbation107428450
,    O
spasticity    O
,    O
and    O
dementia    O
.    O

Damage    O
to    O
the    O
abducens    O
"    O
nucleus    O
"    O
does    O
not    O
produce    O
an    O
isolated    O
sixth    O
nerve    O
palsy    O
,    O
but    O
rather    O
a    O
horizontal    O
gaze    B-Perturbation107428450
palsy    I-Perturbation107428450
that    O
affects    O
both    O
eyes    O
simultaneously    O
.    O

Griscelli    B-Perturbation107428450
syndrome    I-Perturbation107428450
type    I-Perturbation107428450
3    I-Perturbation107428450
is    O
a    O
disorder    O
of    O
melanosome    O
transport    O
presenting    O
initially    O
with    O
hypopigmentation    O
.    O

Afterimages    O
are    O
a    O
common    O
symptom    O
of    O
visual    B-Perturbation107428450
snow    I-Perturbation107428450
.    O

Visions    O
caused    O
by    O
anticholinergics    O
(    O
including    O
Atropa    O
alkaloids    O
)    O
are    O
often    O
characterised    O
by    O
the    O
following    O
:    O
warping    O
or    O
waving    O
of    O
surfaces    O
and    O
edges    O
(    O
distorted    O
perception    O
of    O
objects    O
actually    O
present);flashes    O
of    O
'    O
light    O
'    O
,    O
'    O
smoke    O
'    O
,    O
visual    B-Perturbation107428450
snow    I-Perturbation107428450
,    O
textured    O
surfaces    O
and    O
insect    O
or    O
spider    O
-    O
like    O
forms    O
likely    O
deriving    O
from    O
entoptic    O
phenomena    O
and    O
form    O
constants    O
;    O
and    O
vivid    O
hallucinations    O
(    O
indistinguishable    O
from    O
reality    O
)    O
of    O
lifelike    O
objects    O
,    O
animals    O
and    O
persons    O
not    O
actually    O
present    O
.    O

Visual    B-Perturbation107428450
snow    I-Perturbation107428450

Photophobia    O
is    O
a    O
common    O
symptom    O
of    O
visual    B-Perturbation107428450
snow    I-Perturbation107428450
.    O

Photoleukomelanodermatitis    B-Perturbation107428450
of    I-Perturbation107428450
Kobori    I-Perturbation107428450

Comparison    O
of    O
the    O
base    O
excess    O
with    O
the    O
reference    O
range    O
assists    O
in    O
determining    O
whether    O
an    O
acid/base    B-Perturbation107428450
disturbance    I-Perturbation107428450
is    O
caused    O
by    O
a    O
respiratory    O
,    O
metabolic    O
,    O
or    O
mixed    O
metabolic    O
/    O
respiratory    O
problem    O
.    O

Acid-base    B-Perturbation107428450
homeostasis    I-Perturbation107428450

This    O
condition    O
is    O
one    O
of    O
the    O
four    O
basic    O
categories    O
of    O
disruption    O
of    O
acid–base    B-Perturbation107428450
homeostasis    I-Perturbation107428450
.    O

The    O
surface    O
of    O
biological    O
cells    O
carry    O
many    O
different    O
types    O
of    O
chemical    O
groups    O
,    O
each    O
with    O
a    O
different    O
dissociation    O
constant    O
,    O
causing    O
them    O
to    O
have    O
varying    O
electric    O
charges    O
at    O
a    O
physiological    B-Perturbation107428450
pH    I-Perturbation107428450
This    O
indicates    O
that    O
biosurfaces    O
are    O
chemically    O
heterogeneous    O
.    O

The    O
kidneys    O
maintain    O
acid-base    B-Perturbation107428450
homeostasis    I-Perturbation107428450
by    O
regulating    O
the    O
pH    O
of    O
the    O
blood    O
plasma    O
.    O

In    O
other    O
types    O
of    O
potassium    O
derangement    O
,    O
the    O
acid-base    B-Perturbation107428450
balance    I-Perturbation107428450
is    O
usually    O
disturbed    O
,    O
with    O
metabolic    O
alkalosis    O
and    O
metabolic    O
acidosis    O
often    O
being    O
present    O
.    O

Acid-base    B-Perturbation107428450
physiology    I-Perturbation107428450

Drinking    O
ionized    O
water    O
or    O
alkaline    O
water    O
does    O
not    O
alter    O
the    O
body    O
's    O
pH    O
due    O
to    O
acid-base    B-Perturbation107428450
homeostasis    I-Perturbation107428450
.    O

Riehl    B-Perturbation107428450
melanosis    I-Perturbation107428450
is    O
a    O
form    O
of    O
contact    O
dermatitis    O
,    O
beginning    O
with    O
pruritus    O
,    O
erythema    O
,    O
and    O
pigmentation    O
that    O
gradually    O
spreads    O
which    O
,    O
after    O
reaching    O
a    O
certain    O
extent    O
,    O
becomes    O
stationary    O
.    O

Erythrism    B-Perturbation107428450

Erythrism    B-Perturbation107428450

Necklace    B-Perturbation107428450
of    I-Perturbation107428450
Venus    I-Perturbation107428450

Dyschromatosis    B-Perturbation107428450
universalis    I-Perturbation107428450
hereditaria    I-Perturbation107428450
is    O
a    O
rare    O
genodermatosis    O
characterized    O
by    O
reticulate    O
hyper-    O
and    O
hypo-    O
pigmentated    O
macules    O
in    O
a    O
generalized    O
distribution    O
.    O

Amelanism    B-Perturbation107428450

Amelanism    B-Perturbation107428450

Optic    B-Perturbation107428450
disc    I-Perturbation107428450
pallor    I-Perturbation107428450

In    O
this    O
situation    O
a    O
helpful    O
test    O
to    O
diagnose    O
poisoning    O
is    O
the    O
measurement    O
of    O
the    O
osmolal    B-Perturbation107428450
gap    I-Perturbation107428450
.    O

These    O
charities    O
are    O
the    O
New    O
Hampshire    O
Association    O
for    O
the    O
Blind    O
,    O
which    O
provides    O
vision    B-Perturbation107428450
rehabilitation    I-Perturbation107428450
services    O
,    O
and    O
Guiding    O
Eyes    O
for    O
the    O
Blind    O
,    O
an    O
organization    O
that    O
trains    O
guide    O
dogs    O
and    O
matches    O
them    O
with    O
owners    O
at    O
no    O
charge    O
.    O

He    O
is    O
on    O
the    O
Board    O
of    O
Directors    O
for    O
Lighthouse    O
International    O
,    O
a    O
non    O
-    O
profit    O
organization    O
that    O
does    O
work    O
in    O
vision    B-Perturbation107428450
rehabilitation    I-Perturbation107428450
services    O
,    O
education    O
,    O
research    O
,    O
prevention    O
and    O
advocacy    O
.    O

(    O
Additionally    O
,    O
excessive    O
water    O
consumption    O
can    B-Perturbation107428450
be    I-Perturbation107428450
dangerous    I-Perturbation107428450
.    O
)    O

In    O
medicine    O
,    O
diuretics    O
are    O
used    O
to    O
treat    O
heart    O
failure    O
,    O
liver    O
cirrhosis    O
,    O
hypertension    O
,    O
influenza    O
,    O
water    B-Perturbation107428450
poisoning    I-Perturbation107428450
,    O
and    O
certain    O
kidney    O
diseases    O
.    O

Leah    O
had    O
been    O
at    O
home    O
with    O
friends    O
and    O
had    O
not    O
been    O
dancing    O
,    O
yet    O
consumed    O
about    O
7    O
litres    O
(    O
12    O
pints    O
)    O
of    O
water    O
in    O
less    O
than    O
90    O
minutes    O
,    O
resulting    O
in    O
water    B-Perturbation107428450
intoxication    I-Perturbation107428450
and    O
hyponatremia    O
,    O
which    O
in    O
turn    O
led    O
to    O
serious    O
swelling    O
of    O
the    O
brain    O
,    O
irreparably    O
damaging    O
it    O
.    O

Water    B-Perturbation107428450
overdose    I-Perturbation107428450

The    O
second    O
major    O
risk    O
arises    O
from    O
imbalanced    O
fluid    O
or    O
electrolyte    O
levels    O
,    O
particularly    O
hyponatremia    O
(    O
sodium    O
deficiency    O
,    O
overhydration    O
,    O
or    O
water    B-Perturbation107428450
intoxication    I-Perturbation107428450
)    O
.    O

Water    B-Perturbation107428450
intoxication    I-Perturbation107428450
,    O
also    O
known    O
as    O
water    B-Perturbation107428450
poisoning    I-Perturbation107428450
or    O
hyperhydration    B-Perturbation107428450
,    O
is    O
a    O
potentially    O
fatal    O
disturbance    O
in    O
brain    O
functions    O
that    O
results    O
when    O
the    O
normal    O
balance    O
of    O
electrolytes    O
in    O
the    O
body    O
is    O
pushed    O
outside    O
safe    O
limits    O
by    O
overhydration    O
(    O
excessive    O
water    O
intake    O
)    O
.    O

These    O
levels    O
,    O
taken    O
as    O
a    O
set    O
,    O
can    O
be    O
rapidly    O
performed    O
to    O
indicate    O
several    O
common    O
acute    O
conditions    O
requiring    O
immediate    O
specific    O
medical    O
treatment    O
,    O
such    O
as    O
dehydration    O
/    O
hypovolemia    O
,    O
water    B-Perturbation107428450
intoxication    I-Perturbation107428450
(    O
which    O
can    O
present    O
with    O
similar    O
symptoms    O
as    O
dehydration    O
but    O
requires    O
the    O
opposite    O
treatment    O
)    O
,    O
diabetic    O
shock    O
(    O
either    O
ketoacidosis    O
,    O
hyperglycemia    O
or    O
hypoglycemia    O
)    O
,    O
congestive    O
heart    O
failure    O
,    O
renal    O
failure    O
or    O
liver    O
failure    O
,    O
various    O
substance    O
overdoses    O
or    O
adverse    O
reactions    O
,    O
and    O
others    O
.    O

Poikiloderma    B-Perturbation107428450
of    I-Perturbation107428450
Civatte    I-Perturbation107428450

Best    O
’s    O
vitelliform    B-Perturbation107428450
macular    I-Perturbation107428450
dystrophy    I-Perturbation107428450
(    O
BVMD    O
)    O
is    O
one    O
of    O
the    O
most    O
common    O
Best1-associated    O
diseases    O
.    O

Adult    O
-    O
onset    O
vitelliform    B-Perturbation107428450
macular    I-Perturbation107428450
dystrophy    I-Perturbation107428450
(    O
AVMD    O
)    O
consists    O
of    O
lesions    O
similar    O
to    O
BVMD    O
on    O
the    O
retina    O
.    O

She    O
mainly    O
works    O
as    O
a    O
voice    O
-    O
over    O
artist    O
,    O
and    O
works    O
in    O
audio    B-Perturbation107428450
description    I-Perturbation107428450
.    O

The    O
company    O
is    O
concerned    O
with    O
innovating    O
access    O
for    O
audiences    O
and    O
engages    O
in    O
the    O
creative    O
development    O
of    O
audio    B-Perturbation107428450
description    I-Perturbation107428450
.    O

In    O
2013    O
,    O
audio    B-Perturbation107428450
description    I-Perturbation107428450
allowed    O
him    O
to    O
watch    O
his    O
first    O
silent    O
film    O
,    O
which    O
he    O
joked    O
was    O
"    O
eye    O
-    O
opening    O
"—    O
however    O
,    O
he    O
does    O
not    O
use    O
it    O
when    O
preparing    O
his    O
reviews    O
.    O

The    O
BBC    O
also    O
offers    O
audio    B-Perturbation107428450
description    I-Perturbation107428450
on    O
some    O
popular    O
programmes    O
for    O
visually    O
impaired    O
-    O
viewers    O
as    O
well    O
as    O
sign    O
language    O
interpretation    O
on    O
some    O
of    O
its    O
programmes    O
for    O
deaf    O
and    O
hard    O
-    O
of    O
-    O
hearing    O
viewers    O
.    O

For    O
blind    O
viewers    O
,    O
audio    B-Perturbation107428450
description    I-Perturbation107428450
(    O
Descriptive    O
Video    O
Service    O
,    O
DVS    O
)    O
can    O
be    O
and    O
usually    O
is    O
transmitted    O
along    O
with    O
captions    O
.    O

Although    O
the    O
Fox    O
network    O
itself    O
has    O
expanded    O
the    O
availability    O
of    O
SAP    O
audio    O
since    O
the    O
start    O
of    O
2012    O
to    O
expand    O
the    O
availability    O
of    O
audio    B-Perturbation107428450
description    I-Perturbation107428450
of    O
primetime    O
programming    O
and    O
Spanish    O
language    O
audio    O
to    O
their    O
NFL    O
package    O
,    O
Fox    O
Sports    O
has    O
chosen    O
to    O
retain    O
Spanish    O
audio    O
of    O
their    O
MLB    O
coverage    O
exclusively    O
on    O
Fox    O
Deportes    O
for    O
the    O
time    O
being    O
.    O

MPTV    O
was    O
the    O
last    O
major    O
station    O
in    O
the    O
Milwaukee    O
market    O
to    O
add    O
SAP    O
and    O
DVS    O
services    O
,    O
eight    O
months    O
after    O
FCC    O
requirements    O
regarding    O
audio    B-Perturbation107428450
description    I-Perturbation107428450
came    O
into    O
effect    O
for    O
the    O
Milwaukee    O
market    O
for    O
major    O
commercial    O
stations    O
,    O
though    O
they    O
are    O
voluntary    O
for    O
non    O
-    O
commercial    O
broadcasters    O
.    O

Audio    B-Perturbation107428450
description    I-Perturbation107428450
track    O
,    O
a    O
narration    O
track    O
for    O
visually    O
impaired    O
consumers    O
of    O
visual    O
media    O

Cross    B-Perturbation107428450
syndrome    I-Perturbation107428450
(    O
ILDS    O
E70.380    O
)    O

Vogt–Koyanagi–Harada    B-Perturbation107428450
syndrome    I-Perturbation107428450

Harada's    B-Perturbation107428450
disease    I-Perturbation107428450

Vogt–Koyanagi–Harada    B-Perturbation107428450
disease    I-Perturbation107428450

Progressive    B-Perturbation107428450
macular    I-Perturbation107428450
hypomelanosis    I-Perturbation107428450

In    O
terms    O
of    O
pathology    O
,    O
it    O
has    O
been    O
associated    O
with    O
processes    O
such    O
as    O
amyloidosis    O
,    O
retinitis    B-Perturbation107428450
pigmentosa    I-Perturbation107428450
,    O
infection    O
mechanisms    O
,    O
kidney    O
diseases    O
and    O
various    O
types    O
of    O
congenital    O
hearing    O
loss    O
.    O

Red    O
Szell    O
became    O
the    O
first    O
blind    O
person    O
to    O
climb    O
the    O
Old    O
Man    O
,    O
despite    O
suffering    O
from    O
retinitis    B-Perturbation107428450
pigmentosa    I-Perturbation107428450
that    O
left    O
him    O
with    O
5    O
per    O
cent    O
vision    O
.    O

This    O
field    O
has    O
shown    O
promise    O
in    O
clinical    O
applications    O
,    O
including    O
the    O
treatment    O
of    O
human    O
eye    O
diseases    O
such    O
as    O
retinitis    B-Perturbation107428450
pigmentosa    I-Perturbation107428450
and    O
diabetes    O
.    O

There    O
has    O
been    O
recent    O
research    O
on    O
the    O
role    O
of    O
melanopsin    O
in    O
optogenetic    O
therapy    O
for    O
patients    O
with    O
the    O
degenerative    O
eye    O
disease    O
retinitis    B-Perturbation107428450
pigmentosa    I-Perturbation107428450
(    O
RP    O
)    O
.    O

Retinitis    B-Perturbation107428450
pigmentosa    I-Perturbation107428450

Other    O
pathologies    O
with    O
etiology    O
involving    O
mitochondrial    O
dysfunction    O
include    O
schizophrenia    O
,    O
bipolar    O
disorder    O
,    O
dementia    O
,    O
Alzheimer    O
's    O
disease    O
,    O
Parkinson    O
's    O
disease    O
,    O
epilepsy    O
,    O
stroke    O
,    O
cardiovascular    O
disease    O
,    O
chronic    O
fatigue    O
syndrome    O
,    O
retinitis    B-Perturbation107428450
pigmentosa    I-Perturbation107428450
,    O
and    O
diabetes    O
mellitus    O
.    O

Also    O
in    O
1993    O
he    O
was    O
diagnosed    O
with    O
retinitis    B-Perturbation107428450
pigmentosa    I-Perturbation107428450
,    O
a    O
retinal    O
degenerative    O
disease    O
that    O
leads    O
to    O
progressive    O
sight    O
loss    O
and    O
blindness    B-Perturbation107428450
.    O

(    O
H35.5    O
)    O
Retinitis    B-Perturbation107428450
pigmentosa    I-Perturbation107428450
—    O
genetic    O
disorder    O
;    O
tunnel    O
vision    O
preceded    O
by    O
night    O
-    O
blindness    O

Retinitis    B-Perturbation107428450
Pigmentosa    I-Perturbation107428450

He    O
has    O
also    O
used    O
comparative    O
genomics    O
to    O
contribute    O
directly    O
to    O
the    O
understanding    O
of    O
chromatin    O
structure    O
and    O
the    O
genetics    O
of    O
numerous    O
conditions    O
including    O
asthma    O
,    O
obesity    O
,    O
Alzheimer    O
's    O
disease    O
,    O
retinitis    B-Perturbation107428450
pigmentosa    I-Perturbation107428450
,    O
muscular    O
dystrophies    O
,    O
and    O
Aicardi–    O

He    O
has    O
retinitis    B-Perturbation107428450
pigmentosa    I-Perturbation107428450
,    O
a    O
hereditary    O
eye    O
disease    O
that    O
affects    O
peripheral    O
and    O
night    O
vision    O
.    O

After    O
government    O
service    O
he    O
became    O
a    O
corporate    O
attorney    O
when    O
he    O
was    O
stricken    O
retinitis    B-Perturbation107428450
pigmentosa    I-Perturbation107428450
and    O
lost    O
his    O
sight    O
.    O

Retinal    O
degenerative    O
diseases    O
,    O
such    O
as    O
retinitis    B-Perturbation107428450
pigmentosa    I-Perturbation107428450
(    O
RP    O
)    O
and    O
age    O
-    O
related    O
macular    O
degeneration    O
(    O
AMD    O
)    O
,    O
are    O
two    O
likely    O
candidate    O
diseases    O
in    O
which    O
retinal    O
stimulation    O
may    O
be    O
helpful    O
.    O

Goyal    O
was    O
born    O
and    O
raised    O
in    O
Mumbai    O
,    O
India    O
.    O
Born    O
with    O
perfect    O
vision    O
,    O
he    O
has    O
retinitis    B-Perturbation107428450
pigmentosa    I-Perturbation107428450
,    O
which    O
caused    O
his    O
vision    O
to    O
deteriorate    O
from    O
age    O
9    O
;    O
by    O
22    O
he    O
was    O
entirely    O
blind    O
.    O

He    O
was    O
blind    B-Perturbation107428450
from    O
birth    O
from    O
a    O
combination    O
of    O
macular    O
degeneration    O
and    O
retinitis    B-Perturbation107428450
pigmentosa    I-Perturbation107428450
.    O

Bernstein    O
has    O
been    O
classified    O
as    O
legally    O
blind    O
since    O
birth    O
,    O
as    O
a    O
result    O
of    O
retinitis    B-Perturbation107428450
pigmentosa    I-Perturbation107428450
.    O

People    O
suffering    O
from    O
retinitis    B-Perturbation107428450
pigmentosa    I-Perturbation107428450
seem    O
to    O
have    O
Flammer    O
syndrome    O
quite    O
frequently    O
,    O
possible    O
associations    O
with    O
the    O
vascular    O
factor    O
endothelin-1    O
are    O
under    O
investigation    O
.    O

The    O
company    O
's    O
technologies    O
are    O
aimed    O
at    O
products    O
that    O
might    O
have    O
the    O
potential    O
to    O
treat    O
achromatopsia    B-Perturbation107428450
,    O
X    O
-    O
linked    O
retinoschisis    O
,    O
X    O
-    O
linked    O
retinitis    B-Perturbation107428450
pigmentosa    I-Perturbation107428450
,    O
and    O
age    O
-    O
related    O
macular    O
degeneration    O
.    O

Eye    O
diseases    O
addressed    O
by    O
grants    O
from    O
RPB    O
include    O
macular    O
degeneration    O
,    O
cataracts    O
,    O
glaucoma    O
,    O
diabetic    O
retinopathy    O
,    O
dry    O
eye    O
,    O
corneal    O
diseases    O
,    O
uveitis    O
,    O
low    B-Perturbation107428450
vision    I-Perturbation107428450
,    O
amblyopia    O
and    O
strabismus    O
,    O
retinitis    B-Perturbation107428450
pigmentosa    I-Perturbation107428450
,    O
color    O
blindness    O
and    O
ocular    O
cancers    O
.    O

He    O
was    O
born    O
with    O
the    O
degenerative    O
eye    O
condition    O
retinitis    B-Perturbation107428450
pigmentosa    I-Perturbation107428450
which    O
he    O
inherited    O
from    O
his    O
father    O
.    O

Faiche    O
,    O
who    O
has    O
a    O
congenital    O
eye    O
condition    O
,    O
retinitis    B-Perturbation107428450
pigmentosa    I-Perturbation107428450
,    O
studied    O
physics    O
at    O
Aberdeen    O
University    O
.    O

The    O
committee    O
concluded    O
:    O
"    O
The    O
consensus    O
of    O
all    O
the    O
doctors    O
was    O
that    O
the    O
cases    O
examined    O
had    O
congenital    O
anomalies    O
,    O
diseases    O
due    O
to    O
genetic    O
abnormalities    O
like    O
thalassaemia    O
major    O
and    O
retinitis    B-Perturbation107428450
pigmentosa    I-Perturbation107428450
,    O
moderate    O
to    O
gross    O
splenomegaly    O
due    O
to    O
chronic    O
malaria    O
l    O
infection    O
(    O
as    O
this    O
is    O
hyperendemic    O
area    O
)    O
,    O
malnutrition    O
,    O
post    O
encephalitis    O
,    O
post    O
head    O
injury    O
sequelae    O
and    O
certain    O
habits    O
(    O
alcohol    O
)    O
and    O
have    O
no    O
relation    O
to    O
radiation    O
.    O
"    O

:    O
retinitis    B-Perturbation107428450
pigmentosa    I-Perturbation107428450

Retinitis    B-Perturbation107428450
pigmentosa    I-Perturbation107428450

Leslie    O
works    O
for    O
James    O
and    O
helped    O
raise    O
money    O
through    O
charity    O
events    O
for    O
retinitis    B-Perturbation107428450
pigmentosa    I-Perturbation107428450
,    O
with    O
which    O
she    O
is    O
afflicted    O
.    O

Ana    O
María    O
López    O
Colomé    O
is    O
a    O
distinguished    O
Mexican    O
biochemist    O
who    O
won    O
the    O
2002    O
L'Oréal    O
-    O
UNESCO    O
Award    O
for    O
Women    O
in    O
Science    O
–    O
Latin    O
America    O
for    O
her    O
studies    O
on    O
the    O
human    O
retina    O
and    O
the    O
prevention    O
of    O
retinitis    B-Perturbation107428450
pigmentosa    I-Perturbation107428450
and    O
several    O
retinopathies    O
.    O

Following    O
additional    O
testing    O
,    O
the    O
treatment    O
could    O
be    O
used    O
to    O
heal    O
human    O
sufferers    O
of    O
retinitis    B-Perturbation107428450
pigmentosa    I-Perturbation107428450
.    O

The    O
device    O
,    O
which    O
became    O
available    O
in    O
Europe    O
in    O
2011    O
,    O
uses    O
a    O
combination    O
of    O
ocular    O
implants    O
and    O
camera    O
-    O
equipped    O
eyeglasses    O
to    O
restore    O
vision    O
to    O
people    O
blinded    O
by    O
retinitis    B-Perturbation107428450
pigmentosa    I-Perturbation107428450
.    O

"    O
Whitening    O
clay    O
"    O
,    O
particularly    O
when    O
used    O
to    O
treat    O
facial    O
pigmentation    O
,    O
such    O
as    O
melasma    B-Perturbation107428450
.    O

Melasma    B-Perturbation107428450
,    O
also    O
known    O
as    O
"    O
chloasma    O
"    O
—    O
patchy    O
hyperpigmentation    O

Melasma    B-Perturbation107428450
(    O
also    O
known    O
as    O
chloasma    B-Perturbation107428450
faciei    I-Perturbation107428450
,    O
or    O
the    O
mask    B-Perturbation107428450
of    I-Perturbation107428450
pregnancy    I-Perturbation107428450
when    O
present    O
in    O
pregnant    O
women    O
)    O
is    O
a    O
tan    O
or    O
dark    O
skin    O
discoloration    O
.    O

Chloasma    B-Perturbation107428450

Azelaic    O
acid    O
has    O
been    O
used    O
for    O
treatment    O
of    O
skin    O
pigmentation    O
including    O
melasma    B-Perturbation107428450
and    O
postinflammatory    O
hyperpigmentation    O
,    O
particularly    O
in    O
those    O
with    O
darker    O
skin    O
types    O
.    O

Ringer    O
's    O
lactate    O
solution    O
has    O
a    O
lower    O
rate    O
of    O
acidosis    B-Perturbation107428450
as    O
compared    O
with    O
normal    O
saline    O
.    O

Large    O
amounts    O
may    O
result    O
in    O
fluid    O
overload    O
,    O
swelling    O
,    O
acidosis    B-Perturbation107428450
,    O
and    O
high    O
blood    O
sodium    O
.    O

Furthermore    O
,    O
patients    O
with    O
developmental    O
prosopagnosia    B-Perturbation107428450
,    O
suffering    O
from    O
imparied    O
face    O
identification    O
,    O
generally    O
detect    O
faces    O
normally    O
,    O
suggesting    O
that    O
visual    O
search    O
for    O
faces    O
is    O
facilitated    O
by    O
mechanisms    O
other    O
than    O
the    O
face    O
-    O
identification    O
circuits    O
of    O
the    O
fusiform    O
face    O
area    O
.    O

:    O
:    O
Special    O
Forces    O
(    O
United    O
States    O
Army    O
)    O
in    O
the    O
Vietnam    O
War    O
,    O
Recipient    O
of    O
the    O
Distinguished    O
Service    O
Cross    O
(    O
United    O
States    O
)    O
City    O
Planner    O
and    O
City    O
Councilman    O
of    O
Stanwood    O
,    O
Washington    O
Writer    O
veterans    O
/    O
prosopagnosia    B-Perturbation107428450
advocate    O

Aphantasia    O
is    O
similar    O
to    O
invisible    O
disabilities    O
such    O
as    O
face    B-Perturbation107428450
blindness    I-Perturbation107428450
,    O
word    O
blindness    O
,    O
and    O
tone    O
deafness    O
,    O
though    O
aphantasia    O
itself    O
has    O
not    O
been    O
associated    O
with    O
any    O
functional    O
deficits    O
.    O

He    O
uses    O
the    O
Stand    O
Paper    O
Moon    O
King    O
,    O
which    O
lets    O
him    O
create    O
origami    O
that    O
upon    O
touching    O
a    O
person    O
gives    O
them    O
prospagnosia    B-Perturbation107428450
.    O

Because    O
not    O
all    O
patients    O
with    O
impaired    O
facial    O
processing    O
develop    O
mirrored    O
-    O
self    O
misidentification    O
,    O
such    O
as    O
patients    O
with    O
prosopagnosia    B-Perturbation107428450
,    O
there    O
needed    O
to    O
be    O
a    O
second    O
factor    O
to    O
explain    O
FE    O
’s    O
delusions    O
.    O

,    O
he    O
suffers    O
from    O
prosopagnosia    B-Perturbation107428450
.    O

prosopagnosia    B-Perturbation107428450

Similar    O
research    O
regarding    O
prosopagnosia    B-Perturbation107428450
has    O
determined    O
that    O
the    O
FFA    O
is    O
essential    O
to    O
the    O
recognition    O
of    O
unique    O
faces    O
.    O

C.    O
A.    O
Pallis    O
described    O
a    O
patient    O
,    O
A.H.    O
,    O
who    O
presented    O
with    O
color    B-Perturbation107428450
,    O
face    B-Perturbation107428450
and    O
landmark    O
agnosia    O
as    O
a    O
result    O
of    O
a    O
cerebral    O
embolism    O
.    O

This    O
research    O
was    O
to    O
help    O
Ace    O
cure    O
his    O
prosopagnosia    B-Perturbation107428450
.    O

Citric    B-Perturbation107428450
acid/potassium-sodium    I-Perturbation107428450
citrate    I-Perturbation107428450
is    O
a    O
drug    O
used    O
in    O
the    O
treatment    O
of    O
metabolic    O
acidosis    O
(    O
a    O
disorder    O
in    O
which    O
the    O
blood    O
is    O
too    O
acidic    O
)    O
.    O

See    O
also    O
Anopsia    B-Perturbation107428450
.    O

On    O
an    O
episode    O
of    O
"    O
The    O
Real    O
"    O
,    O
Braxton    O
revealed    O
that    O
she    O
suffered    O
from    O
vitiligo    B-Perturbation107428450
.    O

Alezzandrini    B-Perturbation107428450
syndrome    I-Perturbation107428450
is    O
a    O
very    O
rare    O
syndrome    O
characterized    O
by    O
a    O
unilateral    O
degenerative    O
retinitis    O
,    O
followed    O
after    O
several    O
months    O
by    O
ipsilateral    O
vitiligo    B-Perturbation107428450
on    O
the    O
face    O
and    O
ipsilateral    O
poliosis    O

Vitiligo    B-Perturbation107428450

Leukoderma    B-Perturbation107428450
,    O
not    O
elsewhere    O
classified    O

Khellin    O
has    O
been    O
used    O
as    O
an    O
herbal    O
folk    O
medicine    O
,    O
with    O
use    O
in    O
the    O
Mediterranean    O
dating    O
back    O
to    O
Ancient    O
Egypt    O
,    O
to    O
treat    O
a    O
variety    O
of    O
maladies    O
including    O
:    O
renal    O
colic    O
,    O
kidney    O
stones    O
,    O
coronary    O
disease    O
,    O
bronchial    O
asthma    O
,    O
vitiligo    B-Perturbation107428450
,    O
and    O
psoriasis    O
.    O

Other    O
clinically    O
important    O
side    O
effects    O
with    O
less    O
than    O
10%    O
frequency    O
were    O
ventricular    O
arrhythmia    O
,    O
inflammation    O
of    O
parts    O
of    O
the    O
eye    O
(    O
iridocyclitis    O
)    O
,    O
infusion    O
-    O
related    O
reactions    O
,    O
dizziness    O
,    O
peripheral    O
and    O
sensory    O
neuropathy    O
,    O
peeling    O
skin    O
,    O
erythema    O
multiforme    O
,    O
vitiligo    B-Perturbation107428450
,    O
and    O
psoriasis    O
.    O

Examination    O
under    O
a    O
Wood    O
lamp    O
can    O
also    O
reveal    O
the    O
nevus    O
anemicus    O
patch    O
will    O
not    O
emphasize    O
as    O
a    O
patch    O
of    O
vitiligo    B-Perturbation107428450
would    O
.    O

"    O
Koebnerization    O
"    O
may    O
also    O
occur    O
with    O
skin    O
disorders    O
such    O
as    O
vitiligo    B-Perturbation107428450
and    O
lichen    O
planus    O
.    O

His    O
main    O
focus    O
areas    O
are    O
general    O
dermatology    O
,    O
dermatopathology    O
,    O
autoimmune    O
and    O
hereditary    O
blistering    O
diseases    O
,    O
skin    O
cancer    O
as    O
well    O
as    O
immunological    O
inflammatory    O
skin    O
diseases    O
like    O
atopic    O
dermatitis    O
,    O
collagen    O
diseases    O
,    O
vitiligo    B-Perturbation107428450
and    O
urticaria    O
.    O

He    O
was    O
an    O
expert    O
in    O
the    O
metabolic    O
basis    O
of    O
inherited    O
diseases    O
,    O
particularly    O
vitiligo    B-Perturbation107428450
for    O
which    O
he    O
,    O
in    O
the    O
1980s    O
,    O
developed    O
a    O
skin    O
transplantation    O
therapy    O
.    O

In    O
20%    O
of    O
cases    O
,    O
the    O
hair    O
and    O
skin    O
overlying    O
affected    O
areas    O
may    O
become    O
hyperpigmented    O
or    O
hypopigmented    O
with    O
patches    O
of    O
unpigmented    B-Perturbation107428450
skin    I-Perturbation107428450
.    O

In    O
preliminary    O
studies    O
,    O
3    O
Korean    O
patients    O
with    O
periorbital    O
vitiligo    B-Perturbation107428450
(    O
i.e.    O
skin    O
blanching    O
)    O
were    O
treated    O
topically    O
with    O
the    O
FP    O
receptor    O
agonist    O
,    O
latanoprost    O
,    O
for    O
two    O
months    O
;    O
the    O
three    O
patients    O
experienced    O
20%    O
,    O
50%    O
,    O
and    O
>    O
90%    O
re    O
-    O
pigmentation    O
of    O
their    O
vitiligo    O
lesions    O
.    O

The    O
department    O
conducts    O
research    O
in    O
areas    O
including    O
acterial    O
cooperation    O
,    O
polyketide    O
synthase    O
clusture    O
,    O
antibiotic    O
resistance    O
,    O
Apoptosis    O
,    O
phosphate    O
solubilisation    O
,    O
nitrogen    O
fixation    O
,    O
probiotics    O
,    O
heavy    O
metal    O
toxicity    O
,    O
diabetes    O
,    O
prostate    O
cancer    O
,    O
female    O
infertility    O
,    O
endophytes    O
,    O
magnetoliposomes    O
,    O
protein    O
folding    O
,    O
and    O
vitiligo    B-Perturbation107428450
.    O

The    O
World    O
Vitiligo    O
Day    O
,    O
observed    O
on    O
June    O
25    O
,    O
is    O
an    O
initiative    O
aimed    O
to    O
build    O
global    O
awareness    O
about    O
vitiligo    B-Perturbation107428450
,    O
a    O
frequent    O
and    O
often    O
disfiguring    O
skin    O
disease    O
that    O
can    O
have    O
a    O
significantly    O
negative    O
social    O
and/or    O
psychological    O
impact    O
on    O
patients    O
,    O
in    O
part    O
because    O
of    O
numerous    O
misconceptions    O
still    O
present    O
in    O
large    O
parts    O
of    O
the    O
world    O
.    O

The    O
Vitiligo    O
Research    O
Foundation    O
(    O
VRF    O
)    O
is    O
a    O
New    O
York    O
-    O
based    O
501(c)3    O
non    O
-    O
profit    O
organization    O
focused    O
on    O
the    O
skin    O
disease    O
Vitiligo    B-Perturbation107428450
.    O

Consequently    O
,    O
he    O
considered    O
vitiligo    B-Perturbation107428450
as    O
a    O
"    O
spontaneous    O
cure    O
"    O
.    O

They    O
can    O
be    O
caused    O
by    O
vitiligo    B-Perturbation107428450
in    O
the    O
rare    O
McCune    O
–    O
Albright    O
syndrome    O
.    O

'    O
'    O
the'Vitiligo    O
ponctué    O
'    O
''    O
is    O
a    O
cutaneous    O
condition    O
,    O
an    O
unusual    O
form    O
of    O
vitiligo    B-Perturbation107428450
,    O
characterized    O
by    O
small    O
confetti    O
-    O
like    O
or    O
tiny    O
,    O
discrete    O
macules    O
that    O
may    O
occur    O
on    O
otherwise    O
normal    O
or    O
unusually    O
darkened    O
skin    O
.    O

It    O
can    O
also    O
cause    O
vitiligo    B-Perturbation107428450
(    O
an    O
auto    O
-    O
immune    O
disease    O
causing    O
loss    O
of    O
skin    O
pigment    O
resulting    O
in    O
a    O
blotchy    O
“    O
bleach    O
-    O
splashed    O
”    O
look    O
)    O
,    O
and    O
warts    O
which    O
can    O
be    O
extensive    O
and    O
recalcitrant    O
to    O
treatment    O
.    O

Vitiligo    B-Perturbation107428450

The    O
victim    O
's    O
skin    O
on    O
her    O
abdomen    O
had    O
areas    O
with    O
different    O
colors    O
,    O
possibly    O
indicating    O
that    O
she    O
had    O
vitiligo    B-Perturbation107428450
.    O

Professor    O
Ceccaldi    O
determined    O
that    O
:    O
"    O
Hair    O
,    O
astonishingly    O
preserved    O
,    O
showed    O
some    O
complementary    O
data    O
-    O
especially    O
about    O
pigmentation    O
:    O
Ramses    O
II    O
was    O
a    O
ginger    O
haired    O
'    O
cymnotriche    O
leucoderma    B-Perturbation107428450
'    O
.    O
"    O

Chrysiasis    B-Perturbation107428450
(    O
Gk    O
,    O
"    O
chrysos    O
"    O
–    O
'    O
gold    O
'    O
,    O
"    O
osis    O
"    O
–    O
'    O
condition    O
of    O
'    O
)    O
is    O
a    O
dermatological    O
condition    O
induced    O
by    O
the    O
parenteral    O
administration    O
of    O
gold    O
salts    O
,    O
usually    O
for    O
the    O
treatment    O
of    O
rheumatoid    O
arthritis    O
.    O

The    O
ground    O
water    O
in    O
the    O
local    O
area    O
is    O
known    O
to    O
contain    O
arsenic    O
compounds    O
,    O
and    O
the    O
illness    O
is    O
now    O
believed    O
to    O
have    O
been    O
caused    O
by    O
arsenic    B-Perturbation107428450
poisoning    I-Perturbation107428450
incurred    O
when    O
residents    O
of    O
the    O
area    O
inhaled    O
the    O
vapor    O
of    O
the    O
boiling    O
arsenic    O
-    O
contaminated    O
water    O
.    O

The    O
ground    O
water    O
in    O
the    O
area    O
is    O
known    O
to    O
contain    O
arsenic    O
compounds    O
,    O
and    O
the    O
illness    O
was    O
believed    O
to    O
have    O
been    O
caused    O
by    O
arsenic    B-Perturbation107428450
poisoning    I-Perturbation107428450
incurred    O
when    O
residents    O
of    O
the    O
area    O
inhaled    O
the    O
vapor    O
of    O
the    O
boiling    O
arsenic    O
-    O
contaminated    O
water    O
.    O

By    O
21    O
September    O
,    O
it    O
was    O
believed    O
that    O
the    O
illness    O
was    O
caused    O
by    O
arsenic    B-Perturbation107428450
poisoning    I-Perturbation107428450
.    O

mercury-    O
or    O
arsenic    B-Perturbation107428450
poisoning    I-Perturbation107428450
-    O
induced    O
porphyria    O
,    O
other    O
changes    O
in    O
porphyrin    O
profiles    O
appear    O
,    O
most    O
notably    O
elevations    O
of    O
uroporphyrins    O
I    O
&    O
III    O
,    O
coproporphyrins    O
I    O
&    O
III    O
,    O
and    O
pre    O
-    O
coproporphyrin    O
.    O

Luff    O
also    O
worked    O
on    O
food    O
safety    O
,    O
and    O
another    O
well    O
-    O
known    O
case    O
was    O
the    O
arsenic    B-Perturbation107428450
poisoning    I-Perturbation107428450
that    O
affected    O
beer    O
supplies    O
in    O
Manchester    O
in    O
1900    O
.    O

'    O
'    O
Les    O
différentes    O
formes    O
de    O
l'arsenicisme    O
et    O
en    O
particulier    O
de    O
l'arsenicisme    O
provenant    O
de    O
l'habitation    O
ou    O
des    O
objets    O
domestiques    O
''    O
,    O
1926    O
-    O
Different    O
forms    O
of    O
arsenic    B-Perturbation107428450
poisoning    I-Perturbation107428450
,    O
etc    O
.    O

Arsenic    B-Perturbation107428450
poisoning    I-Perturbation107428450

Chronic    O
exposure    O
to    O
lewisite    O
can    O
cause    O
arsenic    B-Perturbation107428450
poisoning    I-Perturbation107428450
(    O
due    O
to    O
its    O
arsenic    O
content    O
)    O
and    O
development    O
of    O
a    O
lewisite    O
allergy    O
.    O

Arsenic    B-Perturbation107428450
toxicity    I-Perturbation107428450

Arsenic    B-Perturbation107428450
and    I-Perturbation107428450
its    I-Perturbation107428450
compounds    I-Perturbation107428450

He    O
held    O
the    O
position    O
of    O
Earl    O
for    O
only    O
one    O
year    O
before    O
dying    O
from    O
arsenic    B-Perturbation107428450
poisoning    I-Perturbation107428450
.    O

She    O
chiefly    O
used    O
arsenic    B-Perturbation107428450
poisoning    I-Perturbation107428450
,    O
causing    O
gastric    O
pain    O
and    O
rapid    O
decline    O
of    O
health    O
.    O

Arsenic    O
is    O
a    O
moderately    O
abundant    O
element    O
in    O
Earth    O
's    O
crust    O
,    O
and    O
although    O
many    O
arsenic    O
compounds    O
are    O
often    O
considered    O
highly    B-Perturbation107428450
toxic    I-Perturbation107428450
to    O
most    O
life    O
,    O
a    O
wide    O
variety    O
of    O
organoarsenic    O
compounds    O
are    O
produced    O
biologically    O
and    O
various    O
organic    O
and    O
inorganic    O
arsenic    O
compounds    O
are    O
metabolized    O
by    O
numerous    O
organisms    O
.    O

Visible    O
signs    O
of    O
arsenic    B-Perturbation107428450
poisoning    I-Perturbation107428450
were    O
found    O
in    O
47    O
people    O
.    O

Scleral    B-Perturbation107428450
reinforcement    I-Perturbation107428450
surgery    I-Perturbation107428450
for    O
the    O
mitigation    O
of    O
degenerative    O
myopia    O

The    O
refraction    B-Perturbation107428450
error    I-Perturbation107428450
created    O
by    O
the    O
water    O
is    O
mostly    O
corrected    O
as    O
the    O
light    O
travels    O
from    O
water    O
to    O
air    O
through    O
a    O
flat    O
lens    O
,    O
except    O
that    O
objects    O
appear    O
approximately    O
34%    O
bigger    O
and    O
25%    O
closer    O
in    O
water    O
than    O
they    O
actually    O
are    O
.    O

Raskar    O
,    O
together    O
with    O
others    O
developed    O
a    O
computational    O
display    O
technology    O
that    O
allows    O
observers    O
with    O
refractive    B-Perturbation107428450
error    I-Perturbation107428450
,    O
cataracts    O
and    O
some    O
other    O
eye    O
disorders    O
to    O
perceive    O
a    O
focused    O
image    O
on    O
a    O
screen    O
without    O
wearing    O
refraction    O
-    O
corrective    O
spectacles    O
.    O

In    O
optometry    O
and    O
ophthalmology    O
,    O
Zernike    O
polynomials    O
are    O
used    O
to    O
describe    O
aberrations    O
of    O
the    O
cornea    O
or    O
lens    O
from    O
an    O
ideal    O
spherical    O
shape    O
,    O
which    O
result    O
in    O
refraction    B-Perturbation107428450
error    I-Perturbation107428450
.    O

It    O
is    O
similar    O
to    O
photorefractive    O
keratectomy    O
,    O
which    O
is    O
used    O
for    O
the    O
treatment    O
of    O
refractive    B-Perturbation107428450
conditions    I-Perturbation107428450
.    O

In    O
addition    O
to    O
work    O
in    O
ophthalmometry    O
,    O
Woinow    O
published    O
a    O
number    O
of    O
papers    O
on    O
subjects    O
such    O
as    O
ametropia    B-Perturbation107428450
,    O
the    O
blind    O
spot    O
,    O
binocular    O
vision    O
,    O
color    O
vision    O
,    O
accommodation    O
,    O
etc    O
.    O

H52    O
Disorders    B-Perturbation107428450
of    I-Perturbation107428450
refraction    I-Perturbation107428450
and    O
accommodation    O

An    O
automated    O
refraction    O
system    O
is    O
a    O
group    O
of    O
ophthalmic    O
devices    O
used    O
during    O
an    O
eye    O
examination    O
to    O
aid    O
in    O
the    O
determination    O
of    O
a    O
person    O
's    O
refractive    B-Perturbation107428450
error    I-Perturbation107428450
and    O
prescription    O
for    O
glasses    O
or    O
contact    O
lenses    O
.    O

In    O
1922    O
,    O
a    O
patent    O
was    O
filed    O
for    O
the    O
first    O
projection    O
lensmeter    O
,    O
which    O
has    O
a    O
similar    O
system    O
to    O
the    O
standard    O
lensmeter    O
pictured    O
above    O
,    O
but    O
projects    O
the    O
measuring    O
target    O
onto    O
a    O
screen    O
eliminating    O
the    O
need    O
for    O
correction    O
of    O
the    O
observer    O
's    O
refractive    B-Perturbation107428450
error    I-Perturbation107428450
in    O
the    O
instrument    O
itself    O
and    O
reducing    O
the    O
requirement    O
to    O
peer    O
down    O
a    O
small    O
telescope    O
into    O
the    O
instrument    O
.    O

although    O
infantile    O
esotropia    O
is    O
not    O
typically    O
associated    O
with    O
refractive    B-Perturbation107428450
error    I-Perturbation107428450
.    O

Since    O
the    O
cornea    O
does    O
not    O
grow    O
back    O
,    O
laser    O
is    O
used    O
to    O
remodel    O
the    O
cornea    O
refractive    O
properties    O
to    O
correct    O
refraction    B-Perturbation107428450
error    I-Perturbation107428450
,    O
such    O
as    O
astigmatism    O
,    O
myopia    O
,    O
and    O
hyperopia    O
.    O

Marco    O
Abbondanza    O
,    O
,    O
(    O
born    O
June    O
27    O
,    O
1953    O
-    O
Naples    O
,    O
Italy    O
)    O
is    O
an    O
Italian    O
ophthalmologist    O
and    O
eye    O
surgeon    O
,    O
best    O
known    O
for    O
his    O
treatment    O
of    O
keratoconus    O
,    O
refractive    B-Perturbation107428450
errors    I-Perturbation107428450
and    O
cataracts    O
.    O

Idiopathic    B-Perturbation107428450
guttate    I-Perturbation107428450
hypomelanosis    I-Perturbation107428450
(    O
leukopathia    O
symmetrica    O
progressiva    O
)    O

Alezzandrini    B-Perturbation107428450
syndrome    I-Perturbation107428450
is    O
a    O
very    O
rare    O
syndrome    O
characterized    O
by    O
a    O
unilateral    O
degenerative    O
retinitis    O
,    O
followed    O
after    O
several    O
months    O
by    O
ipsilateral    O
vitiligo    B-Perturbation107428450
on    O
the    O
face    O
and    O
ipsilateral    O
poliosis    O

Pigmentatio    B-Perturbation107428450
reticularis    I-Perturbation107428450
faciei    I-Perturbation107428450
et    I-Perturbation107428450
colli    I-Perturbation107428450

This    O
includes    O
Chediak-Higashi    B-Perturbation107428450
syndrome    I-Perturbation107428450
and    O
Elejalde    B-Perturbation107428450
syndrome    I-Perturbation107428450
(    O
neuroectodermal    O
melanolysosomal    O
disease    O
)    O
.    O

Familial    B-Perturbation107428450
progressive    I-Perturbation107428450
hyperpigmentation    I-Perturbation107428450
is    O
characterized    O
by    O
patches    O
of    O
hyperpigmentation    O
,    O
present    O
at    O
birth    O
,    O
which    O
increase    O
in    O
size    O
and    O
number    O
with    O
age    O
.    O

Linea    B-Perturbation107428450
nigra    I-Perturbation107428450
—    O
a    O
hyperpigmented    O
line    O
found    O
on    O
the    O
abdomen    O
during    O
pregnancy    O
.    O

Linea    B-Perturbation107428450
nigra    I-Perturbation107428450

Iron    B-Perturbation107428450
metallic    I-Perturbation107428450
discoloration    I-Perturbation107428450
occurred    O
more    O
frequently    O
in    O
the    O
past    O
when    O
soluble    O
iron    O
compounds    O
were    O
used    O
in    O
the    O
treatment    O
of    O
allergic    O
contact    O
and    O
other    O
dermatitis    O
,    O
and    O
in    O
eroded    O
areas    O
iron    O
was    O
sometimes    O
deposited    O
in    O
the    O
skin    O
,    O
like    O
a    O
tattoo    O
.    O

Conversely    O
excessive    O
fluid    O
intake    O
dilutes    O
the    O
extracellular    O
fluid    O
causing    O
the    O
hypothalamus    O
to    O
register    O
hypotonic    B-Perturbation107428450
hyponatremia    I-Perturbation107428450
conditions    O
.    O

Associative    B-Perturbation107428450
visual    I-Perturbation107428450
agnosia    I-Perturbation107428450

Hemosiderin    B-Perturbation107428450
hyperpigmentation    I-Perturbation107428450
is    O
pigmentation    O
due    O
to    O
deposits    O
of    O
hemosiderin    O
,    O
and    O
occurs    O
in    O
purpura    O
,    O
hemochromotosis    B-Perturbation107428450
,    O
hemorrhagic    O
diseases    O
,    O
and    O
stasis    O
dermatitis    O
.    O

Periorbital    B-Perturbation107428450
hyperpigmentation    I-Perturbation107428450
is    O
characterized    O
by    O
dark    O
circles    O
around    O
the    O
eyes    O
,    O
which    O
are    O
common    O
,    O
often    O
familial    O
,    O
and    O
frequently    O
found    O
in    O
individuals    O
with    O
dark    O
pigmentation    O
or    O
Mediterranean    O
ancestry    O
.    O

Fluid    B-Perturbation107428450
balance    I-Perturbation107428450

This    O
encompasses    O
all    O
functions    O
of    O
the    O
kidney    O
,    O
including    O
maintenance    O
of    O
acid    O
-    O
base    O
balance    O
;    O
regulation    O
of    O
fluid    B-Perturbation107428450
balance    I-Perturbation107428450
;    O
regulation    O
of    O
sodium    O
,    O
potassium    O
,    O
and    O
other    O
electrolytes    O
;    O
clearance    O
of    O
toxins    O
;    O
absorption    O
of    O
glucose    O
,    O
amino    O
acids    O
,    O
and    O
other    O
small    O
molecules    O
;    O
regulation    O
of    O
blood    O
pressure    O
;    O
production    O
of    O
various    O
hormones    O
,    O
such    O
as    O
erythropoietin    O
;    O
and    O
activation    O
of    O
vitamin    O
D.    O

Mineralocorticoids    O
are    O
produced    O
in    O
the    O
adrenal    O
cortex    O
and    O
influence    O
salt    O
and    O
water    O
balances    O
(    O
electrolyte    O
balance    O
and    O
fluid    B-Perturbation107428450
balance    I-Perturbation107428450
)    O
.    O

Experiments    O
in    O
humans    O
found    O
that    O
demineralized    O
water    O
increased    O
diuresis    B-Perturbation107428450
and    O
the    O
elimination    O
of    O
electrolytes    O
,    O
with    O
decreased    O
blood    O
serum    O
potassium    O
concentration    O
.    O

Immersion    O
of    O
the    O
human    O
body    O
in    O
water    O
affects    O
the    O
circulation    O
,    O
renal    O
system    O
,    O
fluid    B-Perturbation107428450
balance    I-Perturbation107428450
,    O
and    O
breathing    O
,    O
because    O
the    O
external    O
hydrostatic    O
pressure    O
of    O
the    O
water    O
provides    O
support    O
against    O
the    O
internal    O
hydrostatic    O
pressure    O
of    O
the    O
blood    O
.    O

Treatments    O
include    O
medication    O
and    O
correction    O
of    O
the    O
fluid    B-Perturbation107428450
and    O
electrolyte    O
balance    O
.    O

Galli–Galli    B-Perturbation107428450
disease    I-Perturbation107428450
is    O
a    O
rare    O
inherited    O
condition    O
that    O
has    O
close    O
resemblance    O
clinically    O
to    O
Dowling-Degos'    B-Perturbation107428450
disease    I-Perturbation107428450
,    O
but    O
is    O
histologically    O
distinct    O
,    O
characterized    O
by    O
skin    O
lesions    O
that    O
are    O
1-    O
to    O
2-mm    O
slightly    O
keratotic    O
red    O
to    O
dark    O
brown    O
papules    O
which    O
are    O
focally    O
confluent    O
in    O
a    O
reticulate    O
pattern    O
.    O

His    O
other    O
son    O
,    O
also    O
named    O
John    O
Punnett    O
Peters    O
(    O
Dec.    O
4    O
,    O
1887    O
-    O
Dec.    O
29    O
,    O
1955    O
)    O
,    O
initially    O
described    O
the    O
Cerebral    B-Perturbation107428450
salt-wasting    I-Perturbation107428450
syndrome    I-Perturbation107428450
.    O

Dyschromatosis    B-Perturbation107428450
symmetrica    I-Perturbation107428450
hereditaria    I-Perturbation107428450
,    O
an    O
inherited    O
dermatosis    O

The    O
Mizuo    O
–    O
Nakamura    O
Phenomenon    O
is    O
a    O
phenomenon    O
observed    O
in    O
Oguchi's    B-Perturbation107428450
disease    I-Perturbation107428450
.    O

Transient    B-Perturbation107428450
neonatal    I-Perturbation107428450
pustular    I-Perturbation107428450
melanosis    I-Perturbation107428450
(    O
also    O
known    O
as    O
"    O
Transient    O
neonatal    O
pustulosis    O
"    O
,    O
and    O
"    O
Lentigines    O
neonatorum    O
"    O
)    O
is    O
a    O
cutaneous    O
condition    O
that    O
presents    O
at    O
birth    O
with    O
1-    O
to    O
3-mm    O
flaccid    O
,    O
superficial    O
fragile    O
pustules    O
,    O
some    O
of    O
which    O
may    O
have    O
already    O
resolved    O
in    O
utero    O
,    O
leaving    O
pigmented    O
macules    O
.    O

Central    B-Perturbation107428450
pontine    I-Perturbation107428450
myelinolysis    I-Perturbation107428450

Other    O
conditions    O
such    O
as    O
central    B-Perturbation107428450
pontine    I-Perturbation107428450
myelinolysis    I-Perturbation107428450
have    O
about    O
a    O
third    O
of    O
patients    O
recover    O
and    O
the    O
other    O
two    O
thirds    O
experience    O
varying    O
degrees    O
of    O
disability    O
.    O

Central    B-Perturbation107428450
pontine    I-Perturbation107428450
myelinolysis    I-Perturbation107428450

This    O
is    O
shown    O
by    O
their    O
poor    O
performance    O
in    O
Ishihara    B-Perturbation107428450
test    I-Perturbation107428450
.    O

---    O
color    B-Perturbation107428450
perception    I-Perturbation107428450
tests    I-Perturbation107428450

hyperphosphatemia    B-Perturbation107428450

Hyperphosphatemia    B-Perturbation107428450
is    O
an    O
electrolyte    O
disturbance    O
in    O
which    O
there    O
is    O
an    O
abnormally    O
elevated    O
level    O
of    O
phosphate    O
in    O
the    O
blood    O
.    O

Hyperphosphatemia    B-Perturbation107428450
,    O
elevated    O
concentrations    O
of    O
phosphate    O
in    O
the    O
blood    O

Hyperphosphatemia    B-Perturbation107428450

A    O
blood    O
test    O
may    O
reveal    O
increases    O
in    O
blood    O
urea    O
nitrogen    O
(    O
BUN    O
)    O
,    O
creatinine    O
,    O
phosphorus    B-Perturbation107428450
,    O
and    O
calcium    O
.    O

This    O
area    O
of    O
functional    O
specialization    O
was    O
also    O
supported    O
by    O
lesion    O
study    O
patients    O
who    O
's    O
damage    O
caused    O
cerebral    O
motion    B-Perturbation107428450
blindness    I-Perturbation107428450
.    O

Motion    B-Perturbation107428450
blindness    I-Perturbation107428450
,    O
a    O
neuropsychological    O
disorder    O
causing    O
an    O
inability    O
to    O
perceive    O
motion    O
.    O

Pallister-Killian    B-Perturbation107428450
syndrome    I-Perturbation107428450
(    O
tetrasomy    O
12p    O
)    O

Renal    O
overproduction    O
of    O
bicarbonate    O
,    O
in    O
either    O
contraction    B-Perturbation107428450
alkalosis    I-Perturbation107428450
or    O
Cushing    O
's    O
disease    O

.    O
They    O
can    O
be    O
distinguished    O
from    O
a    O
partially    O
leucistic    B-Perturbation107428450
common    O
swift    O
by    O
the    O
deeper    O
tail    O
fork    O
,    O
longer    O
wings    O
,    O
bigger    O
head    O
and    O
larger    O
white    O
throat    O
patch    O
.    O

.    O
They    O
can    O
be    O
distinguished    O
from    O
a    O
partially    O
leucistic    B-Perturbation107428450
common    O
swift    O
by    O
the    O
deeper    O
tail    O
fork    O
,    O
longer    O
wings    O
,    O
bigger    O
head    O
and    O
larger    O
white    O
throat    O
patch    O
.    O

Leucism    B-Perturbation107428450

The    O
adjacent    O
mainland    O
population    O
split    O
into    O
the    O
subtropical    O
and    O
partially    O
leucistic    B-Perturbation107428450
Elliot    O
's    O
pheasant    O
(    O
"    O
S.    O
ellioti    O
"    O
)    O
and    O
the    O
tropical    O
Mrs.    O
Hume    O
's    O
pheasant    O
only    O
in    O
the    O
Middle    O
Pleistocene    O
,    O
around    O
half    O
a    O
million    O
years    O
ago    O
.    O

Leucistic    B-Perturbation107428450
or    O
'    O
blonde    O
'    O
hedgehogs    O
occasionally    O
occur    O
.    O

A    O
white    O
stag    O
(    O
or    O
white    O
hind    O
for    O
the    O
female    O
)    O
is    O
a    O
white    O
-    O
colored    O
red    O
deer    O
or    O
fallow    O
deer    O
,    O
explained    O
by    O
a    O
condition    O
known    O
as    O
leucism    B-Perturbation107428450
that    O
causes    O
its    O
hair    O
and    O
skin    O
to    O
lose    O
its    O
natural    O
colour    O
.    O

Leucism    B-Perturbation107428450
is    O
a    O
rare    O
genetic    O
pattern    O
that    O
causes    O
a    O
reduction    O
in    O
the    O
pigment    O
of    O
an    O
animal    O
's    O
hair    O
and    O
skin    O
.    O

Abnormally    O
leucistic    B-Perturbation107428450
or    O
near    O
albino    O
birds    O
have    O
been    O
reported    O
.    O

The    O
star    O
of    O
the    O
attraction    O
is    O
a    O
leucistic    B-Perturbation107428450
alligator    O
named    O
Bouya    O
,    O
a    O
white    O
gator    O
with    O
blue    O
eyes    O
.    O

Selective    O
breeding    O
has    O
resulted    O
in    O
a    O
leucistic    B-Perturbation107428450
strain    O
,    O
which    O
lacks    O
the    O
dark    O
barring    O
of    O
the    O
wild    O
type    O
.    O

Leucism    B-Perturbation107428450

Leucism    B-Perturbation107428450
occurs    O
only    O
in    O
this    O
type    O
of    O
lion    O
,    O
but    O
is    O
quite    O
rare    O
.    O

Hermansky–Pudlak    B-Perturbation107428450
syndrome    I-Perturbation107428450

Hermansky–Pudlak    B-Perturbation107428450
syndrome    I-Perturbation107428450
(    O
ILDS    O
E70.360    O
)    O

Hermansky-Pudlak    B-Perturbation107428450
Syndrome    I-Perturbation107428450

Albinism–deafness    B-Perturbation107428450
syndrome    I-Perturbation107428450
(    O
Woolf    O
syndrome    O
,    O
Ziprkowski    O
–    O
Margolis    O
syndrome    O
)    O

Dyschromia    B-Perturbation107428450
refers    O
to    O
an    O
alteration    O
of    O
the    O
color    O
of    O
the    O
skin    O
or    O
nails    O
.    O

mmol    O
/    O
l    O
[    O
338    O
mg    O
/    O
dl    O
]    O
at    O
2:30pm    O
)    O
—    O
and    O
leave    O
her    O
at    O
significant    O
risk    O
of    O
developing    O
diabetic    B-Perturbation107428450
ketoacidosis    I-Perturbation107428450
.    O

Diabetic    B-Perturbation107428450
ketoacidosis    I-Perturbation107428450
,    O
in    O
which    O
high    O
levels    O
of    O
acidic    O
ketone    O
bodies    O
are    O
produced    O

Another    O
disadvantage    O
of    O
insulin    O
pump    O
use    O
is    O
a    O
higher    O
risk    O
of    O
developing    O
diabetic    B-Perturbation107428450
ketoacidosis    I-Perturbation107428450
if    O
the    O
pump    O
malfunctions    O
.    O

Causes    O
of    O
euthyroid    O
sick    O
syndrome    O
include    O
a    O
number    O
of    O
acute    O
and    O
chronic    O
conditions    O
,    O
including    O
pneumonia    O
,    O
fasting    O
,    O
starvation    O
,    O
anorexia    O
nervosa    O
,    O
sepsis    O
,    O
trauma    O
,    O
cardiopulmonary    O
bypass    O
,    O
malignancy    O
,    O
stress    O
,    O
heart    O
failure    O
,    O
hypothermia    O
,    O
myocardial    O
infarction    O
,    O
chronic    O
renal    O
failure    O
,    O
cirrhosis    O
,    O
and    O
diabetic    B-Perturbation107428450
ketoacidosis    I-Perturbation107428450
.    O

Biologically    O
,    O
infants    O
display    O
fasting    O
hypoglycemia    O
,    O
postprandial    O
hyperglycemia    O
and    O
hyperinsulinemia    O
,    O
which    O
progress    O
to    O
permanent    O
hyperglycemia    O
and    O
recurrent    O
diabetic    B-Perturbation107428450
ketoacidosis    I-Perturbation107428450
.    O

This    O
results    O
in    O
shunting    O
of    O
excess    O
acetyl    O
-    O
CoA    O
into    O
the    O
ketone    O
synthesis    O
pathway    O
via    O
HMG    O
-    O
CoA    O
,    O
leading    O
to    O
the    O
development    O
of    O
diabetic    B-Perturbation107428450
ketoacidosis    I-Perturbation107428450
.    O

The    O
dependence    O
on    O
fat    O
would    O
eventually    O
lead    O
to    O
acidosis    B-Perturbation107428450
,    O
followed    O
by    O
coma    O
and    O
death    O
.    O

This    O
eventually    O
led    O
to    O
acidosis    B-Perturbation107428450
,    O
followed    O
by    O
coma    O
and    O
death    O
.    O

Allen    O
found    O
that    O
a    O
liquids    O
-    O
only    O
diet    O
could    O
eliminate    O
glycosuria    O
and    O
acidosis    B-Perturbation107428450
.    O

The    O
diabetes    O
is    O
usually    O
diagnosed    O
in    O
the    O
first    O
3    O
months    O
of    O
life    O
due    O
to    O
continuing    O
poor    O
weight    O
gain    O
,    O
polyuria    O
,    O
or    O
diabetic    B-Perturbation107428450
ketoacidosis    I-Perturbation107428450
.    O

Other    O
conditions    O
that    O
can    O
predispose    O
to    O
mild    O
hypermagnesemia    O
are    O
diabetic    B-Perturbation107428450
ketoacidosis    I-Perturbation107428450
,    O
adrenal    O
insufficiency    O
,    O
hypothyroidism    O
,    O
hyperparathyroidism    O
and    O
lithium    O
intoxication    O
.    O

Alcohol    O
stimulates    O
the    O
kidneys    O
'    O
excretion    O
of    O
magnesium    O
,    O
which    O
is    O
also    O
increased    O
because    O
of    O
alcoholic    O
and    O
diabetic    B-Perturbation107428450
ketoacidosis    I-Perturbation107428450
,    O
low    B-Perturbation107428450
blood    I-Perturbation107428450
phosphate    I-Perturbation107428450
levels    I-Perturbation107428450
,    O
and    O
hyperaldosteronism    O
resulting    O
from    O
liver    O
disease    O
.    O

Patients    O
with    O
diabetic    B-Perturbation107428450
ketoacidosis    I-Perturbation107428450
should    O
have    O
their    O
magnesium    O
levels    O
monitored    O
to    O
ensure    O
that    O
the    O
serum    O
loss    O
of    O
potassium    O
,    O
which    O
is    O
driven    O
intracellularly    O
by    O
insulin    O
administration    O
,    O
is    O
not    O
exacerbated    O
by    O
additional    O
urinary    O
losses    O
.    O

This    O
can    O
be    O
seen    O
in    O
treatment    O
of    O
diabetic    B-Perturbation107428450
ketoacidosis    I-Perturbation107428450
,    O
refeeding    O
,    O
short    O
-    O
term    O
increases    O
in    O
cellular    O
demand    O
(    O
e.g.    O
hungry    O
bone    O
syndrome    O
)    O
and    O
acute    O
respiratory    O
alkalosis    O
.    O

Milk-alkali    B-Perturbation107428450
syndrome    I-Perturbation107428450

Canthaxanthin    B-Perturbation107428450

Finally    O
,    O
"    O
Lamprologus    O
ocellatus    O
"    O
are    O
similar    O
to    O
other    O
African    O
Cichlids    O
in    O
that    O
their    O
coloring    O
will    O
benefit    O
from    O
a    O
diet    O
containing    O
quantities    O
of    O
beta    O
-    O
carotene    O
and    O
canthaxanthin    B-Perturbation107428450
.    O

Two    O
red    O
keto    O
-    O
carotenoid    O
pigments    O
,    O
canthaxanthin    B-Perturbation107428450
and    O
adonirubin    O
,    O
are    O
responsible    O
for    O
the    O
redness    O
in    O
the    O
red    O
-    O
capped    O
robin    O
's    O
plumage    O
.    O

Vagabond's    B-Perturbation107428450
leukomelanoderma    I-Perturbation107428450
is    O
a    O
skin    O
disorder    O
found    O
in    O
the    O
elderly    O
with    O
a    O
combination    O
of    O
dietary    O
deficiency    O
and    O
lack    O
of    O
hygiene    O
,    O
resulting    O
in    O
an    O
infestation    O
of    O
"    O
Pediculus    O
humanus    O
"    O
.    O

Bicarbonate    O
concentration    O
is    O
also    O
further    O
regulated    O
by    O
renal    B-Perturbation107428450
compensation    I-Perturbation107428450
,    O
the    O
process    O
by    O
which    O
the    O
kidneys    O
regulate    O
the    O
concentration    O
of    O
bicarbonate    O
ions    O
by    O
excreting    O
H+    O
ions    O
into    O
the    O
urine    O
while    O
,    O
at    O
the    O
same    O
time    O
,    O
secreting    O
HCO    O
ions    O
into    O
the    O
blood    O
plasma    O
,    O
or    O
"    O
vice    O
versa    O
"    O
,    O
depending    O
on    O
whether    O
the    O
plasma    O
pH    O
is    O
falling    O
or    O
rising    O
,    O
respectively    O
.    O

Entomopia    B-Perturbation107428450
(    O
from    O
the    O
Greek    O
roots    O
for    O
"    O
insect    O
"    O
and    O
"    O
eye    O
"    O
)    O
,    O
is    O
a    O
form    O
of    O
polyopia    O
in    O
which    O
a    O
grid    O
-    O
like    O
pattern    O
of    O
multiple    O
copies    O
of    O
the    O
same    O
visual    O
image    O
is    O
seen    O
.    O

This    O
effect    O
is    O
also    O
used    O
in    O
pinhole    B-Perturbation107428450
occluder    I-Perturbation107428450
,    O
which    O
are    O
used    O
by    O
ophthalmologists    O
,    O
orthoptists    O
and    O
optometrists    O
to    O
test    O
visual    O
acuity    O
.    O

Apperceptive    B-Perturbation107428450
agnosia    I-Perturbation107428450
is    O
failure    O
in    O
recognition    O
that    O
is    O
due    O
to    O
a    O
failure    O
of    O
perception    O
.    O

Publication    O
of    O
textbooks    O
and    O
other    O
books    O
for    O
general    O
reading    O
in    O
the    O
DAISY    B-Perturbation107428450
standard    O
.    O

DAISY    O
Forum    O
of    O
India    O
is    O
an    O
Associate    O
Member    O
of    O
DAISY    B-Perturbation107428450
Consortium    I-Perturbation107428450
,    O
which    O
is    O
a    O
global    O
consortium    O
working    O
for    O
the    O
development    O
and    O
promotion    O
of    O
the    O
DAISY    B-Perturbation107428450
standard    O
.    O

The    O
organization    O
operates    O
a    O
library    O
that    O
includes    O
more    O
than    O
80,000    O
accessible    O
materials    O
in    O
formats    O
such    O
as    O
Braille    O
,    O
audio    O
,    O
DAISY    B-Perturbation107428450
and    O
e    O
-    O
text    O
.    O

DAISY    B-Perturbation107428450
Digital    I-Perturbation107428450
Talking    I-Perturbation107428450
Book    I-Perturbation107428450

It    O
is    O
used    O
in    O
EPUB    O
2.0    O
e    O
-    O
books    O
and    O
DAISY    B-Perturbation107428450
Digital    I-Perturbation107428450
Talking    I-Perturbation107428450
Book    I-Perturbation107428450
,    O
as    O
well    O
as    O
other    O
places    O
.    O

Familial    O
hypophosphataemia    B-Perturbation107428450

Alcohol    O
stimulates    O
the    O
kidneys    O
'    O
excretion    O
of    O
magnesium    O
,    O
which    O
is    O
also    O
increased    O
because    O
of    O
alcoholic    O
and    O
diabetic    B-Perturbation107428450
ketoacidosis    I-Perturbation107428450
,    O
low    B-Perturbation107428450
blood    I-Perturbation107428450
phosphate    I-Perturbation107428450
levels    I-Perturbation107428450
,    O
and    O
hyperaldosteronism    O
resulting    O
from    O
liver    O
disease    O
.    O

Hypophosphatemia    B-Perturbation107428450
,    O
a    O
low    O
concentration    O
of    O
phosphate    O
in    O
the    O
blood    O

Hypophosphatemia    B-Perturbation107428450
is    O
an    O
electrolyte    O
disturbance    O
in    O
which    O
there    O
is    O
an    O
abnormally    O
low    O
level    O
of    O
phosphate    O
in    O
the    O
blood    O
.    O

Laboratory    O
findings    O
include    O
low    O
-    O
normal    O
serum    O
calcium    O
,    O
moderately    O
low    O
serum    O
phosphate    O
,    O
elevated    O
serum    O
alkaline    O
phosphatase    O
,    O
and    O
low    O
serum    O
1,25    O
dihydroxy    O
-    O
vitamin    O
D    O
levels    O
,    O
hyperphosphaturia    B-Perturbation107428450
,    O
and    O
no    O
evidence    O
of    O
hyperparathyroidism    O
.    O

In    O
November    O
2010    O
the    O
FDA    O
allowed    O
Ocata    O
to    O
begin    O
a    O
Phase    O
I    O
/    O
II    O
human    O
clinical    O
trial    O
to    O
use    O
its    O
retinal    O
pigment    O
epithelium    O
cell    O
therapy    O
to    O
treat    O
Stargardt    B-Perturbation107428450
disease    I-Perturbation107428450
,    O
a    O
form    O
of    O
inherited    O
juvenile    O
macular    O
degeneration    O
.    O

At    O
19    O
he    O
began    O
losing    O
his    O
vision    O
due    O
to    O
Stargardt's    B-Perturbation107428450
disease    I-Perturbation107428450
.    O

In    O
2006    O
,    O
he    O
started    O
losing    O
his    O
sight    O
due    O
to    O
Stargardt    B-Perturbation107428450
disease    I-Perturbation107428450
,    O
a    O
degenerative    O
condition    O
,    O
and    O
became    O
legally    O
blind    O
in    O
2007    O
.    O

The    O
compound    O
is    O
also    O
being    O
investigated    O
as    O
a    O
potential    O
therapy    O
for    O
proliferative    O
diabetic    O
retinopathy    O
,    O
diabetic    O
macular    O
edema    O
and    O
Stargardt    B-Perturbation107428450
disease    I-Perturbation107428450
.    O

Born    O
in    O
Brighton    O
,    O
Quilter    O
is    O
visually    O
impaired    O
after    O
developing    O
Stargardt    B-Perturbation107428450
disease    I-Perturbation107428450
in    O
1992    O
.    O

Common    O
ADRs    O
include    O
:    O
hyponatremia    O
,    O
hypokalemia    O
,    O
hypomagnesemia    B-Perturbation107428450
,    O
dehydration    O
,    O
hyperuricemia    O
,    O
gout    O
,    O
dizziness    O
,    O
postural    O
hypotension    O
,    O
syncope    O
.    O

Hypomagnesemia    B-Perturbation107428450

Hypomagnesemia    B-Perturbation107428450

Other    O
changes    O
in    O
blood    O
chemistry    O
such    O
as    O
hypomagnesemia    B-Perturbation107428450
,    O
hypocalcemia    O
,    O
hyperkalemia    O
,    O
and    O
an    O
increase    O
in    O
blood    O
urea    O
nitrogen    O
(    O
BUN    O
)    O
can    O
occur    O
.    O

Hypermagnesemia    B-Perturbation107428450
/    O
Hypomagnesemia    B-Perturbation107428450

For    O
a    O
detailed    O
description    O
of    O
magnesium    O
homeostasis    O
and    O
metabolism    O
see    O
hypomagnesemia    B-Perturbation107428450
.    O

Hypomagnesemia    B-Perturbation107428450
,    O
also    O
spelled    O
hypomagnesaemia    B-Perturbation107428450
,    O
is    O
an    O
electrolyte    O
disturbance    O
in    O
which    O
there    O
is    O
a    O
low    O
level    O
of    O
magnesium    O
in    O
the    O
blood    O
.    O

Severe    O
hypermagnesemia    B-Perturbation107428450
or    O
hypomagnesemia    B-Perturbation107428450

Tar    B-Perturbation107428450
melanosis    I-Perturbation107428450
(    O
also    O
known    O
as    O
"    O
Melanodermatitis    O
toxica    O
lichenoides    O
"    O
)    O
is    O
an    O
occupational    O
dermatosis    O
that    O
occurs    O
among    O
tar    O
handlers    O
after    O
several    O
years    O
of    O
exposure    O
,    O
characterized    O
by    O
a    O
severe    O
widespread    O
itching    O
that    O
is    O
soon    O
followed    O
by    O
the    O
appearance    O
of    O
reticular    O
pigmentation    O
,    O
telangiectases    O
,    O
and    O
a    O
shiny    O
appearance    O
of    O
the    O
skin    O
.    O

Wende–Bauckus    B-Perturbation107428450
syndrome    I-Perturbation107428450
(    O
Pegum    O
syndrome    O
)    O

Melanoma-associated    B-Perturbation107428450
leukoderma    I-Perturbation107428450

Elevated    O
levels    O
of    O
magnesium    O
(    O
hypermagnesemia    B-Perturbation107428450
)    O
,    O
however    O
,    O
are    O
nearly    O
always    O
caused    O
by    O
a    O
medical    O
treatment    O
.    O

Hypermagnesemia    B-Perturbation107428450

Severe    O
hypermagnesemia    B-Perturbation107428450
or    O
hypomagnesemia    B-Perturbation107428450

Haber    B-Perturbation107428450
syndrome    I-Perturbation107428450

A    O
Yorkie    O
with    O
this    O
condition    O
might    O
exhibit    O
a    O
wide    O
variety    O
of    O
symptoms    O
,    O
such    O
as    O
small    O
stature    O
,    O
poor    O
appetite    O
,    O
weak    O
muscle    O
development    O
,    O
decreased    O
ability    O
to    O
learn    O
,    O
inferior    O
coordination    O
,    O
occasional    O
vomiting    O
and    O
diarrhea    O
,    O
behavioral    O
abnormalities    O
,    O
seizures    O
(    O
especially    O
after    O
a    O
meal    O
)    O
,    O
and    O
blindness    B-Perturbation107428450
,    O
which    O
could    O
lead    O
to    O
a    O
coma    O
and    O
death    O
.    O

Even    O
though    O
most    O
of    O
his    O
biographers    O
assert    O
that    O
he    O
was    O
completely    O
blind    B-Perturbation107428450
,    O
some    O
early    O
biographers    O
are    O
silent    O
about    O
this    O
or    O
do    O
not    O
mention    O
him    O
as    O
being    O
born    O
blind    O
.    O

In    O
one    O
episode    O
(    O
"    O
The    O
Seeing    O
Eye    O
Horse    O
"    O
)    O
a    O
blind    B-Perturbation107428450
character    O
realizes    O
that    O
Isis    O
and    O
Andrea    O
have    O
almost    O
identical    O
voices    O
,    O
but    O
otherwise    O
the    O
series    O
never    O
explored    O
the    O
secret    O
identity    O
dilemma    O
in    O
any    O
serious    O
way    O
.    O

He    O
also    O
had    O
plans    O
for    O
education    O
of    O
the    O
blind    B-Perturbation107428450
people    O
and    O
had    O
helped    O
establishing    O
girl    O
schools    O
in    O
Iran    O
.    O

Blindness    B-Perturbation107428450
or    O
loss    O
of    O
vision    O
indicates    O
involvement    O
of    O
the    O
orbital    O
apex    O
,    O
which    O
is    O
more    O
serious    O
,    O
requiring    O
urgent    O
surgical    O
intervention    O
.    O

Rankin    O
later    O
left    O
for    O
Ethiopia    O
where    O
he    O
was    O
the    O
Bible    O
Society    O
in    O
Ethiopia    O
and    O
later    O
served    O
the    O
visually    B-Perturbation107428450
challenged    I-Perturbation107428450
at    O
a    O
home    O
in    O
Addis    O
Ababa    O
.    O

The    O
isolated    O
community    O
prospered    O
over    O
the    O
years    O
,    O
despite    O
a    O
disease    O
that    O
struck    O
them    O
early    O
on    O
,    O
rendering    O
all    O
newborns    O
blind    B-Perturbation107428450
.    O

Due    O
to    O
their    O
troglobitic    O
lifestyle    O
,    O
thermosbaenaceans    O
lack    O
visual    O
pigments    O
and    O
are    O
therefore    O
blind    B-Perturbation107428450
.    O

Albert    O
also    O
voiced    O
the    O
blind    B-Perturbation107428450
superhero    O
Daredevil    O
in    O
two    O
episodes    O
of    O
"    O
Spider    O
-    O
Man    O
:    O
The    O
Animated    O
Series    O
"    O
in    O
the    O
1990s    O
.    O

Services    O
for    O
the    O
visually    B-Perturbation107428450
impaired    I-Perturbation107428450
are    O
also    O
a    O
key    O
focus    O
for    O
the    O
institution    O
,    O
with    O
a    O
collection    O
of    O
12,000    O
Braille    O
books    O
together    O
with    O
information    O
technology    O
resources    O
for    O
readers    O
.    O

Dominant    O
optic    O
atrophy    O
,    O
or    O
dominant    O
optic    O
atrophy    O
,    O
Kjer    O
's    O
type    O
,    O
is    O
an    O
autosomally    O
inherited    O
disease    O
that    O
affects    O
the    O
optic    O
nerves    O
,    O
causing    O
reduced    O
visual    O
acuity    O
and    O
blindness    B-Perturbation107428450
beginning    O
in    O
childhood    O
.    O

Dominant    O
optic    O
atrophy    O
usually    O
affects    O
both    O
eyes    O
roughly    O
symmetrically    O
in    O
a    O
slowly    O
progressive    O
pattern    O
of    O
vision    B-Perturbation107428450
loss    I-Perturbation107428450
beginning    O
in    O
childhood    O
and    O
is    O
hence    O
a    O
contributor    O
to    O
childhood    O
blindness    O
.    O

Born    O
legally    B-Perturbation107428450
blind    I-Perturbation107428450
,    O
Kern    O
is    O
aided    O
in    O
studio    O
by    O
SONAR    O
’s    O
accessibility    O
and    O
Dancing    O
Dots’    O
assistive    O
music    O
technologies    O
for    O
the    O
vision    O
impaired    O
.    O

Sufferers    O
endure    O
the    O
restriction    O
of    O
visual    O
fields    O
,    O
night    O
blindness    O
,    O
and    O
eventually    O
severe    O
or    O
complete    O
blindness    B-Perturbation107428450
.    O

Every    O
participant    O
at    O
the    O
Paralympics    O
has    O
their    O
disability    O
grouped    O
into    O
one    O
of    O
five    O
disability    O
categories    O
;    O
amputation    O
(    O
the    O
condition    O
may    O
be    O
congenital    O
or    O
sustained    O
through    O
injury    O
or    O
illness    O
)    O
;    O
cerebral    O
palsy    O
;    O
wheelchair    O
athletes    O
(    O
there    O
is    O
often    O
overlap    O
between    O
this    O
and    O
other    O
categories    O
)    O
;    O
visual    B-Perturbation107428450
impairment    I-Perturbation107428450
,    O
including    O
blindness    B-Perturbation107428450
;    O
and    O
"    O
Les    O
autres    O
"    O
,    O
any    O
physical    O
disability    O
that    O
does    O
not    O
fall    O
strictly    O
under    O
one    O
of    O
the    O
other    O
categories    O
,    O
for    O
example    O
dwarfism    O
or    O
multiple    O
sclerosis    O
.    O

Every    O
participant    O
at    O
the    O
Paralympics    O
has    O
their    O
disability    O
grouped    O
into    O
one    O
of    O
five    O
disability    O
categories    O
;    O
amputation    O
(    O
the    O
condition    O
may    O
be    O
congenital    O
or    O
sustained    O
through    O
injury    O
or    O
illness    O
)    O
;    O
cerebral    O
palsy    O
;    O
wheelchair    O
athletes    O
(    O
there    O
is    O
often    O
overlap    O
between    O
this    O
and    O
other    O
categories    O
)    O
;    O
visual    B-Perturbation107428450
impairment    I-Perturbation107428450
,    O
including    O
blindness    B-Perturbation107428450
;    O
and    O
"    O
Les    O
autres    O
"    O
,    O
any    O
physical    O
disability    O
that    O
does    O
not    O
fall    O
strictly    O
under    O
one    O
of    O
the    O
other    O
categories    O
,    O
for    O
example    O
dwarfism    O
or    O
multiple    O
sclerosis    O
.    O

Every    O
participant    O
at    O
the    O
Paralympics    O
has    O
their    O
disability    O
grouped    O
into    O
one    O
of    O
five    O
disability    O
categories    O
;    O
amputation    O
(    O
the    O
condition    O
may    O
be    O
congenital    O
or    O
sustained    O
through    O
injury    O
or    O
illness    O
)    O
;    O
cerebral    O
palsy    O
;    O
wheelchair    O
athletes    O
(    O
there    O
is    O
often    O
overlap    O
between    O
this    O
and    O
other    O
categories    O
)    O
;    O
visual    B-Perturbation107428450
impairment    I-Perturbation107428450
,    O
including    O
blindness    B-Perturbation107428450
;    O
and    O
"    O
Les    O
autres    O
"    O
,    O
any    O
physical    O
disability    O
that    O
does    O
not    O
fall    O
strictly    O
under    O
one    O
of    O
the    O
other    O
categories    O
,    O
for    O
example    O
dwarfism    O
or    O
multiple    O
sclerosis    O
.    O

The    O
World    O
Council    O
for    O
the    O
Welfare    O
of    O
the    O
Blind    O
(    O
WCWB    O
)    O
was    O
an    O
organization    O
of    O
agencies    O
for    O
the    O
blind    O
(    O
visually    B-Perturbation107428450
impaired    I-Perturbation107428450
)    O
established    O
in    O
1949    O
.    O

When    O
he    O
was    O
six    O
years    O
old    O
,    O
he    O
overcame    O
the    O
ordeal    O
of    O
an    O
accident    O
that    O
left    O
him    O
almost    O
completely    O
blind    B-Perturbation107428450
.    O

In    O
2015    O
,    O
Music    O
Maker    O
,    O
a    O
non    O
-    O
profit    O
organization    O
that    O
supports    O
aging    O
blues    O
musicians    O
,    O
discovered    O
Finley    O
busking    O
before    O
a    O
gig    O
in    O
Arkansas    O
,    O
who    O
was    O
deemed    O
legally    B-Perturbation107428450
blind    I-Perturbation107428450
and    O
forced    O
to    O
retire    O
from    O
carpentry    O
.    O

The    O
most    O
severe    O
consequences    O
of    O
eye    O
exposure    O
to    O
lewisite    O
are    O
globe    O
perforation    O
and    O
blindness    B-Perturbation107428450
.    O

Tactile    O
signing    O
is    O
a    O
common    O
means    O
of    O
communication    O
used    O
by    O
people    O
with    O
both    O
a    O
sight    B-Perturbation107428450
and    O
hearing    O
impairment    O
(    O
see    O
Deafblindness    O
)    O
,    O
which    O
is    O
based    O
on    O
a    O
sign    O
language    O
or    O
other    O
system    O
of    O
manual    O
communication    O
.    O

Greer    O
is    O
legally    B-Perturbation107428450
blind    I-Perturbation107428450
and    O
can    O
not    O
drive    O
cars    O
.    O

Summers    O
recruited    O
her    O
to    O
be    O
his    O
research    O
assistant    O
at    O
the    O
World    O
Bank    O
,    O
where    O
she    O
worked    O
for    O
approximately    O
one    O
year    O
on    O
health    O
projects    O
in    O
India    O
dealing    O
with    O
leprosy    O
,    O
AIDS    O
,    O
and    O
blindness    B-Perturbation107428450
.    O

Many    O
of    O
the    O
townspeople    O
then    O
suddenly    O
become    O
blind    B-Perturbation107428450
,    O
and    O
blame    O
the    O
three    O
girls    O
,    O
who    O
are    O
then    O
put    O
on    O
trial    O
.    O

Very    O
severe    O
exposure    O
to    O
vapor    O
or    O
exposure    O
to    O
liquid    O
can    O
cause    O
photophobia    O
(    O
aversion    O
to    O
light    O
)    O
,    O
corneal    O
ulceration    O
,    O
and    O
blindness    B-Perturbation107428450
.    O

This    O
damage    O
can    O
result    O
in    O
impairment    O
of    O
vision    O
,    O
up    O
to    O
and    O
including    O
blindness    B-Perturbation107428450
.    O

Being    O
blind    B-Perturbation107428450
,    O
Toph    O
's    O
mechanoreceptors    O
and    O
other    O
senses    O
are    O
hyper    O
-    O
sensitive    O
.    O

The    O
21-year    O
-    O
old    O
Katongo    O
,    O
who    O
is    O
visually    B-Perturbation107428450
impaired    I-Perturbation107428450
,    O
participated    O
in    O
the    O
800    O
metre    O
and    O
1500    O
metre    O
events    O
.    O

Total    O
or    O
sectorial    O
vision    B-Perturbation107428450
loss    I-Perturbation107428450
typically    O
lasts    O
only    O
a    O
few    O
seconds    O
,    O
but    O
may    O
last    O
minutes    O
or    O
even    O
hours    O
.    O

Anne    O
Sullivan    O
Communication    O
Center    O
(    O
open    O
to    O
all    O
students    O
but    O
emphasizing    O
programs    O
for    O
the    O
deaf    O
and    O
visually    B-Perturbation107428450
impaired    I-Perturbation107428450
)    O
is    O
located    O
just    O
across    O
the    O
greenway    O
in    O
the    O
Longfellow    O
neighborhood    O
.    O

The    O
explosion    O
leaves    O
Garrison    O
blind    B-Perturbation107428450
and    O
cripples    O
Schroeder    O
,    O
reducing    O
his    O
life    O
expectancy    O
to    O
a    O
mere    O
two    O
years    O
.    O

In    O
cooperation    O
with    O
teachers    O
of    O
visually    B-Perturbation107428450
impaired    I-Perturbation107428450
students    O
,    O
Space    O
Camp    O
operates    O
a    O
week    O
-    O
long    O
"    O
Space    O
Camp    O
for    O
Interested    O
Visually    O
Impaired    O
Students    O
"    O
by    O
providing    O
the    O
same    O
experience    O
to    O
visually    O
impaired    O
students    O
as    O
sighted    O
students    O
.    O

Furthermore    O
,    O
his    O
work    O
on    O
visual    O
cycle    O
has    O
led    O
to    O
revolutionary    O
advances    O
in    O
understanding    O
hereditary    O
blindness    B-Perturbation107428450
,    O
leading    O
to    O
implementation    O
of    O
novel    O
pharmacological    O
treatments    O
that    O
can    O
slow    O
retinal    O
degeneration    O
in    O
adults    O
.    O

At    O
the    O
age    O
of    O
one    O
,    O
Kelly    O
was    O
diagnosed    O
with    O
retinoblastoma    O
,    O
a    O
cancerous    O
condition    O
that    O
left    O
him    O
blind    B-Perturbation107428450
.    O

When    O
Joseph    O
and    O
Mary    O
's    O
neighbors    O
complain    O
,    O
they    O
are    O
miraculously    O
struck    O
blind    B-Perturbation107428450
by    O
Jesus    O
.    O

This    O
ability    O
is    O
used    O
by    O
some    O
blind    B-Perturbation107428450
people    O
for    O
acoustic    O
wayfinding    O
,    O
or    O
navigating    O
within    O
their    O
environment    O
using    O
auditory    O
rather    O
than    O
visual    O
cues    O
.    O

It    O
can    O
also    O
result    O
in    O
blindness    B-Perturbation107428450
,    O
facial    O
paralysis    O
,    O
and    O
deafness    O
,    O
due    O
to    O
the    O
increased    O
pressure    O
put    O
on    O
the    O
nerves    O
by    O
the    O
extra    O
bone    O
.    O

Without    O
this    O
extreme    O
cooling    O
the    O
telescope    O
and    O
instruments    O
would    O
literally    O
be    O
'blinded'    B-Perturbation107428450
by    O
their    O
own    O
infrared    O
emissions    O
.    O

Five    O
years    O
later    O
,    O
the    O
poem    O
begins    O
with    O
the    O
now    O
blind    B-Perturbation107428450
Tiriel    O
returning    O
to    O
the    O
kingdom    O
with    O
his    O
dying    O
wife    O
,    O
as    O
he    O
wants    O
his    O
children    O
to    O
see    O
her    O
death    O
,    O
believing    O
them    O
to    O
be    O
responsible    O
and    O
cursing    O
them    O
for    O
betraying    O
him    O
five    O
years    O
previously    O
.    O

Ill    O
health    O
and    O
increasing    O
blindness    B-Perturbation107428450
forced    O
his    O
resignation    O
in    O
1852    O
and    O
he    O
and    O
his    O
second    O
wife    O
returned    O
to    O
England    O
where    O
he    O
died    O
at    O
Clevedon    O
,    O
Somerset    O
in    O
October    O
1871    O
.    O

The    O
inflamed    O
eyes    O
,    O
if    O
left    O
untreated    O
,    O
can    O
result    O
in    O
glaucoma    O
,    O
scars    O
,    O
cataracts    O
,    O
and    O
even    O
blindness    B-Perturbation107428450
.    O

From    O
his    O
"    O
New    O
York    O
Times    O
"    O
obituary    O
:    O
"    O
He    O
liked    O
to    O
recall    O
a    O
summer    O
day    O
in    O
Times    O
Square    O
when    O
he    O
helped    O
a    O
blind    B-Perturbation107428450
man    O
to    O
cross    O
at    O
44th    O
Street    O
.    O

Impaired    B-Perturbation107428450
vision    I-Perturbation107428450
and    O
hearing    O
loss    O
are    O
common    O
chronic    O
problems    O
among    O
older    O
people    O
.    O

It    O
was    O
the    O
first    O
school    O
in    O
the    O
world    O
to    O
teach    O
blind    B-Perturbation107428450
students    O
.    O

She    O
is    O
also    O
study    O
chair    O
for    O
the    O
Age    O
-    O
Related    O
Eye    O
Disease    O
Study    O
2    O
(    O
AREDS2    O
)    O
,    O
a    O
Phase    O
3    O
study    O
that    O
is    O
investigating    O
the    O
use    O
of    O
lutein    O
/    O
zeaxanthin    O
(    O
found    O
in    O
leafy    O
greens    O
such    O
as    O
kale    O
)    O
and/or    O
omega-3    O
polyunsaturated    O
Fatty    O
acids    O
as    O
treatment    O
for    O
age    O
-    O
related    O
macular    O
degeneration    O
(    O
AMD    O
)    O
and    O
Cataracts    O
,    O
the    O
two    O
leading    O
causes    O
of    O
blindness    B-Perturbation107428450
in    O
the    O
United    O
States    O
of    O
America    O
.    O

Kurzweil    O
was    O
a    O
developer    O
of    O
reading    O
machines    O
for    O
the    O
blind    B-Perturbation107428450
,    O
and    O
their    O
company    O
used    O
many    O
of    O
the    O
technologies    O
originally    O
designed    O
for    O
reading    O
machines    O
,    O
and    O
adapted    O
them    O
to    O
musical    O
purposes    O
.    O

In    O
1906    O
,    O
overpowered    O
by    O
mental    O
disease    O
and    O
approaching    O
blindness    B-Perturbation107428450
,    O
he    O
ceased    O
painting    O
.    O

Visually    B-Perturbation107428450
impaired    I-Perturbation107428450
athletes    O
participate    O
in    O
running    O
events    O
with    O
the    O
help    O
of    O
a    O
sighted    O
guide    O
,    O
to    O
whom    O
they    O
may    O
be    O
attached    O
by    O
a    O
tether    O
.    O

Spofford    O
's    O
successor    O
John    O
Russell    O
Young    O
,    O
though    O
only    O
in    O
office    O
for    O
two    O
years    O
,    O
overhauled    O
the    O
Library    O
's    O
bureaucracy    O
,    O
used    O
his    O
connections    O
as    O
a    O
former    O
diplomat    O
to    O
acquire    O
more    O
materials    O
from    O
around    O
the    O
world    O
,    O
and    O
established    O
the    O
Library    O
's    O
first    O
assistance    O
programs    O
for    O
the    O
blind    B-Perturbation107428450
and    O
physically    O
disabled    O
.    O

An    O
accident    O
during    O
infancy    O
left    O
him    O
blind    B-Perturbation107428450
.    O

Reserving    O
the    O
use    O
of    O
a    O
white    O
cane    O
to    O
blind    B-Perturbation107428450
individuals    O
only    O
.    O

Low    O
birth    O
weight    O
and    O
preterm    O
birth    O
are    O
strongly    O
associated    O
with    O
many    O
health    O
problems    O
,    O
such    O
as    O
visual    B-Perturbation107428450
impairment    I-Perturbation107428450
and    O
cerebral    O
palsy    O
,    O
and    O
children    O
born    O
after    O
IVF    O
are    O
roughly    O
twice    O
as    O
likely    O
to    O
have    O
cerebral    O
palsy    O
.    O

For    O
his    O
segment    O
,    O
"    O
Siang    O
Sawan    O
"    O
(    O
"    O
Luminous    O
Sound    O
"    O
)    O
,    O
Pen    O
-    O
Ek    O
chose    O
to    O
interview    O
blind    B-Perturbation107428450
pianist    O
Sila    O
Namthao    O
,    O
letting    O
the    O
musician    O
perform    O
some    O
of    O
the    O
songs    O
composed    O
by    O
the    O
king    O
,    O
and    O
talk    O
about    O
his    O
inspirations    O
and    O
life    O
.    O

Yuki    O
Nakai    O
went    O
on    O
to    O
win    O
a    O
bout    O
in    O
the    O
Vale    O
Tudo    O
Japan    O
1995    O
tournament    O
after    O
his    O
opponent    O
performed    O
an    O
illegal    O
gouge    O
that    O
blinded    B-Perturbation107428450
him    O
in    O
his    O
right    O
eye    O
.    O

From    O
his    O
earliest    O
childhood    O
he    O
was    O
very    O
sickly    O
;    O
at    O
the    O
age    O
of    O
fifteen    O
his    O
sight    O
and    O
hearing    O
were    O
almost    O
completely    O
destroyed    O
;    O
and    O
later    O
in    O
life    O
he    O
became    O
totally    O
blind    B-Perturbation107428450
.    O

Blindness    B-Perturbation107428450
and    O
low    B-Perturbation107428450
vision    I-Perturbation107428450

Like    O
Stevie    O
Wonder    O
,    O
Garrett    O
is    O
also    O
blind    B-Perturbation107428450
.    O

The    O
world    O
’s    O
first    O
talking    O
ATM    O
for    O
the    O
blind    B-Perturbation107428450
was    O
an    O
NCR    O
machine    O
unveiled    O
by    O
the    O
Royal    O
Bank    O
of    O
Canada    O
on    O
October    O
22    O
,    O
1997    O
at    O
a    O
bank    O
branch    O
on    O
the    O
corner    O
of    O
Bank    O
Street    O
and    O
Queen    O
Street    O
in    O
Ottawa    O
,    O
Ontario    O
.    O

Blind    O
Sports    O
Australia    O
(    O
2010    O
)    O
formerly    O
Australian    O
Blind    O
Sports    O
Federation    O
(    O
ABSF    O
)    O
was    O
formed    O
in    O
1980    O
as    O
the    O
national    O
body    O
to    O
co    O
-    O
ordinate    O
sport    O
for    O
the    O
blind    B-Perturbation107428450
and    O
vision-impaired    B-Perturbation107428450
in    O
Australia    O
.    O

The    O
children    O
were    O
given    O
only    O
a    O
little    O
water    O
,    O
no    O
bedding    O
,    O
save    O
for    O
a    O
blanket    O
and    O
many    O
affected    O
by    O
Ophthalmia    O
,    O
went    O
untreated    O
,    O
resulting    O
in    O
blindness    B-Perturbation107428450
.    O

This    O
inconveniences    O
users    O
with    O
blindness    B-Perturbation107428450
who    O
work    O
in    O
Lynx    O
.    O

Other    O
symptoms    O
may    O
include    O
joint    O
pain    O
,    O
thicker    O
skin    O
,    O
deepening    O
of    O
the    O
voice    O
,    O
headaches    O
,    O
and    O
problems    B-Perturbation107428450
with    I-Perturbation107428450
vision    I-Perturbation107428450
.    O

An    O
elderly    O
woman    O
,    O
nicknamed    O
"    O
Peege    O
"    O
and    O
played    O
by    O
Jeanette    O
Nolan    O
,    O
lives    O
in    O
a    O
nursing    O
home    O
where    O
she    O
is    O
suffering    O
from    O
blindness    B-Perturbation107428450
and    O
ailing    O
mental    O
faculties    O
.    O

The    O
Royal    O
Society    O
for    O
the    O
Blind    O
(    O
RSB    O
)    O
is    O
a    O
not    O
-    O
for    O
-    O
profit    O
organisation    O
providing    O
services    O
to    O
over    O
11,000    O
South    O
Australians    O
who    O
are    O
blind    B-Perturbation107428450
or    O
vision    B-Perturbation107428450
impaired    I-Perturbation107428450
.    O

Being    O
blind    B-Perturbation107428450
,    O
he    O
was    O
from    O
1990    O
until    O
1995    O
the    O
Vice    O
-    O
President    O
of    O
the    O
"    O
Braille    O
League    O
"    O
(    O
fr    O
:    O
La    O
Ligue    O
Braille    O
;    O
nl    O
:    O
Brailleliga    O
)    O
,    O
a    O
Belgian    O
non    O
-    O
profit    O
helping    O
visually    O
impaired    O
people    O
.    O

When    O
Jonathon    O
Ratcliff    O
(    O
Bottoms    O
)    O
suddenly    O
becomes    O
blind    B-Perturbation107428450
,    O
doctors    O
fit    O
him    O
with    O
an    O
experimental    O
electronic    O
device    O
designed    O
to    O
partially    O
restore    O
his    O
sight    O
.    O

Luncz    O
,    O
who    O
suffered    O
from    O
early    O
blindness    B-Perturbation107428450
,    O
founded    O
,    O
in    O
conjunction    O
with    O
Dr.    O
Koisewski    O
,    O
an    O
institution    O
for    O
the    O
blind    O
at    O
Jerusalem    O
.    O

On    O
17    O
November    O
2004    O
Andrew    O
Henry    O
Martin    O
Scholtz    O
died    O
from    O
acute    O
asthma    O
after    O
spending    O
the    O
last    O
two    O
months    O
being    O
blind    B-Perturbation107428450
as    O
well    O
.    O

Like    O
other    O
corrosive    O
acids    O
and    O
alkalis    O
,    O
drops    O
of    O
sodium    O
hydroxide    O
solutions    O
can    O
readily    O
decompose    O
proteins    O
and    O
lipids    O
in    O
living    O
tissues    O
via    O
amide    O
hydrolysis    O
and    O
ester    O
hydrolysis    O
,    O
which    O
consequently    O
cause    O
chemical    O
burns    O
and    O
may    O
induce    O
permanent    O
blindness    B-Perturbation107428450
upon    O
contact    O
with    O
eyes    O
.    O

The    O
state    O
of    O
blindness    B-Perturbation107428450
,    O
being    O
unable    O
to    O
see    O

Organized    O
in    O
1855    O
and    O
incorporated    O
by    O
the    O
Kentucky    O
Legislature    O
in    O
1858    O
,    O
the    O
American    O
Printing    O
House    O
for    O
the    O
Blind    O
was    O
established    O
to    O
produce    O
educational    O
materials    O
for    O
the    O
blind    B-Perturbation107428450
and    O
since    O
1879    O
has    O
received    O
an    O
allocation    O
of    O
federal    O
funds    O
to    O
help    O
support    O
this    O
activity    O
.    O

The    O
Kentucky    O
School    O
for    O
the    O
Blind    O
,    O
for    O
all    O
of    O
Kentucky    O
's    O
blind    O
and    O
visually    B-Perturbation107428450
impaired    I-Perturbation107428450
students    O
,    O
is    O
located    O
on    O
Frankfort    O
Avenue    O
in    O
the    O
Clifton    O
neighborhood    O
.    O

Wlodzimierz    O
Dolanski    O
,    O
1886–1973    O
,    O
doctor    O
that    O
treated    O
the    O
blind    B-Perturbation107428450

After    O
the    O
mist    O
passed    O
,    O
his    O
family    O
's    O
camp    O
experienced    O
sudden    O
deaths    O
,    O
outbreaks    O
of    O
skin    O
rashes    O
,    O
vomiting    O
,    O
diarrhoea    O
and    O
temporary    O
and    O
permanent    O
blindness    B-Perturbation107428450
.    O

Blinding    O
is    O
a    O
type    O
of    O
physical    O
punishment    O
which    O
results    O
in    O
complete    O
or    O
nearly    O
complete    O
loss    B-Perturbation107428450
of    I-Perturbation107428450
vision    I-Perturbation107428450
.    O

Maguire    O
v    O
SOCOG    O
1999    O
was    O
a    O
decision    O
of    O
the    O
Australian    O
Human    O
Rights    O
and    O
Equal    O
Opportunity    O
Commission    O
,    O
which    O
ruled    O
on    O
18    O
October    O
1999    O
that    O
a    O
blind    B-Perturbation107428450
man    O
had    O
been    O
directly    O
discriminated    O
against    O
by    O
the    O
failure    O
of    O
a    O
government    O
agency    O
to    O
provide    O
ticketing    O
materials    O
for    O
the    O
Sydney    O
Olympic    O
Games    O
in    O
braille    O
.    O

In    O
March    O
2001    O
,    O
desiring    O
less    O
travel    O
and    O
reduced    O
public    O
visibility    O
,    O
Nathan    O
left    O
Bristol    O
-    O
Myers    O
and    O
became    O
a    O
fund    O
-    O
raiser    O
and    O
later    O
the    O
managing    O
director    O
of    O
Changing    O
Our    O
World    O
,    O
an    O
international    O
fundraising    O
and    O
philanthropic    O
services    O
company    O
headquartered    O
in    O
New    O
York    O
that    O
helps    O
not    O
-    O
for    O
-    O
profit    O
groups    O
raise    O
money    O
for    O
causes    O
such    O
as    O
juvenile    O
blindness    B-Perturbation107428450
and    O
HIV    O
/    O
AIDS    O
in    O
Africa    O
.    O

This    O
seeming    O
contradiction    O
is    O
overcome    O
when    O
one    O
understands    O
that    O
only    O
around    O
10%    O
of    O
all    O
people    O
with    O
blindness    B-Perturbation107428450
can    O
see    O
absolutely    O
nothing    O
at    O
all    O
.    O

There    O
are    O
a    O
number    O
of    O
publications    O
that    O
promote    O
blind    O
education    O
programs    O
and    O
seek    O
to    O
show    O
how    O
art    O
can    O
be    O
constructive    O
for    O
the    O
blind    O
and    O
those    O
with    O
visual    B-Perturbation107428450
impairments    I-Perturbation107428450
,    O
and    O
the    O
ways    O
in    O
which    O
they    O
can    O
be    O
taught    O
to    O
create    O
art    O
.    O

Blind    B-Perturbation107428450
or    O
visually    B-Perturbation107428450
impaired    I-Perturbation107428450
artists    O
work    O
in    O
a    O
variety    O
of    O
different    O
media    O
,    O
and    O
are    O
by    O
no    O
means    O
limited    O
to    O
only    O
one    O
type    O
of    O
art    O
.    O

He    O
tries    O
to    O
represent    O
the    O
visual    O
hallucinations    O
he    O
experiences    O
as    O
a    O
result    O
of    O
Charles    O
Bonnet    O
Syndrome    O
-    O
a    O
consequence    O
of    O
his    O
sightloss    B-Perturbation107428450
.    O

The    O
library    O
was    O
established    O
in    O
1951    O
as    O
a    O
response    O
to    O
the    O
need    O
to    O
rehabilitate    O
soldiers    O
who    O
sustained    O
injuries    O
which    O
blinded    B-Perturbation107428450
them    O
.    O

The    O
concept    O
of    O
it    O
is    O
just    O
like    O
the    O
concept    O
of    O
film    O
"    O
Tom    O
,    O
Dick    O
,    O
and    O
Harry    O
"    O
,    O
with    O
one    O
blind    B-Perturbation107428450
,    O
one    O
deaf    O
and    O
one    O
mute    O
leading    O
character    O
.    O

Visual    B-Perturbation107428450
impairment    I-Perturbation107428450

Shurik    O
,    O
who    O
is    O
riding    O
on    O
the    O
same    O
bus    O
,    O
puts    O
on    O
a    O
pair    O
of    O
sunglasses    O
,    O
and    O
pretends    O
to    O
be    O
visually    B-Perturbation107428450
impaired    I-Perturbation107428450
.    O

Eye    O
injuries    O
can    O
occur    O
when    O
protective    O
equipment    O
is    O
not    O
properly    O
used    O
and    O
such    O
injuries    O
often    O
cause    O
devastating    O
visual    B-Perturbation107428450
loss    I-Perturbation107428450
.    O

A    O
few    O
days    O
later    O
,    O
a    O
blind    B-Perturbation107428450
pirate    O
known    O
only    O
as    O
Pew    O
reaches    O
the    O
inn    O
,    O
and    O
Bones    O
is    O
plainly    O
terrified    O
.    O

Their    O
blindness    B-Perturbation107428450
is    O
healed    O
but    O
they    O
can    O
not    O
understand    O
what    O
they    O
are    O
seeing    O
or    O
walk    O
unaided    O
.    O

The    O
company    O
has    O
a    O
particular    O
interest    O
in    O
producing    O
texts    O
for    O
visually    B-Perturbation107428450
impaired    I-Perturbation107428450
people    O
,    O
including    O
large    B-Perturbation107428450
print    I-Perturbation107428450
books    O
in    O
Italian    O
,    O
English    O
and    O
French    O
.    O

According    O
to    O
Stephen    O
Friar    O
's    O
"    O
New    O
Dictionary    O
of    O
Heraldry    O
"    O
,    O
a    O
griffin    O
's    O
claw    O
was    O
believed    O
to    O
have    O
medicinal    O
properties    O
and    O
one    O
of    O
its    O
feathers    O
could    O
restore    O
sight    O
to    O
the    O
blind    B-Perturbation107428450
.    O

LCA    O
is    O
typically    O
characterized    O
by    O
nystagmus    O
,    O
sluggish    O
or    O
absent    O
pupillary    O
responses    O
,    O
and    O
severe    O
vision    B-Perturbation107428450
loss    I-Perturbation107428450
or    O
blindness    B-Perturbation107428450
.    O

In    O
his    O
twentieth    O
year    O
he    O
became    O
totally    O
blind    B-Perturbation107428450
,    O
but    O
he    O
held    O
to    O
his    O
resolve    O
to    O
enter    O
the    O
ministry    O
,    O
and    O
gave    O
himself    O
to    O
theological    O
and    O
historical    O
study    O
.    O

The    O
stadium    O
has    O
8    O
allocated    O
spaces    O
for    O
those    O
who    O
are    O
Visually    B-Perturbation107428450
Impaired    I-Perturbation107428450
,    O
providing    O
commentary    O
,    O
which    O
is    O
also    O
broadcast    O
to    O
the    O
local    O
hospital    O
.    O

The    O
charity    O
now    O
provides    O
many    O
services    O
to    O
over    O
7000    O
blind    B-Perturbation107428450
and    O
visually    O
impaired    O
people    O
across    O
the    O
County    O
and    O
has    O
offices    O
in    O
Chorley    O
,    O
Penwortham    O
Southport    O
and    O
Morecambe    O
.    O

Al    O
-    O
Kit    O
Kat    O
(    O
Arabic    O
:    O
ألكيت    O
كات    O
)    O
is    O
a    O
1991    O
Egyptian    O
comedy    O
that    O
revolves    O
around    O
Sheikh    O
Hosni    O
,    O
played    O
by    O
Mahmoud    O
Abdel    O
Aziz    O
,    O
a    O
blind    B-Perturbation107428450
man    O
living    O
in    O
the    O
Al    O
-    O
Kit    O
Kat    O
neighborhood    O
in    O
Giza    O
,    O
Egypt    O
.    O

Blue    O
cone    O
monochromacy    O
(    O
BCM    O
)    O
is    O
an    O
inherited    O
eye    O
disease    O
that    O
causes    O
severely    O
impaired    O
color    O
discrimination    O
,    O
low    B-Perturbation107428450
vision    I-Perturbation107428450
,    O
nystagmus    O
and    O
photophobia    O
....    O

She    O
has    O
a    O
disability    O
:    O
She    O
is    O
blind    B-Perturbation107428450
and    O
a    O
T11/B1    O
type    O
athlete    O
.    O

Not    O
knowing    O
how    O
long    O
this    O
condition    O
will    O
take    O
to    O
right    O
itself    O
,    O
Solomon    O
meets    O
lecturer    O
Wren    O
Woods    O
at    O
a    O
support    O
group    O
for    O
the    O
visually    O
impaired    O
(    O
mostly    O
all    O
blind    B-Perturbation107428450
,    O
as    O
is    O
she    O
)    O
.    O

By    O
March    O
that    O
same    O
year    O
,    O
he    O
was    O
caring    O
for    O
thirty    O
orphaned    O
children    O
and    O
a    O
number    O
of    O
people    O
who    O
were    O
disabled    O
,    O
cripple    O
,    O
blind    B-Perturbation107428450
,    O
dumb    O
,    O
and    O
other    O
outcasts    O
.    O

Untreated    O
glaucoma    O
in    O
dogs    O
leads    O
to    O
permanent    O
damage    O
of    O
the    O
optic    O
nerve    O
and    O
resultant    O
visual    O
field    O
loss    O
,    O
which    O
can    O
progress    O
to    O
blindness    B-Perturbation107428450
.    O

Rebecca    O
Rimmington    O
(    O
born    O
14    O
January    O
1983    O
in    O
Grantham    O
,    O
England    O
)    O
is    O
an    O
English    O
sportsperson    O
,    O
a    O
competitive    O
cyclist    O
and    O
former    O
tandem    O
pilot    O
for    O
blind    O
and    O
visually    B-Perturbation107428450
impaired    I-Perturbation107428450
riders    O
.    O

Also    O
in    O
1993    O
he    O
was    O
diagnosed    O
with    O
retinitis    B-Perturbation107428450
pigmentosa    I-Perturbation107428450
,    O
a    O
retinal    O
degenerative    O
disease    O
that    O
leads    O
to    O
progressive    O
sight    O
loss    O
and    O
blindness    B-Perturbation107428450
.    O

(    O
H54    O
)    O
Blindness    B-Perturbation107428450
—    O
the    O
brain    O
does    O
not    O
receive    O
optical    O
information    O
,    O
through    O
various    O
causes    O

Hibbler    O
was    O
born    O
in    O
Tyro    O
,    O
Mississippi    O
,    O
United    O
States    O
,    O
and    O
was    O
blind    B-Perturbation107428450
from    O
birth    O
.    O

It    O
was    O
taught    O
in    O
a    O
Baraita    O
that    O
four    O
types    O
of    O
people    O
are    O
accounted    O
as    O
though    O
they    O
were    O
dead    O
:    O
a    O
poor    O
person    O
,    O
a    O
person    O
affected    O
by    O
skin    O
disease    O
(    O
,    O
"    O
metzora    O
"    O
)    O
,    O
a    O
blind    B-Perturbation107428450
person    O
,    O
and    O
one    O
who    O
is    O
childless    O
.    O

Many    O
dark    O
restaurants    O
employ    O
blind    B-Perturbation107428450
or    O
visually    B-Perturbation107428450
impaired    I-Perturbation107428450
waiters    O
and    O
guides    O
,    O
whose    O
condition    O
enables    O
them    O
to    O
work    O
with    O
little    O
difficulty    O
in    O
darkened    O
surroundings    O
.    O

He    O
comes    O
out    O
of    O
the    O
procedure    O
alive    O
,    O
but    O
he    O
is    O
now    O
blind    B-Perturbation107428450
.    O

Born    O
nearly    O
blind    B-Perturbation107428450
,    O
she    O
was    O
the    O
author    O
of    O
over    O
40    O
books    O
and    O
also    O
served    O
as    O
publisher    O
and    O
director    O
of    O
Editora    O
Vozes    O
.    O

Though    O
he    O
went    O
blind    B-Perturbation107428450
later    O
in    O
age    O
he    O
was    O
able    O
to    O
prepare    O
sermons    O
with    O
the    O
help    O
of    O
an    O
aide    O
.    O

Corinna    O
May    O
(    O
born    O
6    O
October    O
1970    O
in    O
Bremen    O
,    O
Germany    O
as    O
Corinna    O
Meyer    O
)    O
is    O
a    O
blind    B-Perturbation107428450
singer    O
from    O
Germany    O
.    O

Although    O
blind    B-Perturbation107428450
for    O
the    O
final    O
20    O
years    O
of    O
his    O
life    O
,    O
he    O
continued    O
to    O
attend    O
Derby    O
County    O
games    O
.    O

1885    O
–    O
Florida    O
School    O
for    O
the    O
Deaf    O
and    O
the    O
Blind    O
begins    O
as    O
a    O
state    O
-    O
supported    O
residential    O
school    O
for    O
deaf    O
and    O
blind    B-Perturbation107428450
children    O
in    O
Florida    O
.    O

Her    O
interest    O
in    O
working    O
with    O
blind    B-Perturbation107428450
children    O
led    O
her    O
to    O
learn    O
Braille    O
and    O
Moon    O
Code    O
,    O
a    O
system    O
of    O
reading    O
and    O
writing    O
for    O
blind    O
people    O
.    O

Chakshumathi    O
is    O
a    O
nongovernmental    O
,    O
not    O
for    O
profit    O
organization    O
based    O
in    O
Thiruvananthapuram    O
,    O
Kerala    O
,    O
India    O
,    O
working    O
for    O
developing    O
resources    O
for    O
the    O
use    O
of    O
visually    B-Perturbation107428450
impaired    I-Perturbation107428450
people    O
.    O

Eye    O
symptoms    O
,    O
such    O
as    O
light    O
sensitivity    O
,    O
excess    O
tearing    O
,    O
and    O
vision    B-Perturbation107428450
loss    I-Perturbation107428450
have    O
been    O
described    O
.    O

DAISY    O
Forum    O
of    O
India    O
is    O
a    O
not    O
for    O
profit    O
organisation    O
involved    O
in    O
the    O
production    O
of    O
books    O
and    O
other    O
reading    O
materials    O
for    O
persons    O
with    O
print    O
disabilities    O
including    O
blindness    B-Perturbation107428450
.    O

It    O
is    O
a    O
network    O
of    O
more    O
than    O
80    O
organisations    O
working    O
in    O
different    O
parts    O
of    O
India    O
for    O
the    O
welfare    O
of    O
visually    B-Perturbation107428450
impaired    I-Perturbation107428450
people    O
.    O

See    O
Without    O
Looking    O
is    O
a    O
2013    O
fictional    O
Chinese    O
language    O
TV    O
serial    O
broadcast    O
by    O
CCTV-1    O
in    O
2013    O
with    O
collections    O
sold    O
on    O
DVD    O
that    O
incorporates    O
blind    O
masseurs    O
(    O
a    O
common    O
occupation    O
for    O
blind    B-Perturbation107428450
people    I-Perturbation107428450
in    O
China    O
)    O
in    O
the    O
plot    O
.    O

"    O
The    O
Eight    O
Dog    O
Chronicles    O
"    O
took    O
28    O
years    O
to    O
complete    O
(    O
1814–1842    O
)    O
,    O
and    O
Bakin    O
grew    O
blind    B-Perturbation107428450
and    O
lost    O
his    O
wife    O
and    O
son    O
before    O
he    O
completed    O
it    O
.    O
Comprising    O
106    O
volumes    O
,    O
it    O
is    O
one    O
of    O
the    O
world    O
's    O
longest    O
novels    O
.    O

He    O
became    O
deaf    O
around    O
age    O
20    O
,    O
and    O
blind    B-Perturbation107428450
in    O
1955    O
,    O
about    O
19    O
years    O
later    O
.    O

The    O
dying    O
,    O
the    O
blind    B-Perturbation107428450
,    O
the    O
deaf    O
and    O
dumb    O
,    O
the    O
lame    O
,    O
and    O
the    O
paralytic    O
,    O
were    O
said    O
to    O
be    O
instantly    O
cured    O
by    O
him    O
.    O

In    O
1957    O
her    O
studies    O
reached    O
the    O
point    O
where    O
she    O
could    O
diagnose    O
herself    O
:    O
it    O
was    O
soon    O
discovered    O
that    O
she    O
had    O
fallen    O
victim    O
to    O
the    O
rare    O
Von    O
Recklinghausen    O
's    O
disease    O
,    O
which    O
would    O
leave    O
her    O
blind    B-Perturbation107428450
and    O
deaf    O
.    O

The    O
creature    O
eventually    O
introduces    O
himself    O
to    O
the    O
family    O
's    O
blind    B-Perturbation107428450
father    O
,    O
who    O
treats    O
him    O
with    O
kindness    O
.    O

His    O
best    O
known    O
hit    O
as    O
a    O
solo    O
artist    O
is    O
"    O
El    O
Toro    O
"    O
(    O
"    O
The    O
Bull    O
"    O
)    O
,    O
a    O
humorous    O
take    O
on    O
infidelity    O
(    O
and    O
,    O
in    O
one    O
line    O
,    O
about    O
his    O
low    B-Perturbation107428450
vision    I-Perturbation107428450
)    O
.    O

'    O
NALSVI    O
,    O
National    O
Association    O
of    O
Local    O
Societies    O
for    O
Visually    O
Impaired    O
People    O
'    O
based    O
in    O
Doncaster    O
,    O
England    O
is    O
the    O
umbrella    O
organization    O
serving    O
over    O
120    O
UK    O
Charities    O
supporting    O
local    O
people    O
with    O
a    O
visual    B-Perturbation107428450
impairment    I-Perturbation107428450
.    O

Cox    O
was    O
a    O
unique    O
person    O
to    O
run    O
for    O
that    O
office    O
,    O
not    O
only    O
because    O
she    O
is    O
a    O
woman    O
,    O
but    O
also    O
because    O
she    O
is    O
legally    B-Perturbation107428450
blind    I-Perturbation107428450
.    O

She    O
has    O
a    O
brother    O
who    O
has    O
a    O
visual    B-Perturbation107428450
impairment    I-Perturbation107428450
,    O
and    O
her    O
biggest    O
hope    O
is    O
to    O
earn    O
enough    O
money    O
to    O
cure    O
her    O
brother    O
's    O
eyesight    O
.    O

CNIB    O
is    O
a    O
volunteer    O
agency    O
and    O
charitable    O
organization    O
dedicated    O
to    O
assisting    O
Canadians    O
who    O
are    O
blind    B-Perturbation107428450
or    O
living    O
with    O
vision    O
loss    O
,    O
and    O
to    O
provide    O
information    O
about    O
vision    O
health    O
for    O
all    O
Canadians    O
.    O

In    O
a    O
2011    O
interview    O
with    O
"    O
Prevention    O
"    O
,    O
Inaba    O
stated    O
she    O
was    O
legally    B-Perturbation107428450
blind    I-Perturbation107428450
,    O
having    O
a    O
vision    O
of    O
20/750    O
which    O
is    O
corrected    O
with    O
eyeglasses    O
and    O
contact    O
lenses    O
.    O

The    O
series    O
followed    O
the    O
trials    O
and    O
tribulations    O
of    O
Paul    O
Stark    O
(    O
played    O
by    O
Jeffrey    O
Tambor    O
)    O
,    O
a    O
blind    B-Perturbation107428450
university    O
professor    O
.    O

Juan    O
Carlos    O
González    O
Leiva    O
is    O
a    O
blind    B-Perturbation107428450
lawyer    O
and    O
human    O
rights    O
activist    O
in    O
Cuba    O
.    O

25    O
March    O
–    O
ITV    O
's    O
"    O
Network    O
First    O
"    O
strand    O
presents    O
a    O
groundbreaking    O
documentary    O
about    O
Edinburgh    O
's    O
Royal    O
Blind    O
School    O
,    O
a    O
boarding    O
school    O
for    O
visually    B-Perturbation107428450
impaired    I-Perturbation107428450
students    O
.    O

A    O
blind    B-Perturbation107428450
woman    O
(    O
Béatrice    O
Dalle    O
)    O
goes    O
for    O
a    O
ride    O
at    O
night    O
with    O
a    O
driver    O
(    O
Isaach    O
De    O
Bankolé    O
)    O
from    O
the    O
Ivory    O
Coast    O
.    O

Susy    O
Hendrix    O
is    O
a    O
blind    B-Perturbation107428450
Greenwich    O
Village    O
housewife    O
who    O
becomes    O
the    O
target    O
of    O
three    O
con    O
-    O
men    O
searching    O
for    O
the    O
heroin    O
hidden    O
in    O
a    O
doll    O
,    O
which    O
her    O
husband    O
Sam    O
unwittingly    O
transported    O
from    O
Canada    O
as    O
a    O
favor    O
to    O
a    O
woman    O
who    O
has    O
since    O
been    O
murdered    O
.    O

Blindness    B-Perturbation107428450

Species    O
of    O
"    O
Anthia    O
"    O
can    O
spray    O
a    O
jet    O
of    O
formic    O
acid    O
up    O
to    O
,    O
which    O
if    O
not    O
treated    O
,    O
can    O
cause    O
blindness    B-Perturbation107428450
in    O
animals    O
which    O
harass    O
the    O
beetles    O
.    O

Project    O
Insight    O
(    O
P.I.    O
)    O
is    O
a    O
division    O
of    O
the    O
San    O
Francisco    O
Recreation    O
&    O
Parks    O
Department    O
which    O
provides    O
recreational    O
and    O
learning    O
activities    O
for    O
hearing    O
-    O
impaired    O
and    O
vision-impaired    B-Perturbation107428450
children    O
,    O
teenagers    O
,    O
young    O
adults    O
.    O

This    O
includes    O
athletes    O
with    O
mobility    O
disabilities    O
,    O
amputations    O
,    O
blindness    B-Perturbation107428450
,    O
and    O
cerebral    O
palsy    O
.    O

Visual    O
Impairment    O
-    O
Athletes    O
with    O
visual    B-Perturbation107428450
impairment    I-Perturbation107428450
ranging    O
from    O
partial    O
vision    O
,    O
sufficient    O
to    O
be    O
judged    O
legally    B-Perturbation107428450
blind    I-Perturbation107428450
,    O
to    O
total    O
blindness    B-Perturbation107428450
.    O

Smith    O
suffered    O
from    O
hereditary    O
glaucoma    O
,    O
rendering    O
him    O
partially    B-Perturbation107428450
sighted    I-Perturbation107428450
from    O
1906    O
,    O
and    O
completely    O
blind    B-Perturbation107428450
some    O
years    O
before    O
his    O
death    O
.    O

Walker    O
,    O
who    O
was    O
totally    O
blind    B-Perturbation107428450
since    O
birth    O
,    O
said    O
that    O
growing    O
up    O
"    O
radio    O
was    O
my    O
comic    O
books    O
,    O
movies    O
,    O
everything    O
"    O
.    O

Franco    O
Arnò    O
(    O
Karl    O
Malden    O
)    O
,    O
a    O
middle    O
-    O
aged    O
blind    B-Perturbation107428450
man    O
,    O
is    O
out    O
at    O
night    O
walking    O
with    O
his    O
niece    O
Lori    O
(    O
Cinzia    O
De    O
Carolis    O
)    O
when    O
he    O
overhears    O
a    O
man    O
in    O
a    O
parked    O
car    O
mention    O
blackmail    O
.    O

In    O
high    O
doses    O
,    O
wormseed    O
oil    O
causes    O
irritation    O
of    O
skin    O
and    O
mucous    O
membranes    O
,    O
nausea    O
,    O
vomiting    O
,    O
constipation    O
,    O
headache    O
,    O
vertigo    O
,    O
tinnitus    O
,    O
temporary    O
deafness    O
and    O
blindness    B-Perturbation107428450
.    O

Central    O
serous    O
retinopathy    O
(    O
CSR    O
)    O
,    O
also    O
known    O
as    O
central    O
serous    O
chorioretinopathy    O
(    O
CSC    O
or    O
CSCR    O
)    O
,    O
is    O
an    O
eye    O
disease    O
which    O
causes    O
visual    B-Perturbation107428450
impairment    I-Perturbation107428450
,    O
often    O
temporary    O
,    O
usually    O
in    O
one    O
eye    O
.    O

BBBeat    O
is    O
an    O
audio    O
game    O
designed    O
for    O
the    O
visually    B-Perturbation107428450
impaired    I-Perturbation107428450
.    O

He    O
was    O
blind    B-Perturbation107428450
from    O
birth    O
from    O
a    O
combination    O
of    O
macular    O
degeneration    O
and    O
retinitis    B-Perturbation107428450
pigmentosa    I-Perturbation107428450
.    O

Visual    B-Perturbation107428450
impairment    O
,    O
including    O
blindness    O

Poe    O
's    O
father    O
was    O
forced    O
to    O
cease    O
studying    O
dentistry    O
after    O
he    O
experienced    O
momentary    O
blindness    B-Perturbation107428450
.    O

This    O
can    O
refer    O
to    O
external    O
announcements    O
(    O
triggered    O
by    O
the    O
opening    O
of    O
the    O
bus    O
's    O
door    O
)    O
at    O
a    O
bus    O
stop    O
,    O
announcing    O
the    O
vehicle    O
's    O
route    O
number    O
and    O
destination    O
,    O
primarily    O
for    O
the    O
benefit    O
of    O
visually    B-Perturbation107428450
impaired    I-Perturbation107428450
customers    O
,    O
or    O
to    O
internal    O
announcements    O
(    O
to    O
passengers    O
already    O
on    O
board    O
)    O
identifying    O
the    O
next    O
stop    O
,    O
as    O
the    O
bus    O
(    O
or    O
tram    O
)    O
approaches    O
a    O
stop    O
,    O
or    O
both    O
;    O
the    O
latter    O
are    O
often    O
also    O
displayed    O
on    O
an    O
internal    O
LED    O
display    O
or    O
LCD    O
monitor    O
connected    O
to    O
the    O
system    O
while    O
the    O
loudspeakers    O
play    O
them    O
.    O

Carstairs    O
also    O
meets    O
Maggie    O
Brown    O
,    O
who    O
was    O
blinded    B-Perturbation107428450
by    O
gunfire    O
;    O
after    O
saving    O
her    O
life    O
,    O
Carstairs    O
falls    O
in    O
love    O
with    O
Maggie    O
,    O
although    O
Barney    O
believes    O
Maggie    O
is    O
faking    O
her    O
blindness    O
.    O

The    O
black    O
comedy    O
focuses    O
on    O
David    O
,    O
a    O
blind    B-Perturbation107428450
Vietnam    O
War    O
veteran    O
who    O
finds    O
himself    O
unable    O
to    O
come    O
to    O
terms    O
with    O
his    O
actions    O
on    O
the    O
battlefield    O
and    O
alienated    O
from    O
his    O
family    O
because    O
they    O
neither    O
can    O
accept    O
his    O
disability    O
nor    O
understand    O
his    O
wartime    O
experience    O
.    O

The    O
ILAI    O
Fund    O
beneficiaries    O
often    O
have    O
severe    O
physical    O
,    O
emotional    O
and    O
intellectual    O
disabilities    O
,    O
such    O
as    O
blindness    B-Perturbation107428450
,    O
deafness    O
,    O
autism    O
or    O
Down    O
syndrome    O
.    O

By    O
1959    O
,    O
Devundara    O
Vaccissara    O
Thera    O
was    O
ailing    O
,    O
had    O
gone    O
visually    B-Perturbation107428450
impaired    I-Perturbation107428450
and    O
disabled    O
.    O

Freedom    O
Scientific    O
is    O
a    O
company    O
that    O
makes    O
accessibility    O
products    O
for    O
computer    O
users    O
with    O
low-vision,    B-Perturbation107428450
blindness    B-Perturbation107428450
,    O
and    O
learning    O
disabilities    O
.    O

All    O
households    O
where    O
at    O
least    O
one    O
person    O
is    O
registered    O
blind    B-Perturbation107428450
or    O
partially    B-Perturbation107428450
sighted    I-Perturbation107428450
.    O

Shortly    O
thereafter    O
,    O
he    O
was    O
diagnosed    O
with    O
diabetes    O
,    O
which    O
left    O
him    O
bound    O
to    O
a    O
wheelchair    O
,    O
blind    B-Perturbation107428450
and    O
placed    O
on    O
dialysis    O
.    O

Born    O
three    O
months    O
prematurely    O
,    O
Nikki    O
suffered    O
from    O
chronic    O
health    O
problems    O
,    O
including    O
visual    B-Perturbation107428450
impairment    I-Perturbation107428450
,    O
and    O
was    O
later    O
diagnosed    O
with    O
Asperger    O
syndrome    O
.    O

Also    O
,    O
14    O
secondary    O
schools    O
(    O
numbered    O
2    O
,    O
3    O
,    O
4    O
,    O
6    O
,    O
7    O
,    O
9    O
,    O
10    O
,    O
12    O
,    O
14    O
,    O
15    O
,    O
16    O
,    O
19    O
,    O
21    O
,    O
23    O
)    O
,    O
7    O
professional    O
or    O
professional    O
-    O
technical    O
schools    O
(    O
numbered    O
1    O
through    O
7    O
)    O
,    O
and    O
3    O
boarding    O
schools    O
,    O
including    O
one    O
for    O
visually    B-Perturbation107428450
impaired    I-Perturbation107428450
are    O
located    O
in    O
the    O
city    O
.    O

1    O
)    O
Idiocy    O
and    O
mongolism    O
(    O
especially    O
cases    O
combined    O
with    O
blindness    B-Perturbation107428450
and    O
deafness    O
)    O
,    O

Born    O
:    O
Einar    O
Englund    O
,    O
Swedish    O
-    O
Finnish    O
composer    O
,    O
best    O
known    O
for    O
his    O
compositions    O
including    O
"    O
The    O
War    O
Symphony    O
"    O
and    O
"    O
Blackbird    O
"    O
,    O
in    O
Ljugarn    O
,    O
Gotland    O
,    O
Sweden    O
(    O
d.    O
1999    O
)    O
;    O
David    O
"    O
Stringbean    O
"    O
Akeman    O
,    O
American    O
country    O
musician    O
,    O
known    O
for    O
his    O
banjo    O
work    O
on    O
the    O
TV    O
country    O
music    O
variety    O
show    O
"    O
Hee    O
Haw    O
"    O
,    O
in    O
Annville    O
,    O
Kentucky    O
(    O
d.    O
1973    O
,    O
murdered    O
)    O
;    O
George    O
H.    O
Marshall    O
,    O
British    O
educator    O
,    O
developer    O
of    O
assistive    O
technology    O
for    O
children    O
with    O
visual    B-Perturbation107428450
disabilities    I-Perturbation107428450
(    O
d.    O
1984    O
)    O

Qusai    O
Khouli    O
as    O
Yazan    O
:    O
Yazan    O
is    O
a    O
blind    B-Perturbation107428450
artist    O
with    O
a    O
generous    O
,    O
loving    O
and    O
mild    O
-    O
mannered    O
personality    O
.    O

His    O
father    O
,    O
Thomas    O
,    O
was    O
from    O
Scotland    O
,    O
and    O
had    O
been    O
blind    B-Perturbation107428450
as    O
a    O
child    O
in    O
an    O
accident    O
.    O

She    O
works    O
hard    O
to    O
support    O
her    O
widowed    O
sister    O
,    O
unmarried    O
sister    O
,    O
her    O
blind    B-Perturbation107428450
younger    O
brother    O
,    O
her    O
mother    O
,    O
her    O
drunkard    O
brother    O
Murthy    O
(    O
Jaiganesh    O
)    O
and    O
his    O
family    O
.    O

He    O
was    O
left    O
partially    O
blind    B-Perturbation107428450
by    O
a    O
mis    O
-    O
prescribed    O
medication    O
while    O
still    O
an    O
infant    O
.    O

Tear    O
gas    O
,    O
formally    O
known    O
as    O
a    O
lachrymator    O
agent    O
or    O
lachrymator    O
(    O
from    O
the    O
Latin    O
"    O
lacrima    O
"    O
,    O
meaning    O
"    O
tear    O
"    O
)    O
,    O
sometimes    O
colloquially    O
known    O
as    O
mace    O
,    O
is    O
a    O
chemical    O
weapon    O
that    O
causes    O
severe    O
eye    O
,    O
respiratory    O
,    O
and    O
skin    O
irritation    O
,    O
pain    O
,    O
bleeding    O
,    O
and    O
even    O
blindness    B-Perturbation107428450
.    O

She    O
became    O
blind    B-Perturbation107428450
in    O
the    O
late    O
1880s    O
,    O
and    O
died    O
in    O
Baltimore    O
in    O
1897    O
.    O

After    O
consuming    O
the    O
poisoned    O
curry    O
,    O
the    O
unfortunate    O
Mr.    O
Cheema    O
began    O
to    O
vomit    O
and    O
over    O
the    O
course    O
of    O
the    O
next    O
hour    O
suffered    O
total    O
paralysis    O
of    O
all    O
four    O
limbs    O
,    O
blindness    B-Perturbation107428450
,    O
a    O
drastic    O
fall    O
in    O
blood    O
pressure    O
and    O
heart    O
failure    O
,    O
leading    O
to    O
his    O
death    O
within    O
an    O
hour    O
of    O
his    O
admission    O
to    O
hospital    O
.    O

T    O
Block    O
also    O
holds    O
the    O
staffroom    O
,    O
the    O
staff    O
kitchen    O
and    O
the    O
Visual    B-Perturbation107428450
Impairment    I-Perturbation107428450
Resource    O
Base    O
(    O
Or    O
VI    O
Unit    O
as    O
it    O
's    O
usually    O
called    O
)    O

It    O
contains    O
walking    O
paths    O
,    O
a    O
café    O
,    O
a    O
children    O
's    O
play    O
area    O
,    O
a    O
Fragrant    O
Garden    O
for    O
the    O
blind    B-Perturbation107428450
,    O
a    O
large    O
fountain    O
,    O
tennis    O
courts    O
,    O
basketball    O
courts    O
,    O
areas    O
for    O
soccer    O
and    O
Frisbee    O
,    O
and    O
home    O
field    O
for    O
Savannah    O
Shamrocks    O
Rugby    O
Club    O
.    O

She    O
founded    O
the    O
Pyongyang    O
School    O
for    O
the    O
Deaf    O
and    O
Blind    B-Perturbation107428450
.    O

In    O
1894    O
,    O
she    O
initiated    O
the    O
teaching    O
of    O
sight    O
-    O
impaired    O
people    O
in    O
Korea    O
by    O
teaching    O
a    O
blind    B-Perturbation107428450
girl    O
,    O
using    O
a    O
modification    O
of    O
Braille    O
that    O
she    O
had    O
developed    O
.    O

Almost    O
all    O
people    O
with    O
albinism    O
are    O
visually    O
impaired    O
,    O
with    O
the    O
majority    O
being    O
classified    O
as    O
legally    B-Perturbation107428450
blind    I-Perturbation107428450
.    O

Individuals    O
have    O
vision    B-Perturbation107428450
impairment    I-Perturbation107428450
due    O
to    O
several    O
malformations    O
in    O
the    O
eyes    O
such    O
as    O
small    O
eyeballs    O
,    O
blockage    O
in    O
the    O
tear    O
ducts    O
or    O
lacking    O
eyes    O
completely    O
.    O

The    O
Jernigan    O
Institute    O
is    O
a    O
research    O
and    O
training    O
institute    O
developed    O
and    O
run    O
by    O
the    O
blind    B-Perturbation107428450
,    O
the    O
first    O
and    O
only    O
of    O
its    O
kind    O
.    O

The    O
goal    O
of    O
the    O
institute    O
is    O
to    O
understand    O
the    O
struggles    O
of    O
blindness    B-Perturbation107428450
and    O
work    O
toward    O
the    O
independence    O
of    O
blind    O
individuals    O
.    O

The    O
man    O
turned    O
out    O
to    O
be    O
nearly    O
blind    B-Perturbation107428450
,    O
except    O
for    O
limited    O
peripheral    O
vision    O
in    O
one    O
eye    O
,    O
and    O
this    O
headgear    O
were    O
special    O
glasses    O
(    O
a    O
"    O
JORDY    O
,    O
"    O
a    O
magnifying    O
device    O
)    O
that    O
allowed    O
him    O
limited    O
vision    O
with    O
which    O
to    O
see    O
the    O
game    O
.    O

Indira    O
Gandhi    O
Eye    O
Hospital    O
and    O
Research    O
Centre    O
(    O
IGEHRC    O
)    O
was    O
established    O
by    O
the    O
Trust    O
(    O
RGCT    O
)    O
in    O
2006    O
to    O
address    O
a    O
requirement    O
for    O
quality    O
and    O
affordable    O
eye    O
care    O
and    O
eliminate    O
curable    O
blindness    B-Perturbation107428450
in    O
Northern    O
India    O
.    O

There    O
are    O
several    O
psychological    O
and    O
physiological    O
effects    O
that    O
cause    O
blindness    B-Perturbation107428450
to    O
some    O
visual    O
stimulus    O
.    O

More    O
severe    O
exposures    O
can    O
result    O
in    O
keratitis    O
,    O
iritis    O
,    O
corneal    O
perforation    O
,    O
and    O
blindness    B-Perturbation107428450
.    O

Motor    O
skills    O
and    O
speech    O
are    O
lost    O
,    O
and    O
optic    O
atrophy    O
causes    O
blindness    B-Perturbation107428450
.    O

Bart    O
visits    O
Mr.    O
Mitchell    O
to    O
ask    O
for    O
his    O
dog    O
back    O
,    O
but    O
when    O
he    O
sees    O
that    O
the    O
man    O
is    O
blind    B-Perturbation107428450
and    O
lonely    O
,    O
and    O
hears    O
how    O
he    O
and    O
Santa    O
's    O
Little    O
Helper    O
have    O
bonded    O
,    O
he    O
grows    O
heartsick    O
and    O
leaves    O
.    O

They    O
were    O
more    O
successful    O
in    O
Baol    O
than    O
in    O
Cayor    O
where    O
they    O
provided    O
one    O
Damel    O
by    O
the    O
name    O
of    O
Dé    O
Tialao    O
-    O
the    O
blind    B-Perturbation107428450
king    O
who    O
tried    O
to    O
conceal    O
his    O
physical    O
disability    O
but    O
was    O
later    O
found    O
out    O
and    O
deposed    O
(    O
reigned    O
:    O
1693    O
—    O
1697    O
)    O
.    O

At    O
the    O
Paralympics    O
,    O
judo    O
was    O
contested    O
by    O
visually    B-Perturbation107428450
impaired    I-Perturbation107428450
athletes    O
.    O

Research    O
to    O
Prevent    O
Blindness    O
(    O
RPB    O
)    O
is    O
a    O
nonprofit    O
organization    O
created    O
in    O
1960    O
by    O
Jules    O
Stein    O
,    O
the    O
founder    O
of    O
Music    O
Corporation    O
of    O
America    O
,    O
to    O
stimulate    O
research    O
to    O
eliminate    O
blinding    B-Perturbation107428450
diseases    O
.    O

Eye    O
diseases    O
addressed    O
by    O
grants    O
from    O
RPB    O
include    O
macular    O
degeneration    O
,    O
cataracts    O
,    O
glaucoma    O
,    O
diabetic    O
retinopathy    O
,    O
dry    O
eye    O
,    O
corneal    O
diseases    O
,    O
uveitis    O
,    O
low    B-Perturbation107428450
vision    I-Perturbation107428450
,    O
amblyopia    O
and    O
strabismus    O
,    O
retinitis    B-Perturbation107428450
pigmentosa    I-Perturbation107428450
,    O
color    O
blindness    O
and    O
ocular    O
cancers    O
.    O

Pierce    O
is    O
a    O
totally    O
blind    B-Perturbation107428450
man    O
who    O
planned    O
to    O
earn    O
certification    O
from    O
the    O
Appalachian    O
Mountain    O
Club    O
(    O
AMC    O
)    O
for    O
climbing    O
all    O
48    O
of    O
the    O
state    O
's    O
mountains    O
over    O
4000    O
feet    O
tall    O
by    O
the    O
year    O
2020    O
.    O

School    O
for    O
the    O
Blind    O
is    O
a    O
resource    O
center    O
and    O
special    O
school    O
for    O
the    O
blind    B-Perturbation107428450
in    O
Peć    O
,    O
Kosovo    O
.    O

School    O
for    O
the    O
blind    B-Perturbation107428450
and    O
the    B-Perturbation107428450
visually    I-Perturbation107428450
impaired    I-Perturbation107428450
–    O
resource    O
center    O
Dr.    O
Xheladin    O
Deda    O
in    O
Peć    O
is    O
the    O
only    O
institution    O
in    O
Kosovo    O
that    O
offers    O
education    O
to    O
blind    O
and    O
visually    O
impaired    O
children    O
.    O

Every    O
participant    O
at    O
the    O
Paralympics    O
has    O
their    O
disability    O
grouped    O
into    O
one    O
of    O
five    O
disability    O
categories    O
;    O
amputation    O
,    O
the    O
condition    O
may    O
be    O
congenital    O
or    O
sustained    O
through    O
injury    O
or    O
illness    O
;    O
cerebral    O
palsy    O
;    O
wheelchair    O
athletes    O
,    O
there    O
is    O
often    O
overlap    O
between    O
this    O
and    O
other    O
categories    O
;    O
visual    B-Perturbation107428450
impairment    I-Perturbation107428450
,    O
including    O
blindness    O
;    O
Les    O
autres    O
,    O
any    O
physical    O
disability    O
that    O
does    O
not    O
fall    O
strictly    O
under    O
one    O
of    O
the    O
other    O
categories    O
,    O
for    O
example    O
dwarfism    O
or    O
multiple    O
sclerosis    O
.    O

He    O
has    O
a    O
disability    O
:    O
he    O
is    O
blind    B-Perturbation107428450
and    O
is    O
an    O
B1/S11    O
type    O
swimmer    O
.    O

Neil    O
Fachie    O
MBE    O
(    O
born    O
12    O
March    O
1984    O
)    O
is    O
a    O
Scottish    O
Paralympic    O
multiple    O
sports    O
athlete    O
competing    O
in    O
events    O
for    O
individuals    O
with    O
a    O
visual    B-Perturbation107428450
impairment    I-Perturbation107428450
.    O

The    O
combination    O
of    O
high    O
-    O
pressure    O
waves    O
,    O
explosive    O
fragments    O
,    O
and    O
falling    O
debris    O
may    O
produce    O
multiple    O
injuries    O
including    O
brain    O
injury    O
,    O
loss    O
of    O
limbs    O
,    O
burns    O
,    O
fractures    O
,    O
blindness    B-Perturbation107428450
,    O
and    O
hearing    O
loss    O
,    O
with    O
60    O
percent    O
of    O
those    O
injured    O
in    O
this    O
way    O
,    O
having    O
some    O
degree    O
of    O
traumatic    O
brain    O
injury    O
.    O

He    O
is    O
also    O
known    O
for    O
his    O
virtuosity    O
on    O
the    O
guitar    O
,    O
and    O
particularly    O
known    O
for    O
his    O
version    O
of    O
"    O
Voodoo    O
Child    O
"    O
by    O
Jimi    O
Hendrix    O
,    O
which    O
he    O
has    O
played    O
with    O
his    O
guitar    O
using    O
his    O
teeth    O
or    O
objects    O
thrown    O
by    O
the    O
public    O
such    O
as    O
:    O
carrots    O
,    O
slippers    O
,    O
sandals    O
,    O
tennis    O
balls    O
,    O
or    O
canes    O
for    O
the    O
blind    B-Perturbation107428450
.    O

Natalie    O
's    O
only    O
friend    O
is    O
Jo    O
Carter    O
,    O
the    O
strongest    O
and    O
tallest    O
girl    O
of    O
their    O
school    O
,    O
where    O
Natalie    O
is    O
often    O
teased    O
due    O
to    O
her    O
visual    B-Perturbation107428450
impairment    I-Perturbation107428450
and    O
perceived    O
as    O
crazy    O
because    O
she    O
owns    O
a    O
spider    O
named    O
Itsy    O
.    O

They    O
included    O
a    O
three    O
-    O
dimensional    O
chess    O
game    O
,    O
a    O
device    O
to    O
aid    O
blind    B-Perturbation107428450
painters    O
by    O
using    O
musical    O
notes    O
to    O
identify    O
colors    O
,    O
and    O
an    O
instrument    O
of    O
revenge    O
against    O
telemarketers    O
who    O
interrupted    O
dinner    O
.    O

Mary    O
is    O
Sarah    O
and    O
Chase    O
's    O
cousin    O
,    O
a    O
humorous    O
,    O
independent    O
girl    O
who    O
does    O
n't    O
let    O
the    O
fact    O
that    O
she    O
is    O
blind    B-Perturbation107428450
get    O
in    O
the    O
way    O
of    O
her    O
positive    O
attitude    O
and    O
independence    O
.    O

In    O
1802    O
Pelham    O
became    O
blind    B-Perturbation107428450
.    O

These    O
episodes    O
resulted    O
in    O
neurological    O
symptoms    O
including    O
paresthesias    O
,    O
loss    O
of    O
physical    O
coordination    O
,    O
difficulty    O
in    O
speech    O
,    O
narrowing    O
of    O
the    O
visual    O
field    O
,    O
hearing    O
impairment    O
,    O
blindness    B-Perturbation107428450
,    O
and    O
death    O
.    O

Gami    O
is    O
a    O
gentle    O
and    O
reserved    O
blind    B-Perturbation107428450
girl    O
,    O
while    O
Gilson    O
is    O
hyperactive    O
and    O
often    O
gets    O
into    O
mischief    O
.    O

Students    O
who    O
attend    O
the    O
college    O
are    O
aged    O
over    O
16    O
and    O
blind    B-Perturbation107428450
or    O
partially    O
sighted    O
.    O

The    O
college    O
is    O
actively    O
involved    O
in    O
the    O
development    O
and    O
use    O
of    O
assistive    O
technology    O
to    O
aid    O
visually    B-Perturbation107428450
impaired    I-Perturbation107428450
people    O
in    O
their    O
everyday    O
lives    O
.    O

He    O
was    O
released    O
in    O
1945    O
,    O
by    O
which    O
time    O
he    O
was    O
blind    B-Perturbation107428450
.    O

the    O
dance    O
of    O
the    O
handicapped    O
)    O
is    O
a    O
Korean    O
folk    O
dance    O
that    O
was    O
performed    O
by    O
the    O
lower    O
class    O
peasants    O
to    O
satirize    O
the    O
Korean    O
nobility    O
(    O
Yangban    O
)    O
by    O
depicting    O
them    O
as    O
the    O
handicapped    O
persons    O
and    O
sick    O
persons    O
such    O
as    O
paraplegics    O
,    O
midgets    O
,    O
hunchbacks    O
,    O
the    O
deaf    O
,    O
the    O
blind    B-Perturbation107428450
,    O
lepers    O
,    O
as    O
well    O
as    O
characters    O
from    O
Pansori    O
and    O
other    O
Korean    O
folklore    O
.    O

In    O
1994    O
Lapthisophon    O
suffered    O
a    O
major    O
deterioration    O
of    O
his    O
vision    O
because    O
of    O
an    O
optic    O
nerve    O
disease    O
,    O
and    O
became    O
legally    B-Perturbation107428450
blind    I-Perturbation107428450
after    O
intensive    O
medical    O
treatment    O
.    O

Reviewing    O
the    O
documentary    O
for    O
BBC    O
Radio    O
4    O
's    O
"    O
In    O
Touch    O
"    O
,    O
the    O
opera    O
singer    O
Denise    O
Leigh    O
,    O
who    O
is    O
herself    O
visually    B-Perturbation107428450
impaired    I-Perturbation107428450
was    O
generally    O
positive    O
about    O
it    O
.    O
"    O

Tom    O
(    O
Tim    O
Gebbels    O
)    O
,    O
actor    O
,    O
39    O
years    O
old    O
,    O
blind    B-Perturbation107428450

DTBook    O
was    O
developed    O
by    O
the    O
Daisy    O
Consortium    O
as    O
an    O
accessible    O
file    O
format    O
similar    O
to    O
HTML    O
,    O
with    O
special    O
regard    O
to    O
the    O
requirements    O
of    O
the    O
visually    B-Perturbation107428450
impaired    I-Perturbation107428450
.    O

The    O
winner    O
of    O
the    O
first    O
season    O
was    O
visually    B-Perturbation107428450
impaired    I-Perturbation107428450
singer    O
Bogdana    O
Petrova    O
.    O

A    O
weakness    O
of    O
the    O
eyes    O
,    O
ending    O
in    O
total    O
blindness    B-Perturbation107428450
,    O
occasioned    O
his    O
taking    O
up    O
the    O
studies    O
with    O
which    O
his    O
name    O
is    O
now    O
connected    O
.    O

Also    O
,    O
the    O
records    O
kept    O
by    O
the    O
Department    O
of    O
Social    O
Security    O
currently    O
show    O
that    O
there    O
are    O
at    O
least    O
51    O
persons    O
who    O
are    O
visually    B-Perturbation107428450
impaired    I-Perturbation107428450
.    O

Programs    O
and    O
services    O
are    O
specially    O
designed    O
to    O
achieve    O
therapeutic    O
benefits    O
for    O
youth    O
and    O
adults    O
,    O
ages    O
15    O
months    O
to    O
57    O
years    O
,    O
with    O
a    O
broad    O
spectrum    O
of    O
disabilities    O
,    O
including    O
but    O
not    O
limited    O
to    O
:    O
amputees    O
,    O
spinal    O
cord    O
injury    O
,    O
traumatic    O
brain    O
injury    O
,    O
cerebral    O
palsy    O
,    O
spina    O
bifida    O
,    O
brittle    O
bone    O
disease    O
,    O
autism    O
,    O
intellectual    O
disabilities    O
,    O
and    O
blindness    B-Perturbation107428450
.    O

Every    O
participant    O
at    O
the    O
Paralympics    O
has    O
their    O
disability    O
grouped    O
into    O
one    O
of    O
five    O
disability    O
categories    O
;    O
amputation    O
,    O
the    O
condition    O
may    O
be    O
congenital    O
or    O
sustained    O
through    O
injury    O
or    O
illness    O
;    O
cerebral    O
palsy    O
;    O
wheelchair    O
athletes    O
,    O
there    O
is    O
often    O
overlap    O
between    O
this    O
and    O
other    O
categories    O
;    O
visual    B-Perturbation107428450
impairment    I-Perturbation107428450
,    O
including    O
blindness    B-Perturbation107428450
;    O
Les    O
autres    O
,    O
any    O
physical    O
disability    O
that    O
does    O
not    O
fall    O
strictly    O
under    O
one    O
of    O
the    O
other    O
categories    O
,    O
for    O
example    O
dwarfism    O
or    O
multiple    O
sclerosis    O
.    O

An    O
Egyptian    O
papyrus    O
dating    O
to    O
the    O
Ramesside    O
era    O
called    O
"    O
"    O
The    O
wise    O
doctrine    O
of    O
Amenemope    O
,    O
son    O
of    O
Kanakht    O
"    O
"    O
(    O
papyrus    O
B.M.    O
10474    O
)    O
includes    O
appeals    O
to    O
not    O
treat    O
dwarfs    O
and    O
other    O
handicapped    O
people    O
(    O
such    O
as    O
blind    B-Perturbation107428450
people    I-Perturbation107428450
,    O
cripples    O
and    O
autists    O
)    O
badly    O
or    O
to    O
backbite    O
over    O
them    O
.    O

Under    O
the    O
personal    O
leadership    O
of    O
Shparo    O
,    O
blind    B-Perturbation107428450
,    O
deaf    O
,    O
amputees    O
and    O
quadriplegic    O
people    O
have    O
ascended    O
mountain    O
peaks    O
and    O
crossed    O
deserts    O
,    O
including    O
the    O
ice    O
ones    O
.    O

She    O
is    O
legally    B-Perturbation107428450
blind    I-Perturbation107428450
and    O
discovered    O
the    O
body    O
.    O

Esmeralda    O
,    O
the    O
Peñareal    O
's    O
baby    O
girl    O
,    O
was    O
born    O
blind    B-Perturbation107428450
,    O
but    O
the    O
kindness    O
of    O
her    O
heart    O
provides    O
her    O
the    O
light    O
to    O
be    O
happy    O
and    O
the    O
illusion    O
to    O
believe    O
that    O
someday    O
she    O
will    O
meet    O
love    O
.    O

British    O
researchers    O
successfully    O
cure    O
blindness    B-Perturbation107428450
in    O
mice    O
using    O
an    O
injection    O
of    O
photosensitive    O
cells    O
.    O

Blind    B-Perturbation107428450
cat    O
:    O
This    O
cat    O
is    O
introduced    O
in    O
the    O
Suburbs    O
world    O
.    O

It    O
does    O
not    O
chase    O
Mr.    O
Squeak    O
because    O
it    O
has    O
poor    B-Perturbation107428450
vision    I-Perturbation107428450
and    O
only    O
walks    O
in    O
its    O
drawn    O
path    O
.    O

Recovery    O
from    O
blindness    O
is    O
the    O
phenomenon    O
of    O
a    O
blind    B-Perturbation107428450
person    O
gaining    O
the    O
ability    O
to    O
see    O
,    O
usually    O
as    O
a    O
result    O
of    O
medical    O
treatment    O
.    O

In    O
a    O
poisoning    O
case    O
reported    O
in    O
1992    O
,    O
one    O
German    O
family    O
who    O
consumed    O
"    O
H.    O
nidulans    O
"    O
experienced    O
nausea    O
,    O
impaired    O
movement    O
,    O
visual    B-Perturbation107428450
impairment    I-Perturbation107428450
,    O
liver    O
and    O
kidney    O
failure    O
;    O
symptoms    O
began    O
about    O
12    O
hours    O
after    O
consuming    O
the    O
mushroom    O
.    O

Text    O
-    O
based    O
browsers    O
are    O
often    O
very    O
useful    O
for    O
users    O
with    O
visual    B-Perturbation107428450
impairment    I-Perturbation107428450
or    O
partial    O
blindness    B-Perturbation107428450
.    O

They    O
also    O
visit    O
Rico    O
Rodriguez    O
,    O
a    O
soldier    O
who    O
was    O
blinded    B-Perturbation107428450
,    O
lost    O
his    O
right    O
arm    O
and    O
leg    O
,    O
and    O
sustained    O
facial    O
burns    O
from    O
saving    O
Tommy    O
from    O
a    O
rocket    O
-    O
propelled    O
grenade    O
,    O
previously    O
during    O
the    O
ambush    O
in    O
Iraq    O
.    O

Cytomegalovirus    O
retinitis    O
,    O
also    O
known    O
as    O
CMV    O
retinitis    O
,    O
is    O
an    O
inflammation    O
of    O
the    O
retina    O
of    O
the    O
eye    O
that    O
can    O
lead    O
to    O
blindness    B-Perturbation107428450
.    O

Poikiloderma    B-Perturbation107428450

Side    O
-    O
effects    O
may    O
be    O
mild    O
such    O
as    O
itchiness    O
,    O
folliculitis    O
,    O
sunburn    O
,    O
poikiloderma    B-Perturbation107428450
,    O
and    O
a    O
theoretical    O
risk    O
of    O
nonmelanoma    O
skin    O
cancer    O
or    O
melanoma    O
has    O
been    O
suggested    O
.    O

Quadrichrome    B-Perturbation107428450
vitiligo    I-Perturbation107428450

Additionally    O
,    O
there    O
have    O
been    O
case    O
reports    O
of    O
fatal    O
lactic    B-Perturbation107428450
acidosis    I-Perturbation107428450
in    O
pregnant    O
women    O
receiving    O
combination    O
therapy    O
of    O
stavudine    O
and    O
didanosine    O
with    O
other    O
antiviral    O
agents    O
.    O

Lactic    B-Perturbation107428450
acidosis    I-Perturbation107428450

Serious    O
side    O
effects    O
include    O
liver    O
disease    O
,    O
lactic    B-Perturbation107428450
acidosis    I-Perturbation107428450
,    O
and    O
worsening    O
hepatitis    O
B    O
among    O
those    O
already    O
infected    O
.    O

More    O
severe    O
side    O
effects    O
include    O
hypersensitivity    O
,    O
liver    O
damage    O
,    O
and    O
lactic    B-Perturbation107428450
acidosis    I-Perturbation107428450
.    O
Genetic    O
testing    O
can    O
indicate    O
whether    O
a    O
person    O
is    O
at    O
higher    O
risk    O
of    O
developing    O
hypersensitivity    O
.    O

The    O
use    O
of    O
nucleoside    O
drugs    O
such    O
as    O
abacavir    O
can    O
very    O
rarely    O
cause    O
lactic    B-Perturbation107428450
acidosis    I-Perturbation107428450
.    O

Lactic    B-Perturbation107428450
acidosis    I-Perturbation107428450
,    O
due    O
to    O
anaerobic    O
metabolism    O
during    O
heavy    O
exercise    O
or    O
hypoxia    O

Biochemically    O
,    O
arsenic    O
prevents    O
use    O
of    O
thiamine    O
resulting    O
in    O
a    O
clinical    O
picture    O
resembling    O
thiamine    O
deficiency    O
.    O
Poisoning    O
with    O
arsenic    O
can    O
raise    O
lactate    O
levels    O
and    O
lead    O
to    O
lactic    B-Perturbation107428450
acidosis    I-Perturbation107428450
.    O

A    O
deficiency    O
of    O
pyruvate    O
carboxylase    O
can    O
cause    O
lactic    B-Perturbation107428450
acidosis    I-Perturbation107428450
as    O
a    O
result    O
of    O
lactate    O
build    O
up    O
.    O

The    O
authors    O
proposed    O
that    O
chronic    O
exposure    O
to    O
alpha    O
-    O
mangostin    O
,    O
a    O
xanthone    O
,    O
could    O
be    O
toxic    O
to    O
mitochondrial    O
function    O
,    O
leading    O
to    O
impairment    O
of    O
cellular    O
respiration    O
and    O
production    O
of    O
lactic    B-Perturbation107428450
acidosis    I-Perturbation107428450
.    O

GRACILE    O
is    O
an    O
acronym    O
for    O
growth    O
retardation    O
,    O
amino    O
aciduria    O
(    O
amino    O
acids    O
in    O
the    O
urine    O
)    O
,    O
cholestasis    O
,    O
iron    B-Perturbation107428450
overload    I-Perturbation107428450
,    O
lactic    B-Perturbation107428450
acidosis    I-Perturbation107428450
,    O
and    O
early    O
death    O
.    O

It    O
was    O
marketed    O
as    O
DBI    O
by    O
Ciba    O
-    O
Geigy    O
,    O
but    O
was    O
withdrawn    O
from    O
most    O
markets    O
in    O
the    O
late    O
1970s    O
due    O
to    O
a    O
high    O
risk    O
of    O
lactic    B-Perturbation107428450
acidosis    I-Perturbation107428450
,    O
which    O
was    O
fatal    O
in    O
50%    O
of    O
cases    O
.    O

Consequences    O
of    O
the    O
alcohol    O
induced    O
redox    O
changes    O
in    O
the    O
human    O
body    O
include    O
increased    O
triglyceride    O
production    O
,    O
increased    O
amino    O
acid    O
catabolism    O
,    O
inhibition    O
of    O
the    O
citric    O
acid    O
cycle    O
,    O
lactic    B-Perturbation107428450
acidosis    I-Perturbation107428450
,    O
ketoacidosis    O
,    O
hyperuricemia    O
,    O
disturbance    O
in    O
cortisol    O
and    O
androgen    O
metabolism    O
and    O
increased    O
fibrogenesis    O
.    O

Area    O
19    O
has    O
been    O
noted    O
to    O
receive    O
inputs    O
from    O
the    O
retina    O
via    O
the    O
superior    O
colliculus    O
and    O
pulvinar    O
,    O
and    O
may    O
contribute    O
to    O
the    O
phenomenon    O
of    O
blindsight    B-Perturbation107428450
.    O

Blindsight    B-Perturbation107428450

In    O
1999    O
,    O
Kentridge    O
and    O
his    O
collaborators    O
,    O
Heywood    O
and    O
Weiskrantz    O
,    O
were    O
the    O
first    O
to    O
demonstrate    O
that    O
a    O
patient    O
with    O
the    O
neurological    O
condition    O
blindsight    B-Perturbation107428450
was    O
capable    O
of    O
directing    O
his    O
attention    O
to    O
stimuli    O
that    O
he    O
could    O
not    O
see    O
.    O

Throughout    O
,    O
Crick    O
cites    O
various    O
experiments    O
which    O
illustrate    O
the    O
narrow    O
points    O
he    O
is    O
making    O
about    O
visual    O
awareness    O
,    O
such    O
as    O
studies    O
investigating    O
the    O
phenomenon    O
of    O
blindsight    B-Perturbation107428450
in    O
macaques    O
.    O

Blindsight    B-Perturbation107428450
-    O
when    O
a    O
blind    O
person    O
can    O
perceive    O
visual    O
stimuli    O
unconsciously    O
.    O

Piebaldism    B-Perturbation107428450

Piebaldism    B-Perturbation107428450
(    O
ILDS    O
E70.350    O
)    O

Piebaldism    B-Perturbation107428450

Activating    O
mutations    O
in    O
this    O
gene    O
are    O
associated    O
with    O
gastrointestinal    O
stromal    O
tumors    O
,    O
testicular    O
seminoma    O
,    O
mast    O
cell    O
disease    O
,    O
melanoma    O
,    O
acute    O
myeloid    O
leukemia    O
,    O
while    O
inactivating    O
mutations    O
are    O
associated    O
with    O
the    O
genetic    O
defect    O
piebaldism    B-Perturbation107428450
.    O

Phlebotomy    O
(    O
incision    O
into    O
a    O
vein    O
)    O
is    O
also    O
the    O
treatment    O
of    O
certain    O
diseases    O
such    O
as    O
hemochromatosis    B-Perturbation107428450
and    O
primary    O
and    O
secondary    O
polycythemia    O
.    O

Hemochromatosis    B-Perturbation107428450
(    O
excessive    O
iron    O
in    O
the    O
blood    O
)    O

Chronic    O
disorders    O
such    O
as    O
liver    O
disease    O
,    O
asthma    O
and    O
haemochromatosis    B-Perturbation107428450

Hemochromatosis    B-Perturbation107428450

Chapter    O
1    O
:    O
Hemochromatosis    B-Perturbation107428450
,    O
bloodletting    O
,    O
and    O
human    O
iron    O
consumption    O

In    O
1984    O
,    O
Steinbeck    O
was    O
diagnosed    O
with    O
hemochromatosis    B-Perturbation107428450
,    O
a    O
genetic    O
disease    O
that    O
causes    O
iron    O
retention    O
.    O

GRACILE    O
is    O
an    O
acronym    O
for    O
growth    O
retardation    O
,    O
amino    O
aciduria    O
(    O
amino    O
acids    O
in    O
the    O
urine    O
)    O
,    O
cholestasis    O
,    O
iron    B-Perturbation107428450
overload    I-Perturbation107428450
,    O
lactic    B-Perturbation107428450
acidosis    I-Perturbation107428450
,    O
and    O
early    O
death    O
.    O

Iron    B-Perturbation107428450
overload    I-Perturbation107428450
disorder    I-Perturbation107428450

Paige    O
was    O
diagnosed    O
with    O
HFE    B-Perturbation107428450
hereditary    I-Perturbation107428450
haemochromatosis    I-Perturbation107428450
in    O
1996    O
a    O
genetic    O
disorder    O
that    O
creates    O
iron    B-Perturbation107428450
overload    I-Perturbation107428450
in    O
the    O
body    O
.    O

As    O
such    O
,    O
these    O
effects    O
are    O
only    O
seen    O
in    O
patients    O
suffering    O
from    O
hemochromatosis    B-Perturbation107428450
,    O
an    O
iron    O
-    O
storage    O
disease    O
characterized    O
by    O
excessive    O
iron    O
saturation    O
in    O
transferrin    O
.    O

Haemochromatosis    B-Perturbation107428450

Erythrocytapheresis    O
–    O
removal    O
of    O
erythrocytes    O
(    O
red    O
blood    O
cells    O
)    O
in    O
people    O
with    O
iron    B-Perturbation107428450
overload    I-Perturbation107428450
as    O
a    O
result    O
of    O
Hereditary    B-Perturbation107428450
haemochromatosis    I-Perturbation107428450
or    O
transfusional    O
iron    O
overload    O

In    O
comparison    O
to    O
DCM    O
,    O
RCM    O
is    O
often    O
secondarily    O
caused    O
by    O
other    O
diseases    O
such    O
as    O
amyloidosis    O
,    O
scleroderma    O
,    O
hemachromatosis    B-Perturbation107428450
(    O
iron    O
overload    O
)    O
and    O
eosinophilic    O
granulomatosis    O
with    O
polyangiitis    O
.    O

Other    O
causes    O
of    O
chronic    O
liver    O
disease    O
are    O
genetic    O
or    O
autoimmune    O
disease    O
,    O
such    O
as    O
hemochromatosis    B-Perturbation107428450
,    O
Wilson    O
's    O
disease    O
,    O
autoimmune    O
hepatitis    O
,    O
and    O
primary    O
biliary    O
cirrhosis    O
.    O

Other    O
zonal    O
injury    O
patterns    O
include    O
zone    O
I    O
deposition    O
of    O
hemosiderin    O
in    O
hemochromatosis    B-Perturbation107428450
and    O
zone    O
II    O
necrosis    O
in    O
yellow    O
fever    O
.    O

There    O
are    O
a    O
few    O
disorders    O
that    O
are    O
known    O
to    O
cause    O
cirrhosis    O
and    O
lead    O
to    O
cancer    O
,    O
including    O
hereditary    O
hemochromatosis    B-Perturbation107428450
and    O
primary    O
biliary    O
cirrhosis    O
.    O

Diet    O
control    O
in    O
hemochromatosis    B-Perturbation107428450
could    O
decrease    O
the    O
risk    O
of    O
iron    B-Perturbation107428450
overload    I-Perturbation107428450
,    O
decreasing    O
the    O
risk    O
of    O
cancer    O
.    O

It    O
is    O
specifically    O
used    O
in    O
iron    O
overdose    O
,    O
hemochromatosis    B-Perturbation107428450
either    O
due    O
to    O
multiple    O
blood    O
transfusions    O
or    O
an    O
underlying    O
genetic    O
condition    O
,    O
and    O
aluminium    O
toxicity    O
in    O
people    O
on    O
dialysis    O
.    O

This    O
agent    O
is    O
also    O
frequently    O
used    O
to    O
treat    O
hemochromatosis    B-Perturbation107428450
,    O
a    O
disease    O
of    O
iron    O
accumulation    O
that    O
can    O
be    O
either    O
genetic    O
or    O
acquired    O
.    O

A    O
dilute    O
black    O
(    O
BB    O
or    O
Bb    O
)    O
dog    O
is    O
generally    O
known    O
as    O
blue    O
,    O
but    O
a    O
dog    O
with    O
a    O
merle    O
coat    O
does    O
not    O
test    O
BB    O
or    O
Bb    O
but    O
still    O
is    O
a    O
blue    O
dilute    O
from    O
the    O
"    O
merle    O
"    O
gene    O
The    O
merle    O
gene    O
creates    O
mottled    O
patches    O
of    O
color    O
in    O
a    O
solid    O
or    O
piebald    O
coat    O
,    O
blue    O
or    O
odd-colored    B-Perturbation107428450
eyes    I-Perturbation107428450
,    O
and    O
can    O
affect    O
skin    O
pigment    O
as    O
well    O
.    O

Since    O
merle    O
causes    O
random    O
modifications    O
,    O
however    O
,    O
both    O
dark    O
-    O
eyed    O
,    O
blue    O
-    O
eyed    O
,    O
and    O
odd-colored    B-Perturbation107428450
eyes    I-Perturbation107428450
are    O
possible    O
.    O

Heterochromia    B-Perturbation107428450
iridis    I-Perturbation107428450

Alaskan    O
Klee    O
Kai    O
with    O
Heterochromia    B-Perturbation107428450
.    O

Lady    O
has    O
black    O
hair    O
,    O
eyes    B-Perturbation107428450
of    I-Perturbation107428450
different    I-Perturbation107428450
colors    I-Perturbation107428450
and    O
a    O
signature    O
weapon    O
,    O
the    O
Kalina    O
-    O
Ann    O
(    O
a    O
customized    O
missile    O
launcher    O
,    O
similar    O
to    O
MANPADS    O
)    O
.    O

He    O
is    O
of    O
Japanese    O
descent    O
,    O
has    O
black    O
hair    O
with    O
red    O
streaks    O
at    O
the    O
end    O
,    O
has    O
heterochromia    B-Perturbation107428450
,    O
his    O
left    O
eye    O
is    O
green    O
and    O
his    O
right    O
eye    O
is    O
violet    O
.    O

Eye    O
colour    O
varies    O
from    O
brown    O
to    O
blue    O
,    O
and    O
occasionally    O
eyes    B-Perturbation107428450
of    I-Perturbation107428450
differing    I-Perturbation107428450
colour    I-Perturbation107428450
occur    O
;    O
this    O
is    O
usually    O
seen    O
with    O
merles    O
.    O

Blue    O
Merle    O
Border    O
Collie    O
puppy    O
at    O
fourteen    O
weeks    O
demonstrating    O
species    O
-    O
typical    O
behaviours    O
including    O
"    O
eye    O
"    O
(    O
gaze    O
and    O
lowered    O
stance    O
)    O
;    O
this    O
dog    O
's    O
eyes    B-Perturbation107428450
are    I-Perturbation107428450
different    I-Perturbation107428450
colours    I-Perturbation107428450
,    O
which    O
is    O
not    O
uncommon    O
in    O
merles    O
.    O

>    O
5–15%    O
:    O
blurred    O
vision    O
,    O
burning    O
and    O
stinging    O
,    O
conjunctival    O
hyperemia    O
,    O
foreign    O
body    O
sensation    O
,    O
itching    O
,    O
increased    O
(    O
brown    O
)    O
pigmentation    O
of    O
the    O
iris    O
causing    O
(    O
heterochromia    B-Perturbation107428450
)    O
,    O
lengthening    O
and    O
thickening    O
of    O
the    O
eyelashes    O
(    O
used    O
,    O
like    O
bimatoprost    O
,    O
in    O
the    O
cosmetic    O
industry    O
as    O
eyelash    O
growth    O
enhancers    O
)    O
,    O
punctate    O
epithelial    O
keratopathy    O

Other    O
ocular    O
abnormalities    O
include    O
ophthalmoplegia    O
(    O
paralysis    O
of    O
one    O
or    O
more    O
of    O
the    O
extraocular    O
muscles    O
)    O
and    O
other    O
types    O
of    O
strabismus    O
,    O
uveitis    O
,    O
and    O
heterochromia    B-Perturbation107428450
of    O
the    O
iris    O
.    O

is    O
a    O
half    O
-    O
demon    O
and    O
half    O
-    O
human    O
girl    O
with    O
heterochromia    B-Perturbation107428450
.    O

One    O
of    O
the    O
most    O
distinguishing    O
characteristics    O
of    O
Frankie    O
is    O
that    O
she    O
has    O
heterochromia    B-Perturbation107428450
her    O
right    O
eye    O
is    O
blue    O
whilst    O
her    O
left    O
eye    O
is    O
green    O
.    O

Their    O
eyes    O
are    O
typically    O
pale    O
blue    O
,    O
although    O
they    O
may    O
also    O
be    O
brown    O
,    O
green    O
,    O
blue    O
,    O
yellow    O
,    O
or    O
heterochromic    B-Perturbation107428450
.    O

He    O
has    O
a    O
condition    O
called    O
heterochromia    B-Perturbation107428450
,    O
meaning    O
his    O
eyes    O
are    O
two    O
different    O
colors    O
;    O
his    O
left    O
eye    O
is    O
green    O
,    O
while    O
his    O
right    O
eye    O
is    O
blue    O
.    O

The    O
contract    O
to    O
Griffith    O
's    O
Triangle    O
-    O
Fine    O
Arts    O
was    O
conditional    O
on    O
passing    O
a    O
film    O
test    O
to    O
ensure    O
that    O
her    O
heterochromia    B-Perturbation107428450
(    O
she    O
had    O
one    O
brown    O
eye    O
,    O
one    O
blue    O
eye    O
)    O
would    O
not    O
be    O
a    O
distraction    O
in    O
close    O
-    O
up    O
shots    O
.    O

He    O
has    O
complete    B-Perturbation107428450
heterochromia    I-Perturbation107428450
,    O
from    O
which    O
one    O
of    O
his    O
eyes    O
is    O
blue    O
,    O
and    O
the    O
other    O
green    O
.    O

Heterochromia    B-Perturbation107428450
iridum    I-Perturbation107428450

Other    O
cast    O
members    O
include    O
Annabelle    O
Wallis    O
as    O
Amy    O
,    O
a    O
young    O
woman    O
with    O
heterochromia    B-Perturbation107428450
;    O
Don    O
Creech    O
as    O
CIA    O
Agent    O
Stryker    O
,    O
father    O
of    O
Major    O
William    O
Stryker    O
(    O
a    O
character    O
who    O
appears    O
in    O
"    O
X2    O
"    O
,    O
"    O
X    O
-    O
Men    O
Origins    O
:    O
Wolverine    O
"    O
,    O
"    O
X    O
-    O
Men    O
:    O
Days    O
of    O
Future    O
Past    O
"    O
,    O
and    O
"    O
X    O
-    O
Men    O
:    O
Apocalypse    O
"    O
)    O
;    O
Michael    O
Ironside    O
;    O
Ray    O
Wise    O
;    O
James    O
Remar    O
;    O
Brendan    O
Fehr    O
;    O
and    O
Aleksander    O
Krupa    O
also    O
portrayed    O
small    O
roles    O
in    O
this    O
film    O
.    O

Zima    O
is    O
also    O
notable    O
for    O
her    O
two    B-Perturbation107428450
different    I-Perturbation107428450
eye    I-Perturbation107428450
colors    I-Perturbation107428450
,    O
her    O
right    O
eye    O
being    O
brown    O
and    O
the    O
left    O
one    O
being    O
hazel    O
.    O

Postinflammatory    B-Perturbation107428450
hypopigmentation    I-Perturbation107428450
is    O
a    O
cutaneous    O
condition    O
characterized    O
by    O
decreased    O
pigment    O
in    O
the    O
skin    O
following    O
inflammation    O
of    O
the    O
skin    O
.    O

Nevus    B-Perturbation107428450
depigmentosus    I-Perturbation107428450

Titanium    B-Perturbation107428450
metallic    I-Perturbation107428450
discoloration    I-Perturbation107428450
has    O
been    O
reported    O
to    O
have    O
occurred    O
with    O
titanium    O
-    O
containing    O
ointment    O
causing    O
papules    O
on    O
the    O
penis    O
of    O
a    O
patient    O
.    O

Tietz    B-Perturbation107428450
syndrome    I-Perturbation107428450

Haemochromatosis    B-Perturbation107428450
(    O
or    O
hemochromatosis    B-Perturbation107428450
)    O
type    B-Perturbation107428450
1    I-Perturbation107428450
(    O
also    O
HFE    B-Perturbation107428450
hereditary    I-Perturbation107428450
haemochromatosis    I-Perturbation107428450
or    O
HFE-related    B-Perturbation107428450
hereditary    I-Perturbation107428450
haemochromatosis    I-Perturbation107428450
)    O
is    O
a    O
hereditary    O
disease    O
characterized    O
by    O
excessive    O
intestinal    O
absorption    O
of    O
dietary    O
iron    O
resulting    O
in    O
a    O
pathological    O
increase    O
in    O
total    O
body    O
iron    O
stores    O
.    O

The    O
condition    O
is    O
sometimes    O
confused    O
with    O
juvenile    O
hemochromatosis    O
,    O
which    O
is    O
a    O
hereditary    B-Perturbation107428450
hemochromatosis    I-Perturbation107428450
caused    O
by    O
mutations    O
of    O
a    O
gene    O
called    O
hemojuvelin    O
.    O

Paige    O
was    O
diagnosed    O
with    O
HFE    B-Perturbation107428450
hereditary    I-Perturbation107428450
haemochromatosis    I-Perturbation107428450
in    O
1996    O
a    O
genetic    O
disorder    O
that    O
creates    O
iron    B-Perturbation107428450
overload    I-Perturbation107428450
in    O
the    O
body    O
.    O

Erythrocytapheresis    O
–    O
removal    O
of    O
erythrocytes    O
(    O
red    O
blood    O
cells    O
)    O
in    O
people    O
with    O
iron    B-Perturbation107428450
overload    I-Perturbation107428450
as    O
a    O
result    O
of    O
Hereditary    B-Perturbation107428450
haemochromatosis    I-Perturbation107428450
or    O
transfusional    O
iron    O
overload    O

A    O
system    O
of    O
geometrically    O
shaped    O
code    O
signs    O
known    O
as    O
Coloradd    B-Perturbation107428450
was    O
developed    O
by    O
Professor    O
Miguel    O
Neiva    O
of    O
the    O
University    O
of    O
Minho    O
,    O
Portugal    O
in    O
2010    O
to    O
indicate    O
colours    O
to    O
people    O
who    O
have    O
difficulty    O
discerning    O
them    O
.    O

Intramuscular    O
administration    O
of    O
hydroxocobalamin    O
is    O
also    O
the    O
preferred    O
treatment    O
for    O
pediatric    O
patients    O
with    O
intrinsic    O
cobalamin    O
metabolic    O
diseases    O
,    O
for    O
vitamin    O
B12    O
deficient    O
patients    O
with    O
tobacco    B-Perturbation107428450
amblyopia    I-Perturbation107428450
(    O
which    O
is    O
thought    O
to    O
perhaps    O
have    O
a    O
component    O
of    O
cyanide    O
poisoning    O
from    O
cyanide    O
in    O
cigarette    O
smoke    O
)    O
;    O
and    O
for    O
treatment    O
of    O
patients    O
with    O
pernicious    O
anemia    O
who    O
have    O
optic    O
neuropathy    O
.    O

Griscelli    B-Perturbation107428450
syndrome    I-Perturbation107428450

Griscelli    B-Perturbation107428450
syndrome    I-Perturbation107428450

Hypomagnesemia    O
is    O
not    O
necessarily    O
magnesium    B-Perturbation107428450
deficiency    I-Perturbation107428450
.    O

Hypomagnesemia    O
can    O
be    O
present    O
without    O
magnesium    B-Perturbation107428450
deficiency    I-Perturbation107428450
and    O
vice    O
versa    O
.    O

Magnesium    B-Perturbation107428450
deficiency    I-Perturbation107428450
(medicine)    I-Perturbation107428450

Congenital    B-Perturbation107428450
achromatopsia    I-Perturbation107428450
is    O
characterized    O
the    O
same    O
way    O
,    O
however    O
it    O
is    O
genetic    O
,    O
while    O
Cerebral    O
Achromatopsia    O
occurs    O
as    O
a    O
result    O
of    O
damage    O
to    O
certain    O
parts    O
of    O
the    O
brain    O
.    O

(    O
H53.5    O
)    O
Achromatopsia    B-Perturbation107428450
/    O
Maskun    O
—    O
a    O
low    O
cone    O
count    O
or    O
lack    O
of    O
function    O
in    O
cone    O
cells    O

C.    O
A.    O
Pallis    O
described    O
a    O
patient    O
,    O
A.H.    O
,    O
who    O
presented    O
with    O
color    B-Perturbation107428450
,    O
face    B-Perturbation107428450
and    O
landmark    O
agnosia    O
as    O
a    O
result    O
of    O
a    O
cerebral    O
embolism    O
.    O

This    O
was    O
further    O
supported    O
from    O
lesion    O
studies    O
where    O
individuals    O
were    O
unable    O
to    O
see    O
colours    O
after    O
damage    O
,    O
a    O
disorder    O
known    O
as    O
achromatopsia    B-Perturbation107428450
.    O

The    O
company    O
's    O
technologies    O
are    O
aimed    O
at    O
products    O
that    O
might    O
have    O
the    O
potential    O
to    O
treat    O
achromatopsia    B-Perturbation107428450
,    O
X    O
-    O
linked    O
retinoschisis    O
,    O
X    O
-    O
linked    O
retinitis    B-Perturbation107428450
pigmentosa    I-Perturbation107428450
,    O
and    O
age    O
-    O
related    O
macular    O
degeneration    O
.    O

Achromatopsia    B-Perturbation107428450

Pigmented    O
purpuric    O
dermatosis    O
(    O
also    O
known    O
as    O
"    O
progressive    O
pigmentary    O
dermatosis    O
,    O
"    O
"    O
purpura    O
pigmentosa    O
chronica    O
,    O
"    O
"    O
pigmentary    O
purpuric    O
eruptions    O
,    O
"    O
or    O
"    O
progressive    O
pigmenting    O
purpura    O
"    O
or    O
"Schamberg's    B-Perturbation107428450
disease"    I-Perturbation107428450
)    O
refers    O
to    O
one    O
of    O
the    O
three    O
major    O
classes    O
of    O
skin    O
conditions    O
characterized    O
by    O
purpuric    O
skin    O
eruptions    O
.    O

:*    O
Schamberg's    B-Perturbation107428450
disease    I-Perturbation107428450

"    O
Dewey    O
"    O
.    O
Leicester    O
:    O
Ulverscroft    O
,    O
2009    O
.    O
Large-print    B-Perturbation107428450
ed    O
.    O
.    O

For    O
example    O
,    O
the    O
school    O
may    O
accommodate    O
a    O
student    O
with    O
visual    O
impairments    O
by    O
providing    O
a    O
large-print    B-Perturbation107428450
textbook    O
.    O

Large    B-Perturbation107428450
font    I-Perturbation107428450
books    O

1987    O
,    O
Ulverscroft    O
Large-print    B-Perturbation107428450
Edition    O
,    O
Hardcover    O
,    O

The    O
Central    O
Library    O
for    O
the    O
Blind    O
,    O
Visually    O
Impaired    O
and    O
Handicapped    O
(    O
Israel    O
)    O
(    O
Hebrew    O
:    O
הספרייה    O
המרכזית    O
לעיוורים    O
,    O
כבדי    O
ראיה    O
ומוגבלים    O
)    O
supplies    O
people    O
who    O
can    O
not    O
read    O
books    O
,    O
for    O
various    O
disabilities    O
,    O
with    O
books    O
which    O
are    O
suitable    O
for    O
them    O
,    O
either    O
in    O
Braille    O
,    O
large    B-Perturbation107428450
print    I-Perturbation107428450
,    O
or    O
recorded    O
formats    O
.    O

The    O
company    O
has    O
a    O
particular    O
interest    O
in    O
producing    O
texts    O
for    O
visually    B-Perturbation107428450
impaired    I-Perturbation107428450
people    O
,    O
including    O
large    B-Perturbation107428450
print    I-Perturbation107428450
books    O
in    O
Italian    O
,    O
English    O
and    O
French    O
.    O

1971    O
,    O
Ulverscroft    O
Large-print    B-Perturbation107428450
Edition    O
,    O
Hardcover    O
,    O
362    O
pp    O

1965    O
,    O
Ulverscroft    O
Large-print    B-Perturbation107428450
Edition    O
,    O
Hardcover    O
,    O
253    O
pp    O
.    O

It    O
has    O
been    O
published    O
in    O
hardcover    O
,    O
audiobook    O
,    O
ebook    O
,    O
and    O
large-print    B-Perturbation107428450
editions    O
.    O

On    O
May    O
4    O
,    O
Thorndike    O
Press    O
published    O
a    O
large-print    B-Perturbation107428450
edition    O
in    O
hardcover    O
.    O

1969    O
,    O
Ulverscroft    O
Large-print    B-Perturbation107428450
Edition    O
,    O
Hardcover    O
,    O
343    O
pp    O
,    O

The    O
church    O
building    O
has    O
wheelchair    O
-    O
accessible    O
toilets    O
,    O
baby    O
-    O
changing    O
facilities    O
,    O
an    O
Audio    O
induction    O
loop    O
,    O
large-print    B-Perturbation107428450
hymn    O
books    O
,    O
and    O
guide    O
dogs    O
are    O
welcome    O
.    O

1973    O
,    O
Ulverscroft    O
Large-print    B-Perturbation107428450
Edition    O
,    O
Hardcover    O
,    O
322    O
p.    O

Peutz-Jeghers    B-Perturbation107428450
syndrome    I-Perturbation107428450
—    O
an    O
autosomal    O
dominant    O
disorder    O
characterized    O
by    O
hyperpigmented    O
macules    O
on    O
the    O
lips    O
and    O
oral    O
mucosa    O
and    O
gastrointestinal    O
polyps    O
.    O

Peutz-Jeghers    B-Perturbation107428450
syndrome    I-Perturbation107428450

"    O
Peutz-Jeghers    B-Perturbation107428450
syndrome    I-Perturbation107428450
"    O
is    O
associated    O
with    O
polyps    O
of    O
the    O
GI    O
tract    O
and    O
also    O
increased    O
pigmentation    O
around    O
the    O
lips    O
,    O
genitalia    O
,    O
buccal    O
mucosa    O
feet    O
and    O
hands    O
.    O

File    O
:    O
Peutz    O
-    O
Jeghers    O
syndrome    O
polyp.jpg|Micrograph    O
of    O
a    O
Peutz-Jeghers    B-Perturbation107428450
colonic    I-Perturbation107428450
polyp    I-Perturbation107428450
-    O
a    O
type    O
of    O
hamartomatous    O
polyp    O
.    O
H&E    O
stain    O
.    O

Peutz–Jeghers    B-Perturbation107428450
syndrome    I-Perturbation107428450
can    O
cause    O
dark    O
spots    O
on    O
the    O
oral    O
mucosa    O
or    O
on    O
the    O
lips    O
or    O
the    O
skin    O
around    O
the    O
mouth    O
.    O

Lycopenemia    B-Perturbation107428450

Selective    O
bred    O
varieties    O
most    O
commonly    O
available    O
in    O
the    O
aquarium    O
trade    O
are    O
opaline    O
(    O
with    O
a    O
marbled    O
pattern    O
)    O
,    O
platinum    O
(    O
whitish    O
)    O
,    O
blue    O
and    O
golden    O
(    O
xanthochromistic    B-Perturbation107428450
)    O
.    O

Lutino    O
is    O
a    O
term    O
used    O
to    O
describe    O
birds    O
that    O
exhibit    O
a    O
yellow    O
pigmentation    O
known    O
as    O
xanthochromism    B-Perturbation107428450
.    O

Xanthochromism    B-Perturbation107428450

But    O
,    O
in    O
patients    O
with    O
severe    O
endogenous    O
or    O
exogenous    O
hypertriglyceridemia    O
and    O
in    O
patients    O
with    O
high    O
plasma    O
protein    O
concentration    O
(    O
usually    O
due    O
to    O
paraproteinemia    O
)    O
,    O
water    O
portion    O
of    O
plasma    O
is    O
replaced    O
with    O
either    O
lipid    O
or    O
protein    O
causing    O
falsely    O
low    O
electrolyte    O
value    O
(    O
pseudohyponatremia    B-Perturbation107428450
)    O
.    O

Achromatopsic    O
artist    O
Neil    O
Harbisson    O
was    O
the    O
first    O
to    O
use    O
such    O
a    O
device    O
in    O
early    O
2004    O
,    O
the    O
eyeborg    B-Perturbation107428450
allowed    O
him    O
to    O
start    O
painting    O
in    O
color    O
by    O
memorizing    O
the    O
sound    O
of    O
each    O
color    O
.    O

Revesz    B-Perturbation107428450
syndrome    I-Perturbation107428450

Between    O
this    O
condition    O
and    O
NF-1    O
an    O
important    O
difference    O
is    O
the    O
absence    O
of    O
tumor    O
growths    O
(    O
Lisch    B-Perturbation107428450
nodules    I-Perturbation107428450
and    O
neurofibromas    O
which    O
are    O
common    O
in    O
NF-1    O
)    O
in    O
LS    O
.    O

The    O
U.S.    O
FDA    O
recommends    O
that    O
silver    O
acetate    O
intake    O
be    O
limited    O
to    O
756    O
mg    O
over    O
a    O
short    O
period    O
of    O
time    O
;    O
excessive    O
intake    O
may    O
cause    O
argyria    B-Perturbation107428450
.    O

Upper    O
-    O
class    O
families    O
who    O
used    O
silver    O
eating    O
utensils    O
every    O
day    O
gradually    O
ingested    O
small    O
pieces    O
of    O
silver    O
into    O
their    O
bodies    O
and    O
eventually    O
developed    O
a    O
mild    O
form    O
of    O
a    O
condition    O
called    O
Argyria    B-Perturbation107428450
,    O
in    O
which    O
the    O
skin    O
takes    O
on    O
a    O
blue    O
-    O
gray    O
color    O
,    O
thus    O
becoming    O
known    O
as    O
"    O
bluebloods    O
"    O
.    O

He    O
meets    O
a    O
man    O
known    O
simply    O
as    O
"    O
the    O
Blue    O
Man    O
"    O
who    O
suffered    O
from    O
argyria    B-Perturbation107428450
caused    O
by    O
silver    O
nitrate    O
poisoning    O
and    O
worked    O
at    O
Ruby    O
Pier    O
's    O
sideshow    O
(    O
while    O
it    O
was    O
still    O
open    O
,    O
during    O
the    O
days    O
of    O
Eddie    O
's    O
childhood    O
)    O
and    O
whose    O
real    O
name    O
is    O
Joseph    O
Corvelzchik    O
.    O

Treated    O
as    O
a    O
child    O
with    O
silver    O
nitrate    O
tincture    O
for    O
frequent    O
bronchitis    O
and    O
severe    O
sinus    O
infections    O
,    O
Walton    O
,    O
who    O
had    O
extremely    O
fair    O
skin    O
,    O
absorbed    O
the    O
pigment    O
of    O
the    O
tincture    O
causing    O
her    O
skin    O
to    O
turn    B-Perturbation107428450
gray    I-Perturbation107428450
and    O
darken    O
as    O
she    O
aged    O
.    O

Other    O
adverse    O
complications    O
included    O
five    O
reported    O
cases    O
of    O
spinal    O
cord    O
injuries    O
(    O
e.g.    O
migrating    O
broken    O
needles    O
or    O
needling    O
too    O
deeply    O
)    O
,    O
four    O
brain    O
injuries    O
,    O
four    O
peripheral    O
nerve    O
injuries    O
,    O
five    O
heart    O
injuries    O
,    O
seven    O
other    O
organ    O
and    O
tissue    O
injuries    O
,    O
bilateral    O
hand    O
edema    O
,    O
epithelioid    O
granuloma    O
,    O
pseudolymphoma    O
,    O
argyria    B-Perturbation107428450
,    O
pustules    O
,    O
pancytopenia    O
,    O
and    O
scarring    O
due    O
to    O
hot    O
-    O
needle    O
technique    O
.    O

Mohini    O
was    O
checked    O
for    O
Chédiak-Higashi    B-Perturbation107428450
syndrome    I-Perturbation107428450
in    O
1960    O
,    O
but    O
the    O
results    O
were    O
inconclusive    O
.    O

Chédiak-Steinbrinck-Higashi’s    B-Perturbation107428450
syndrome    I-Perturbation107428450

Chédiak–Higashi    B-Perturbation107428450
syndrome    I-Perturbation107428450

Lysosomal    O
trafficking    O
regulator    O
is    O
a    O
vesicular    O
transport    O
protein    O
associated    O
with    O
Chédiak-Higashi    B-Perturbation107428450
syndrome    I-Perturbation107428450
.    O

#    O
exercise-associated    B-Perturbation107428450
hyponatremia    I-Perturbation107428450
or    O
other    O
electrolyte    O
imbalance    O
;    O

Woronoff's    B-Perturbation107428450
ring    I-Perturbation107428450

The    O
impact    O
of    O
the    O
Stewart    O
analysis    O
has    O
been    O
slow    O
in    O
coming    O
but    O
there    O
has    O
been    O
a    O
recent    O
resurgence    O
in    O
interest    O
,    O
particularly    O
as    O
this    O
approach    O
provides    O
explanations    O
for    O
several    O
areas    O
which    O
are    O
otherwise    O
difficult    O
to    O
understand    O
(    O
"    O
e.g.    O
"    O
,    O
dilutional    O
acidosis    O
,    O
acid-base    B-Perturbation107428450
disorder    I-Perturbation107428450
related    O
to    O
changes    O
in    O
plasma    O
albumin    O
concentration    O
)    O
.    O

base    O
homeostasis    O
,    O
and    O
is    O
key    O
to    O
understanding    O
disorders    O
such    O
as    O
acid–base    B-Perturbation107428450
imbalance    I-Perturbation107428450
.    O

An    O
afterimage    O
may    O
be    O
a    O
normal    O
phenomenon    O
(    O
physiological    O
afterimage    O
)    O
or    O
may    O
be    O
pathological    O
(    O
palinopsia    B-Perturbation107428450
)    O
.    O

Palinopsia    B-Perturbation107428450

Galli–Galli    B-Perturbation107428450
disease    I-Perturbation107428450
is    O
a    O
rare    O
inherited    O
condition    O
that    O
has    O
close    O
resemblance    O
clinically    O
to    O
Dowling-Degos'    B-Perturbation107428450
disease    I-Perturbation107428450
,    O
but    O
is    O
histologically    O
distinct    O
,    O
characterized    O
by    O
skin    O
lesions    O
that    O
are    O
1-    O
to    O
2-mm    O
slightly    O
keratotic    O
red    O
to    O
dark    O
brown    O
papules    O
which    O
are    O
focally    O
confluent    O
in    O
a    O
reticulate    O
pattern    O
.    O

••    O
Yemenite    B-Perturbation107428450
deaf-blind    I-Perturbation107428450
hypopigmentation    I-Perturbation107428450
syndrome    I-Perturbation107428450
(    O
1990    O
)    O

Hypokalemic    B-Perturbation107428450
acidosis    I-Perturbation107428450

Visual    B-Perturbation107428450
disturbances    I-Perturbation107428450

Bella    O
Alexandrovna    O
Nisan    O
is    O
a    O
Russian    O
ophthalmologist    O
,    O
founder    O
of    O
modern    O
methods    O
of    O
vision    B-Perturbation107428450
disorder    I-Perturbation107428450
correction    I-Perturbation107428450
.    O

Types    O
of    O
incomitant    O
strabismus    O
include    O
:    O
Duane    O
syndrome    O
,    O
horizontal    B-Perturbation107428450
gaze    I-Perturbation107428450
palsy    I-Perturbation107428450
,    O
and    O
congenital    O
fibrosis    O
of    O
the    O
extraocular    O
muscles    O
.    O

Binasal    B-Perturbation107428450
hemianopsia    I-Perturbation107428450

Poikiloderma    B-Perturbation107428450
vasculare    I-Perturbation107428450
atrophicans    I-Perturbation107428450
,    O
a    O
skin    O
disease    O

Poikiloderma    B-Perturbation107428450
vasculare    I-Perturbation107428450
atrophicans    I-Perturbation107428450

Shiitake    B-Perturbation107428450
mushroom    I-Perturbation107428450
dermatitis    I-Perturbation107428450
(    O
flagellate    O
mushroom    O
dermatitis    O
,    O
mushroom    O
worker    O
's    O
disease    O
,    O
shiitake    O
-    O
induced    O
toxicoderma    O
)    O


